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Abstract 
Irrational use of drugs is considered as the main health resource wasted. WHO encouraged 
countries to implement drug promoting programs for appropriate use of drugs which could 
save up to (5%) of countries health expenditure. 
The overall aim of the study is assessing the drug use at the NGHs in the GG based on the 
recommended WHO core prescribing indicators, assessing the prescribing writing skills and 
assessing the knowledge, attitude and practice of the NGHs physicians toward local formulary. 
The design of this study is a cross section: quantitative analytical design. The quantitative data 
were collected using 3 tools: First tool was a well-structured questionnaire which was used to 
collect data on physicians‘ knowledge, attitude and practice toward local formulary. The other 
tools are three checklists that were used to collect data on Physicians‘ compliance with WHO 
core prescribing indicators and prescribing writing skills. Finally, the last tool is developed key 
drugs list based on drug list in the MOH hospitals and included recommended WHO key 
drugs. In total, 198 questionnaires were collected. 1130 checklist was used to extract data from 
the in-patient medication sheets (admitted cases); 898 checklists were used to extract data from 
discharge sheet; and 998 checklists were used to extract data from the out-patient reports. 
Analysis of data was conducted using SPSS program; the analysis involved conducting 
frequency distributions, mean percentages, one-way Anova and Chi square test. 
Findings of the study have showed that there is a positive attitude among physicians about the 
local formulary and its benefits. The majority of the study participants agreed on the 
importance and necessity of local formulary for: provision of quality health services; reduction 
of wasting in financial resources; reducing patient harm; and on the fact that the listed drugs in 
the local formulary are selected on scientific bases. Also, a positive practice orientation toward 
prescribing drugs from local formulary had been shown. The majority of the study participants 
didn‘t communicate with hospital pharmacists properly. There was a negative perception 
toward hospital management efforts. Provision of treatment protocols was neglected. On the 
other hand, Polypharmacy prevalence was (2.5) and highest prescribed therapeutic drug groups 
were analgesic (38.9%) and antibiotics (33.9%). More than two thirds of encounters with 
antibiotic (67.9%) and one third of encounters with injection (30.2%). Very low percentage in 
using generic name of drugs (3.3%). The majority of the drugs prescribed from the local 
formularies (88.7%). The average drug costs per encounter in the NGHs was (10.9$). Less 
than half of the drug costs in the NGHs spent on antibiotics. Regarding prescription writing 
skills, prescribers showed good compliance in writing prescriber‘s information while poor 
compliance occurred in patient‘s information and prescriptions information. Percent of the 
availability of key drugs in the stock in NGHs range from (70.8%) to (100%). 
There is a need to develop approved local formulary and treatment protocols in each hospital, 
implement a continuous education and training programs concerning local formulary and 
treatment protocols; to disseminate printed and softcopies copies of the hospital local 
formulary; to activate the monitoring and computerized system to improve physicians‘ drug 
prescribing pattern. There is a need to conduct more research studies (qualitative and 
quantitative studies) to compare patient care indicators in the governmental hospital and NGHs 
in the GG.  
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1 Chapter One 
Introduction  
1.1 Background 
Rational Use of Drugs (RUD) concept concerns with drug therapy part from the overall 
medical intervention. RUD is considered as a main stone to evaluate the quality of health 
care for any health care system. RUD or it can call as Rational Use of Medicines (RUM) 
defined as Patients receive medications appropriate to their clinical needs, in doses that 
meet their own individual requirements, for an adequate period of time, and at the lowest 
cost to them and their community (Adogu, Okechukwu, Egenti et al., 2015). 
Irrational use of drugs is a global phenomenon. More than 50% of all drugs worldwide are 
prescribed, dispensed or sold inappropriately, while 50% failed to take them correctly 
(Desalegn, 2012). Moreover, about one-third of the world‘s population lacks access to 
essential drugs. Across developing countries, spending on drugs accounts for 20-60% of 
cumulative healthcare expenditure, with upwards of 90% of the population purchasing 
medicines directly out of pocket (WHO, 2015). Also, irrational use of drugs is considered 
as wasting of resources which lead to reduce the capability of providing other vital drugs, 
beside all this facts about economic consequences of using drugs irrationally, the irrational 
use of drugs have public health consequences as: antibiotic resistance, due to widespread 
overuse of antibiotics, as well as their use in under-therapeutic dosage, risk of infection due 
to improper use of injections as injection-related disorders are abscesses, polio, hepatitis 
and AIDS (ÇELİK, ŞENCAN, & CLARK, 2013; Persad, 2019),  
WHO recognized the importance of RUD objectives in the developing countries and 
developed countries so far, so, the National Drug Policy has been promulgated in 1995 for 
implementation the agreed objectives of the National Health Policy prepared in 1991 of 
which represented in providing health for all and improving and managing the activities 
related to drug production, import, export, storage, supply, sales, distribution, quality 
assessment, regulatory control, rational use and information flow (Kanter, 2019). 
In the year 2000 Palestinian Ministry of Health (MOH) developed the first Essential Drug 
List (EDL) which had been considered as an important first step to improve and maintain 
the availability, accessibility and appropriateness of drugs provided to clients. The process 
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was guided by WHO recommendations for selection and update of local formulary. As a 
result, Palestinian MOH established the Palestinian National Drug Formulary (PNF) in the 
year 2002. Training courses were implemented among the majority of governmental health 
care staff during 2002-2004. Later on, local formulary was updated several times, the last 
one was in 2013 (MOH, 2013).  
UNRWA clinics operate on the basis of a list of drugs that closely follows the WHO local 
formulary and MOH facilities working based on two drug lists: one in the Gaza 
Governorates (GG) and one in the West Bank (WB) with the purpose of improving the 
prescription patterns (Obeidallah, Mahariq, Barzeq et al., 2000), although these facts, an 
irrational use of drugs in UNRWA clinics and MOH facilities occur. 
The governmental hospitals facilities in the GG still suffer from over prescribing, irrational 
prescribing and prescribing expensive brand name drugs are prevalent in health facilities. 
The problem is very serious because of the large consumption of drugs, thus mainly due to 
governmental health facilities either hospitals or Primary Health Care (PHC) services are 
provided almost freely for persons with medical insurance. Also, other factors as the poor 
level of communication between the medical staff (physicians and pharmacist) and the 
managerial staff play an important role in irrational use of drugs (Bisan Center, 2006) . 
Palestinian Non-Governmental Organizations (PNGOs) have increasingly been promoted 
as alternative health care providers in the GG, furthering the same goals but less hampered 
by government inefficiencies and resource constraints. However, the reality of the NGO 
health care provision is more complex. The NGOs may suffer from resource constraints 
and management inefficiencies similar to those of government providers. For their drug 
supply, they tend to rely on donations from international NGOs and other organizations. 
However, when in need, they buy from local manufacturers and wholesalers (Kruk, 
Freedman, Anglin et al., 2010). Regarding drug expenditures of PNGOs and charitable 
societies, reliable data on their drug expenditures are not available and are difficult to 
obtain and PNGOs generally charge nominal fees for drugs. Obeidallah and colleagues 
(2000) illustrated that drug expenditures of PNGOs are estimated at around 8 million US$ 
a year. It was estimated that on average 80% of the NGOs budget was funded by external 
donors (Gerster 2012).  
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For the local drug list in the NGO hospitals in Palestine, many NGOs operate on the basis 
of a restricted list and WHO was recommended to implement local drug list for NGO 
hospitals and at all levels of care (Obeidallah, Mahariq, Barzeq et al., 2000). 
This study will handle RUD subject in terms of prescribing drugs pattern in the PNGO 
hospitals in the GG to evaluate and asses the drug use situation by measuring the WHO 
indicators and the related factors that can affect in drug use. Irrational use of drugs may 
result due to various reasons and may lead to serious negative health and economic 
consequences. 
1.2 Research problem 
The high cost of health services can represent a true challenge to reach WHO global goal 
―universal coverage‖, the health expenditure is about 5.3 trillion US$ which represents one 
of the largest portions of expenditure in the world (Xu, Saksena, Jowett et al., 2010). 
Moreover ,wasting health resources due to misuse is another challenge to reach the global 
goal, the wasting in conservative estimate percentage is ranged from 20-40% (WHO, 
2010b) and drugs consider as the main health recourse wasted due to irrational use of 
drugs. Improper prescribing behavior of drugs by prescribers has a negative impact on 
medical resources and lead to serious financial overload, as well as undesired health 
impacts on patients. In the same context, WHO encouraged countries to implement drug 
promoting programs for appropriate use of drugs which could save up to 5% of countries 
health expenditure (WHO, 2010b). 
On the other hand, Palestinian Central Bureau for Statistics (PCBS) demonstrated that the 
Palestinian National Authority (PNA) spent about 11% of the Gross Domestic Product 
(GDP) on health (PCBS 2016a) , also, the Palestinian MOH and the PCBS indicated that 
PNGOs account for 32% of the total number of hospital beds , and for 26% of the human 
resources employed by the sector (Al-Ghanim, 2004; Mataria, Khatib, Donaldson et al., 
2009). Also, PNGOs share 8% of the total health services utilization while United Nation 
Relief and Works Agency (UNRWA) accounts up to 46% of health service utilization. The 
low utilization of NGO health services is explained by the availability of public health 
insurance and (in UNRWA‘s case) free services (Bisan Center, 2006). 
Several studies had been conducted in the GG and clarified the presence of irrational use of 
drugs in the different health provider sectors the MOH and UNRWA. In MOH PHC clinics 
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and hospitals in the GG, studies showed poor using and compliance with local formulary, 
low percentage in using generic name of drugs and polypharmacy (Fattouh & Hamad, 
2010; Al-khodary, 2016). 
In addition, PHC UNRWA clinics in the GG studies explored polypharmacy, high 
percentage of encounter receiving antibiotic, high percentage of compliance with UNRWA 
formulary (Saleh, 2008; Baba, 2012). 
Regarding to NGO health facilities, there is one study had been conducted in PHC NGOs 
clinics in the WB and showed polypharmacy prevalence and high encounter receiving of 
antibiotic (Khatib, Daoud, Abu‐Rmeileh et al., 2008) while in the GG, as far as researcher 
known, no study indicated the use of drugs in non-governmental hospitals (NGHs). 
Generally, information in prescribing practices in Palestine is lacking so this study will 
contribute in providing more information about the prescribing pattern in one of the main 
health providers in the GG.  
1.3 Justification 
In the GG, prescribing indicators had been studied to measure the rational use of drugs 
(RUD) in the MOH hospitals. The study found that a polypharmacy present and around 
two thirds of the physicians showed no compliance with local formulary drugs (Al-
khodary, 2016). In addition, a study conducted in MOH PHC clinics illustrated that the 
poly-pharmacy prevalence among elderly patients (Abed, 2011). On the other hand, an 
evaluation study in all the governmental PHC clinics in the GG and found that high 
compliance with local formulary from the physicians participated in the study using the 
local formulary and half of them reported problems in using it. There is a polypharmacy 
evidence with very low compliance in prescribing drugs by generic name (Fattouh & 
Hamad, 2010). 
On the other hand, studies conducted in PHC UNRWA clinics indicated that majority of 
the prescribers showed compliance in prescribing drugs from UNRWA formulary, on the 
other hand, the study illustrated that low prescribing of injection, low prescribing by 
generic name, high encounter receiving antibiotic and polypharmacy prevalence (Saleh, 
2008; Baba, 2012).  
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In the same context, In the WB, CARE International conducted a study in 41 NGOs PHC 
and showed polypharmacy prevalence and high encounter receiving antibiotics. Also, high 
injections and combined medications percentage present. Provision of reference sources 
and treatment guidelines implementation were also inadequate (Khatib, Daoud, Abu‐
Rmeileh et al., 2008). 
To the researcher best knowledge, this study will be the first to handle the topic of RUD at 
the NGHs in the GG in the proposed focus way. 
This study will conduct in the NGHs in the GG to provide information about core 
prescribing drugs indicators in regard to patient treatment, these indicators used to measure 
the performance of the prescribers. The drug use indicators are best understood as first line 
measure to estimate further questioning and guide subsequent action.  
1.4 Study objectives 
1.4.1 General objective 
The study aims to assess the drug use at the NGHs in the GG based on the recommended 
WHO core prescribing indicators. 
1.4.2 Specific objectives 
More specially the study aims to address the following objectives: 
1) To assess the drug prescribing practice at the NGHs in the GG. 
2) To assess physicians‘ current level of knowledge, attitudes and practices concerning 
local formulary at the NGHs in the GG. 
3) To investigate the prescription writing skills of the physicians at the NGHs in the GG. 
4) To compare the compliance of the prescribers in prescribing drugs from local 
formulary and the knowledge about the presence of hospital local formulary by various 
variables between selected NGHs in the GG.  
5) To propose recommendations that could improve physicians‘ practices at the NGHs in 
the GG. 
1.5 Research questions 
1) How is the situation regarding drug prescribing practices at the NGHs in the GG? 
2) What are the practices deficiencies in prescribing at the NGHs in the GG? 
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3) What are the prescribing trends of physicians concerning prescription writing skills? 
4) What are the main factors affecting drug prescribing practices at the NGHs in the GG?  
5) Are physicians aware of the concept of local formulary?  
6) Have physicians participated in updating local formulary?  
7) To what degree physicians comply with local formulary at the NGHs in the GG?  
8) Do the NGHs implement effective local formulary orientation programs for the medical 
staff?  
9) Do we have variations in prescribing practices among different NGHs in the GG?  
1.6 Context of the study 
1.6.1 Geographic context 
Palestine is a geographic region in Western Asia between the Mediterranean Sea and the 
Jordan River, it lies between longitudes 33‘ 15‖ and 29‘ 30‖; and between latitudes 35‘ 40‖ 
and 34‘ 15‖. the entire area of Palestine is about 27,009 Km2, stretching from Ras 
AlNakoura in the north to Ommerreshrash in the south. Palestine is bordered by Lebanon 
in the north with a border length of 79 km; Syria with border length of 70 Km, and Jordan 
with border length of 360 Km from the east. To the south, Palestine is bordered by Egypt 
with a total length of 240 Km border. Mediterranean Sea limits Palestine from the west 
with a coast length of 224 Km. Palestine also overlooks the Gulf of Aqaba with a coast 
length of 10.5 Km {AlDabbagh, 1997 #59;amcham, 2015 #294} . Nowadays, PNA is 
limited to two geographically separated areas, the GG (also called southern governorates, 
Gaza Strip, GS), and the West bank governorates (also called northern governorates, WB), 
with a total area of 6020 Km
2
 which represents 22% of historical state of Palestine (PCBS, 
2013a). The GG is the southern district in the Palestinian Authority territory and is located 
in the south-west of Palestine with an area of 365 Km
2
. 
1.6.2 Demography context 
According to the PCBS Population, Housing and Establishments Census 2017, in 2017, the 
population of occupied Palestine was estimated 4,780 million, in the WB (including East 
Jerusalem) 2,881 million and 1.899 million living in the GG. Approximately 61.1% resided 
in the WB and 38.9% in the GG. Males ratio to Female respectively is (103:100). 39.7 % 
of Palestinian population is below 17 years (47% in the WB and 48% in the GG). The 
population is expected to increase by 50% by 2020. Population density of Palestine is 
varying according to the geographical area: 5,204 individuals/km
2
 in the GG. Population 
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density of Palestine is varying according to the geographical area, in the GG it is 5,204 
persons/ Km
2
 compared to a WB of 510 persons/ Km
2
 in 2017 (PCBS, 2018), noting that 
66% of the total population of Gaza Strip are refugees. The flux of refugees turned the 
Gaza Strip in one of the highest population densities in the world (BCPS, 2018). The 
refugee population is refugees represented 42.5% of the population of the State of Palestine 
(2017), living in 27 refugee camps. In Jerusalem, there are 91,274 registered refugees and 
18,719 non- registered refugees (PCBS, 2016). 
The GG population spread over five governorates; North Gaza, Gaza City, Mid Zone, 
Khan-Younis and Rafah (PCBS, 2013). The population includes 67% refugees and 33% 
non-refugees, with high literacy rate estimated by 96.4%. The poverty rate among the GG 
population reached about 38% (PCBS, 2013b). This high population density demands a 
huge covering of essential services, most importantly the health services. Moreover, the 
high poverty and unemployment rates increase the burden on the country as a whole and 
on the health system in particular, specially the governmental sector. 
1.6.3 Socio-Economic Context 
The financial circumstances in the GG characterized by high level of poverty and low 
income, the difficult political and economic conditions deteriorate the life of people due to 
the high level of uncertainty and recurrent wars (Elshaer, 2016). People suffer from the 
constricted siege that prevents importing and exporting of goods and aids across the GG 
borders. 
The Palestinian economy has severely damaged because of the current political situation 
and the siege imposed on the GG. Since the end of the second intifada, Israel has imposed 
a blockade on the GG in addition to recurrent wars and other attacks on the territory 
resulted in degraded economic conditions and mass destruction of infrastructure and 
industry. Israel-Gaza border closures, which became more limiting after Hamas held 
control of the GG in June 2007, have resulted in high unemployment, high poverty rates, 
and collapse of the private sector that had depended on mainly on export markets (Al-
qedra, 2018). 
In the GG, the unemployment rate reaches 49.1% but in WB it was 18.3% in the 1st 
quarter 2018, and for men it was 25.0% but for women it was 48.9%. young people (20-24 
years), had the peak unemployment rate in the 1st quarter 2018 (49.6%) (PCBS, 2018).  
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1.6.4 Political context of the GG 
After the beginning of Al-Aqsa intifada (2000), Israeli siege and closure of crossings was 
imposed on the GG. The Israeli authorities implemented a collective punishment to all 
Palestinians in the GG by tightening the siege more intensively after the Palestinian 
legislative elections in 2006 and the election of Hamas Islamic movement. Intensity of the 
sieges and continuous blockade of borders were dramatically increased after the political 
rift in 2007. In 2016 Israel continued to enforce severe and discriminatory restrictions on 
Palestinians‘ human rights, to facilitate the transfer of Israeli civilians to the occupied WB, 
and to severely restrict the movement of people and goods into and out of the GG. The 
allowed imports to the GG amounted to less than half of the 2006 pre-closure levels 
("World Report," 2014). In 2013, deterioration of the health status has increased due to bad 
economic situation after the closure of the illegal tunnels with Egypt, which was 
considered in certain period of time as a sole source of all goods needed for the GG. The 
MOH became hardly able to provide all operational needs of the health services including 
drugs, medical disposables, medical equipment, lab materials, and others. Additionally, 
services are frequently interrupted by electricity blackouts and insufficient supplies of 
drugs and disposables and limited training opportunities for medical staff. This further 
threatens the health of the population, which is already at increasing risk. Following the 
establishment of the reconciliation government, there is a void in local leadership at 
ministerial levels and in sufficient cash flow causing an imminent threat of a breakdown in 
key public health services. This comes on top of an already severely strained situation 
caused by ten years of Israeli siege on the GG (UNRWA, 2014). 
1.6.5 Palestinian health care system 
The first official National Health Plan (NHP) was published in 1994 and developed and 
published again in 1999. NHP aimed to regulate the health sector and integrate the 
activities of the four main health-care providers: the Palestinian MOH, PNGOs, the 
UNRWA, and a cautiously developing private sector (Mataria, Khatib, Donaldson et al., 
2009), In the GG the health infrastructure comprises of MOH, UNRWA, PNGOs, military 
medical services and numerous private sector health care providers (Health cluster, 2014) . 
Since 2000 the health care system deteriorated due to unstable political situation. UNRWA 
and NGOs sector role is supporting MOH health facilities and decrease workload. 
UNRWA provides PHC services to the refugee population, and purchases secondary and 
tertiary care services when needed. The NGOs sector is supported by international 
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organizations and community resources. They include organizations with social, and 
political motivations. They provide different health services including outpatient and 
inpatient care, psychosocial support, rehabilitation, health education, and emergency care 
(Schoenbaum, Afifi, & Deckelbaum, 2005). The private for-profit health sector also 
provides the three levels of care through a wide range of practices (WHO Strategy, 2005). 
1.6.6 Palestinian non-governmental health organizations (PNGOs) 
The NGOs, in general terms, are defined as private, voluntary agencies which fund, 
implement or actively support development assistance programs (Frantz, 1987). NGOs 
were the services provider services for the most Palestinian marginalized groups and 
provided essential services that the Israelis failed to make them available (PASSIA, 1998). 
PNGOs received substantial financial support from local charities, the Palestinian 
Liberation Organization (PLO), Arab governments and NGOs, as well as foreign donor 
states and NGOs. PNGOs divided to private-, For-Profit-Sector and private-, For non-
Profit-Sector and both have their own services, number of them specialized in certain 
health care services (Abuiyada & Abdulkarim, 2016). 
Unlike health NGOs in the other parts of the world, PNGOs have had a busier and more 
complex agenda that could not be adequately realized solely by providing health services 
(Abdulhadi, 1996). In addition to providing desperately needed health services, PNGOs 
had to become involved in national struggles in their own ways. These factors contributed 
to the uniqueness of Palestinian NGOs (Claudet, 1996). 
PNGOs bankrolled by private benefactors encompass a sizable portion of the health care 
economy in the PNA. A World Bank survey found that 11.7% of Palestinians used NGOs 
most frequently for their health needs. 13.3% of households in the WB relied on NGOs 
compared to 8.1% of households in the GG. The World Bank report explained that fewer 
NGOs operate in the GG than in the WB and that Gaza residents are more likely to be 
classified as refugees and therefore to have access to services provided by UNRWA. The 
Department for International Development (DFID), a British government agency, found 
that a visit to an NGO-run PHC clinic cost twice as much as a visit to a government clinic 
and four times as much as a visit to a UNRWA facility. PCBS put the figure at 26% in 
2005 (Bisan Center, 2006) while in 2015, Palestinian Health Information Center (PHIC) 
annual report of the GG indicated that NGOs employed 19.7% of workers in the 
Palestinian health sector in both PHC center and hospitals. 
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1.6.7 Pharmaceuticals in Palestine 
The MOH is responsible for ensuring the availability of pharmaceuticals to patients. The 
Palestinian Government suffer from severe financial constraints due to many reasons first 
the difficult political situation, second, the limited resources available to the government and 
third, the governments heavy reliance on international assistance lead to become the MOH 
is unable to meet the needs of patients in either the WB or the GG at all times from its 
stocks of pharmaceuticals or to ensure the availability of needed medical supplies 
(Assembly, 2016). In 2015, Palestinian MOH suffered from a budget deficit which count as 
44%, drugs and medical and laboratory supplies consumed most of the MOH‘s budget 
(Shahin, 2011). In 2015, 30% of essential drugs and between 25 and 30% of medical 
equipment were unavailable. According to PNA Pharmaceutical Country Profile in 2011. In 
Palestine, the total annual expenditure on health (THE) in 2008 was US$ 893.8 million. The 
total annual health expenditure was 15.6 % of the GDP. The total annual expenditure on 
health per capita was US$ 165.5. Total public expenditure on pharmaceuticals is 54.1 
million US$ (Shahin, 2011). For NGOs clinics in the WB, a study showed that the large 
NGOs had a selection committee responsible for decisions with regard to the quality and 
quantity of centrally purchased medications. However, in these organizations it was not 
possible to adhere to the local formulary mainly because specialists decide about what is 
needed in most cases. On the other hand, main institutions‘ and individual clinics‘ 
procurement systems depended largely on cash availability. Bulk purchasing was not always 
possible and tendering was not practical for small clinics. Most medications were locally 
purchased or obtained through donations (Khatib, Daoud, & Mataria, 2004). 
1.7 Operational definitions of terms 
1.7.1 Rational use of drugs (RUD) 
Patients receive medications appropriate to their clinical needs, in doses that meet their 
own individual requirements, for an adequate period of time, and at the lowest cost to them 
and their community (Kar, Pradhan, & Mohanta, 2010). 
The researcher defines RUD in term of prescribing practices and formulary situation in 
the selected health facilities by evaluate the current situation with the WHO 
recommendations, thus can occur by measuring prescribing indicators and health facility 
indicators.  
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1.7.2 Key drugs 
A short list of 10-15 essential drugs must be compiled that should always be available  
(WHO, 1993). 
The researcher defines key drugs list of the hospital as a list of essential drugs for all 
departments in the hospital that should always be available. 
1.7.3 Local drug list 
It Is a selected list of drugs in NGO health facility, the list selected with regard to disease 
prevalence and public health relevance, evidence of clinical efficacy and safety, and 
comparative costs and cost-effectiveness (WHO, 2013). 
The researcher defines local drug list or formulary of the hospital as those drug list or 
formulary was considered as the priority of the hospital in the last two years. the drugs had 
been choosing depend on the hospital services, evidence on efficacy and safety and 
comparative cost-effectiveness. 
1.7.4 Non-Governmental Organizations (NGOs) 
The term NGOs is broad and encompasses a whole set of institutions, associations and 
organizations that constitute the so-called third sector (Abuiyada & Abdulkarim, 2016) . 
1.7.5 Secondary Health Care (SHC)  
In Palestine, hospitals provide secondary and tertiary health care services. the main 
provider for the SHC services is hospitals. 
The researcher defines SHC services as all services provided through hospitals except 
the services which are provided in the tertiary hospitals, these services which involved the 
following: oncology, hematology department, Burns unit, diagnostic radiology, 
ophthalmology, obstetrics and gynecology service, neonatal intensive care unit, open heart 
surgeries, catheterization unit , mental health (psychiatry and psychology) and physical 
therapy (Hensher, Price, & Adomakoh, 2006). 
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2 Chapter Two 
Literature Review 
This Chapter starts by presenting the conceptual framework guiding this study; then, it 
highlights Palestinian health care system and local formulary concept and content training 
program, prescribers‘ practices and their impact in RUD based on WHO recommended 
groups of indicators, health care facility factors that affecting from the managerial point of 
view. Finally, it reviews the RUD concept, ways to promote the RUD and causes of 
irrational drug use. 
2.1 Conceptual framework 
According to the literature the RUD in the NGHs effected by three factors which are health 
care system in Palestine in general and in the GG particularly, prescribers‘ practices and 
the health care facility Figure (2.1). 
2.1.1 Palestinian health care system 
Since 1967, a division of the Israeli Military known as the Health Department of the Civil 
Administration (HDCA) had been responsible for overseeing health care in the occupied 
territories. During this time, HDCA‘s work was greatly supported by three other major 
sources of health care: NGOs, the UN, and the private sector. Shortly after Oslo and the 
corresponding transfer of jurisdiction, the PNA established a  MOH to administrate health 
care in Gaza and the West Bank (Wikipedia, 2019). 
The Palestinian MoH, UNRWA, Military Health Services, NGOs, and the private sector 
cover primary, secondary, and tertiary health care services. According to the MoH (2017), 
there are 743 primary health care centers in Palestine (583 in the West Bank and 160 in 
Gaza), and 81 hospitals (51 in the West Bank, including East Jerusalem, and 30 in 
Gaza)(PNIPH, 2018) .  
According to WHO recommendation countries and institutions can promotion RUD by 
implementing approved and effective activities included: standard treatment guidelines; 
essential drug lists; drug and therapeutic committees; problem-based basic training in 
pharmacotherapy; and targeted continuing education. 
However, when these activities are being implemented, care is necessary to ensure success 
(Laing, Hogerzeil, & Ross-Degnan, 2001).  
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2.1.1.1 National Drug Policies and the essential drug list 
Drugs make an essential contribution to the health of the community, but rapidly rising 
drug budgets have caused governments to seek ways of ensuring this expenditure results in 
value for money. The National drug Policy was established against this background to 
implement a quality use of drugs (Weekes, Mackson, Fitzgerald et al., 2005). 
Compliance with local formulary is established effectively and efficiently in the presence of 
policies and guidelines (WHO, 2003b). 
2.1.1.2 National Standard Treatment Guidelines (STGs)   
The goal of the Standard Treatment Guidelines is to promote high standards of clinical 
practice and to improve the quality of health care to the public. STGs summarize 
recommended prevention and treatment strategies for commonly occurring disease 
conditions in the country (WHO, 2017).  
2.1.1.3 Medical education and training program 
Medical education is education related to the practice of being a medical practitioner; 
either the initial training to become a physician (i.e., medical school and internship), or 
additional training thereafter (e.g., residency, fellowship and continuing medical 
education). 
Medical education and training vary considerably across the world. Various teaching 
methodologies have been utilized in medical education, which is an active area of 
educational research (Flores-Mateo & Argimon, 2007). 
2.1.1.4 Monitoring and evaluation system 
Monitoring and evaluation (M&E) has gained increasing significance in the health sector 
during the last decade, partly due to increasing public demand for measurement and 
accountability in the use of health sector resources (Glasgow, Vogt, & Boles, 1999). 
2.1.2 Prescribers’ practices 
Physicians are the main prescribers of medication for the patients so they have a direct 
impact in RUD. Prescribers‘ practices affected with number of factors as prescribers‘ 
characteristics, prescribing pattern, continuous in-services education and training 
programs, prescription written skills. The rational drug prescribing practice is an important 
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health concern around the globe that not only interferes patient‘s life but also the 
socioeconomic issues (Amin, Khan, Azam, et al., 2011). 
2.1.2.1 Prescribers’ characteristics 
Physician's characteristic includes socioeconomic characteristics, years of work 
experience, work attitude, and knowledge. Socioeconomic characteristics includes: age, 
gender, place of permanent residency, place of work, managerial positions gained during 
his work, and type of medical specialty. 
2.1.2.2 Prescribers knowledge and attitude 
The prescribers‘ characteristics include socioeconomic characteristic represented in the 
work knowledge and attitude, experience of the prescribers and level of education (Wilson, 
Hatcher, Barton et al., 1996), studies showed that the scientific evidence was very 
important in influencing their prescribing practices (Ladd, Mahoney, & Emani, 2009; 
EFMHACA , 2012).  
In relation to the physicians‘ knowledge and attitude, according to WHO guidelines, the 
medical staff should have adequate knowledge and training in the health care service they 
provide. The medical staff attitude towards prescribing drugs from the local formulary will 
affect their compliance with it and the service they provide. Compliance with local 
formulary needs a specialized medical staff who believes that local formulary will improve 
the services more than other drugs (WHO, 2002a). 
2.1.2.3 Prescribing pattern 
Irrational prescribing is a global problem. Bad prescribing habits lead to ineffective and 
unsafe treatment, exacerbation or prolongation of illness, distress and harm to the patient, 
and higher costs. Irrational prescribing patterns are perpetuated through patient pressure, 
bad example of colleagues, and high-powered salesmanship by drug company 
representatives (EFMHACA , 2012). 
Assessment of drug use patterns with the WHO drug use indicators is becoming 
increasingly necessary to promote RUD in developing countries (WHO, 1993; H. V. 
Hogerzeil, Ross-Degnan, Laing et al., 1993). Before activities are started to promote RUD, 
an effort should be made to describe and quantify the situation. Several well-established 
survey methods are available for this purpose. One assessment method is a prescribing 
survey using the WHO health facility drug use indicators. These quantitative indicators are 
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now widely accepted as a global standard for problem identification and have been used in 
over 30 developing countries (Laing, Hogerzeil, & Ross-Degnan, 2001). 
2.1.2.4 Prescribing writing skills 
Prescribing is one of the biggest steps in practice in the transition from being a medical 
student to being a Foundation Year 1 (F1) doctor. Prescribing could be considered 
simplistically to consist of two related but distinct components: the pharmacological 
knowledge (basic and clinical) which provides the knowledge base that is required to 
understand drug effects, interactions and contra‐ indications and the practical and 
procedural skills of prescribing such as calculating the correct dosage and writing up a 
prescription on a drug chart. Both components are essential for safe and effective 
prescribing (Rothwell, Burford, Morrison et al., 2012). 
2.1.2.5 Continuous in-services education and training programs 
Even though 75% of CEOs worldwide say that a skilled, educated, and adaptable 
workforce should be a government/business priority, there‘s a growing lack of experienced 
and well-trained staff in the healthcare environment in many regions around the globe. To 
counter this trend, there‘s a need to raise awareness that education doesn‘t come to an end 
once people are in the middle of their professional career. Because the healthcare industry 
is continuously evolving, technologies considered best practice today can change 
drastically in just the span of a decade. That‘s why care providers have to regularly keep 
up with new techniques and technologies and expand their knowledge and skills – which 
means continuous education is not a nice-to-have but an absolute necessity for any 
healthcare professional who wants to provide high-quality patient care (Health 
Management.org, 2017). 
2.1.3 Health care facility 
In this component, we studied the factors that affecting in the health care facility from the 
managerial point of view as drug availability (procurement and donation), Drug therapeutic 
committee (DTC), availability of local formulary and self-auditing and monitoring system. 
2.1.3.1 Drug supply and availability (procurement and donation) 
Increasing population, widening income gaps, changing epidemiological patterns, 
constrained public budgets and rising pharmaceutical expenditures are pressing 
governments to find new approaches to ensure equitable access to drugs as RUD; and 
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quality, safety, and efficacy of drugs. Availability of drugs could be through donation or 
procurement. Donation may be channeled through aid agencies in emergency situations or 
be included by governments in development aid. They may be sent from groups of 
concerned individuals or NGOs with regular links to the developing world. Drug donations 
may also have a commercial face; used by companies to obtain tax deductions on unused 
stock or create a later market for certain products (WHO, 1996).  
2.1.3.2 Availability of local formulary 
Availability of local formulary is considered as a challenge, lack of systematic 
procurement, supply and distribution system and poor demand management are all the key 
reasons for low availability. 
The availability of local formulary in health care facility is so crucial that no health care 
services can be provided without such availability. It represents one of the main building 
blocks of a sound health care system (WHO, 2010a). 
2.1.3.3 Drug therapeutic committee (DTC) 
DTC is the committee that evaluates the clinical use of drugs, develops policies for 
managing pharmaceutical use and administration, and manages the formulary system. 
DTCs can provide the leadership and structure to select appropriate drug for the formulary, 
identify drug use problems, promote RUD, and help reduce pharmaceutical costs (USAID, 
MSH, WHO, 2007). 
Also, regarding WHO, DTC main objective is to ensure the efficiency and quality of 
hospital services through optimal use of drugs (WHO, 2003). 
2.1.3.4 Self-auditing and monitoring system 
There is a need to establish simple systems to monitor key pharmaceutical indicators that 
might change as a result of implementing system-wide reforms. Policy-makers and 
managers should select a few locally appropriate indicators and collect them on a regular 
basis in order to be able to respond in a timely way to negative changes (Laing, Hogerzeil, 
& Ross-Degnan, 2001). 
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Figure (‎2.1): Self -developed conceptual framework 
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2.2 Literature Review 
2.2.1 RUD Concept 
RUD is defined as Patients receive drugs appropriate to their clinical needs, in doses that 
meet their own individual requirements, for an adequate period of time, and at the lowest 
cost to them and their community (WHO, 2002a), irrational use occurs with polypharmacy, 
using wrong or ineffective medication, underuse or incorrect use of effective medications. 
These actions negatively affect the quality of therapy, raised the cost of therapy or cause 
adverse reaction or negative physic social effects. Prescriber lack of knowledge and 
experience, prescribing process, patient and community decision and the health system 
itself all consider as factors can lead to irrational use of drugs (WHO, 2012).   
In 2010, the WHO reported that nearly half of the drugs are used inappropriately (WHO, 
2010c). Irrational use of drugs lead to Lack of access to drugs and inappropriate doses 
result in serious morbidity and mortality, particularly for childhood infections and chronic 
diseases, such as hypertension, diabetes, epilepsy and mental disorders, Inappropriate use 
and over-use of drugs waste resources - often out-of-pocket payments by patients - and 
result in significant patient harm in terms of poor patient outcomes and adverse drug 
reactions. Furthermore, over-use of antimicrobials is leading to increased antimicrobial 
resistance and non-sterile injections to the transmission of hepatitis, HIV/AIDS and other 
blood-borne diseases, Finally, irrational over-use of drugs can stimulate inappropriate 
patient demand, and lead to reduced access and attendance rates due to drugs stock-outs 
and loss of patient confidence in the health system (WHO, 2002b). 
Strategies to address irrational use of drugs characterized as educational, managerial, 
economic or regulatory, whichever method is selected a successful intervention is likely to 
focus on key factors, target facilities with the poorest practices and use credible sources 
and communication channels (WHO, 2012). 
2.2.2 Promotion of RUD  
In 2014, the world bank reveal that the total global expenditure for health represent 9.9% 
from global GDP ( World Bank Group , 2014) .The WHO estimates that the appropriate 
use of drugs can result in about 50%–70% cost-efficiency in drugs expenditure (Asenso & 
Agyeman, 2016). The WHO (2002) recommended twelve useful and effective core 
interventions to promote RUD. However, when these activities are being implemented, 
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care is necessary to ensure success. These twelve core interventions include: (1) a 
mandated multi-disciplinary national body to coordinate drug use policies; (2) standard 
clinical treatment guidelines (STGs); (3) local formulary based on treatments of choice; (4) 
drug and therapeutic committees in districts and hospitals (also called Pharmacy and 
Therapeutic committees, P&T committee); (5) problem- based pharmacotherapy training in 
undergraduate curricula; (6) continuing in-service medical education as a licensure 
requirement; (7) supervision, audit and feedback; (8) independent information on drugs; 
(9) public education about drugs; (10) avoidance of perverse financial incentives; (11) 
appropriate and enforced regulation; and (12) sufficient government expenditure to ensure 
availability of drugs and staff (WHO, 2012). 
2.2.3 Strategy to promote RUD 
The following strategies have been advocated by WHO for promoting RUD (WHO, 
2002a). There is 3 M concept in RUD: Medicines Mean Money. Thus, RUD means less 
profit and income for those dealing with drugs; prescribers, and sellers. 
WHO has recommended national strategies to promote the RUD as previously mentioned 
above. These 12 core interventions are based on evidence from the experiences gained over 
the past 20 years to promote the RUD ever since the definition of RUD was first 
formulated in Nairobi in 1985. Much of this evidence was presented at the two 
international conferences on improving the use of drugs held in Thailand in 1997 and 
2004. Data from the WHO Technical Cooperation for Essential Drugs and Traditional 
Medicine database of the pharmaceutical situation surveyed in 146 WHO Member States 
through a questionnaire in 2003. Unfortunately, it can be seen that many of the policies 
recommended by WHO are not being implemented. 
Without appropriate policies, it will be very difficult to achieve RUD through education 
alone because of all the other conflicting messages and incentives generated in health care 
systems through inappropriate activities (WHO, 2006). 
The medical practitioners have wide scope and responsibility too in promoting RUD for 
better health care. Educational strategies to health care practitioners and consumers have 
been proved successful model for promoting RUD. One of the educational strategies is to 
train the medical students of different levels on RUD. The concept and usefulness of RUD 
need to be the part of the curriculum. A WHO manual ―Guide to Good Prescribing: a 
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Practical Manual‖ is a useful publication for under graduate and post graduate students is a 
welcome step in this endeavor (WHO, 2001).  
2.2.4 EDL or local formulary Concept 
The Alma-Ata declaration during the International Conference on Primary Health Care in 
1978 reaffirms that health is a fundamental human right and the attainment of the highest 
possible level of health is a most important worldwide social goal. The Alma Ata 
declaration has outlined the eight essential components of primary health care and 
provision of essential drugs is one of them (Taylor, 2003). WHO introduced the concept of 
essential drugs in 1977 (WHO, 2002b). Essential drugs are those that satisfy the priority 
health care needs of the population. They are selected with due regard to public health 
relevance, evidence on efficacy and safety, and comparative cost-effectiveness. Essential 
drugs are intended to be available within the context of functioning health systems at all 
times in adequate amounts, in the appropriate dosage forms, with assured quality and 
adequate information, and at a price the individual and the community can afford. The 
implementation of the concept of essential drugs is intended to be flexible and adaptable to 
many different situations; exactly which drugs are regarded as essential remains a national 
responsibility. Experience has shown that careful selection of a limited range of essential 
drugs results in a higher quality of care, better management of drugs (including improved 
quality of prescribed drugs), and a more cost-effective use of available health resources. 
The WHO has developed the first EDL in 1977 and since then the list has been revised 
every 2 years. The current one is the 21
st
 model list released in June 2019 (WHO, 2019). 
The EDL or local formulary contains limited cost-effective and safe drugs, while the open 
pharmaceutical market is flooded with large number of drugs many of which are of 
doubtful value. The model list of WHO serves as a guide for the development of national 
and institutional EDL or local formulary. The concept of essential drugs has been 
worldwide accepted as a powerful tool to promote health equity and its impact is 
remarkable as the essential drugs are proved to be one of the most cost-effective elements 
in health care. 
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2.2.5 RUD benefits 
The reasons for use of irrational drugs or combined products included easy availability 
without prescription; ignorance of harmful effects; misleading advertisements; and 
attractive incentives for marketing and/or prescribing. The public should be educated about 
the harmful effects of drugs, and especially of self-medication. More emphasis is needed 
on preventative aspects of health rather than curative ones. Availability of drug 
information to all practitioners from independent sources and periodic audit of 
prescriptions may help to curb misuse of drugs. Medical associations should urge 
government to ban harmful drugs and irrational combinations, and request a secure supply 
of essential drugs. Irrational drug use leads to reduction in the quality of drug therapy, 
wastage of resources, increased treatment cost, increased risk for adverse drug reactions, 
and emergence of drug resistance (Bhartiy, Shinde, Nandeshwar et al., 2008) 
2.2.6 Irrational use of drugs consequences  
2.2.6.1 Risk of antibiotic resistance  
The prevalence of infections caused by antibiotic-resistant pathogens is escalating globally 
and cause infections associated with greater mortality and morbidity (Davey, Brown, 
Charani et al., 2013). Despite strenuous efforts to control antibiotic usage and to promote 
optimal prescribing, practitioners continue to prescribe excessively and inappropriately; it 
is estimated that up to 50% of antibiotic usage in hospitals is inappropriate (Davey, Brown, 
Charani et al., 2013). Antibiotic resistance has a substantial economic impact because of 
the need for more expensive second-line drugs and longer hospital stays associated with 
therapy failure (McGowan Jr, 2001). Some studies suggest a relation between resistance 
rates and the volume of antibiotic use (Lopez-Lozano, Monnet, Yagüe et al., 2000; 
Tacconelli, 2009). Also, other studies reported antibiotics overprescribing, in Bangladesh 
55.57 % of the doctors prescribe antibiotics in suspected infection while only 33.46 % of 
them prescribe antibiotics in confirmed cases (Hasan, Hossain, Akter et al., 2009). These 
results are similar in other studies done in some neighboring Arab countries in the Middle 
East and gulf countries, Syria, Jordan, U.A.E, Yemen and Sudan, where over use of 
antibiotics was the most common drug use problem in these countries. Percentage of 
prescriptions containing antibiotics in Syria, Jordan were 45% ,55% (Lewis), in U.A.E 
31.1% (Rasool, Fahmy, Abu-Gharbieh et al., 2010), in Yemen 64.5% (Bashrahil, 2010). 
Additionally, Ethiopia 58.1% (Desalegn, 2012), 47% in Lao (Keohavong, Syhakhang, 
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Sengaloundeth et al., 2006) and 58% in the Islamic Republic of Iran (Cheraghali, Nikfar, 
Behmanesh et al., 2004) have the same overuse antibiotics problem. In the GG recent 
studies showed the same common problem ether in UNRWA clinics 32.9% (Baba, 2012) 
or in the governmental PHC in the GG 67.5% (Ayoub, Musalam & Mahadi, 2017). 
In addition, modelling studies show the value of infection-control practices and restricted 
use of antibiotics to control meticillin-resistant S aureus in hospitals (Mackenzie, Bruce, 
Struelens et al., 2007; Aldeyab, Monnet, López-Lozano et al., 2008). Similarly, the quality 
of both infection-control practices and antibiotic use plays a part in the incidence of C 
difficile infection (Owens Jr, Donskey, Gaynes et al., 2008; Aldeyab, Harbarth, Vernaz et 
al., 2009). One way of tackling resistance is to use antibiotics appropriately to prevent and 
treat infections (Hulscher, Grol, & van der Meer, 2010).  
Appropriate antibiotic use in hospitals entails finding a middle road between their potent 
ability to reduce the mortality and morbidity of patients with infectious diseases and their 
potentially hazardous effects (ie, serious adverse events, drug interactions, and induction of 
resistant strains). Unnecessary use of antibiotic agents, and use of the newest, broad-
spectrum antibiotics when narrow-spectrum and older agents would suffice can lead to 
increases in resistance, harm patients, and increase treatment costs. Conversely, unjustified 
therapy with narrow-spectrum agents that ineffectively treats the causative pathogen can 
also be detrimental to the patient (Kollef, 2000).  
In developed countries antibiotic stewardship programmes are present. The role of these 
programmes is to strike a balance between the potent ability of antibiotics for individual 
patients and their potentially hazardous effects. Initiatives to support appropriate antibiotic 
use are relevant because of its effects on bacterial resistance, clinical outcome, and costs 
(Hulscher, Grol, & van der Meer, 2010). 
The common recommendations is the challenge to reduce inappropriate and excessive 
antibiotic prescribing, the implication being that antibiotic resistance is largely a 
consequence of the selective pressures of antibiotic usage and that reducing these pressures 
by the judicious administration of antibiotics will facilitate a return of susceptible bacteria 
or, at least, will prevent or slow the pace of the emergence of resistant strains (Davey, 
Brown, Charani et al., 2013). 
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2.2.6.2 Wasting of resources  
One of the most important duties of health authorities is to ensure the efficacy and cost 
effectiveness of health care system services. Developing countries have limited budgets 
specified to health care, therefore they need good planning to provide essential drugs and 
promote RUD to reduce the cost of health services (Soleymani, Valadkhani, & Dinarvand, 
2009).  
Appropriate use of drugs is an essential element in achieving quality of health and medical 
care for patients and the community as a whole (El Mahalli, 2012).  
Tackling the issue of irrational drug use is considered to be essential not only to improve 
healthcare delivery towards ensuring patient safety, but also to allow for optimal utilization 
of resources. This stems from the fact that as much as 25%–70% of overall health 
expenditure in developing countries is spent on drugs whereas, around 10% of health 
expenditure in most high-income countries is consumed by drugs (WHO, 2008a).  
The World Bank has also defined RUD as comprising two key principles: (1) the use of 
drugs according to scientific data on efficacy, safety, and compliance; and (2) the cost-
effective use of drugs within the constraints of a given health system (Almarsdóttir & 
Traulsen, 2005; May, 2008). 
The WHO and the World Bank definitions differ in two main areas: (1) the use of scientific 
data in prescribing, which appears to be more enforced in the Word bank definition; and 
(2) while the World Bank definition incorporates countries‘ financial capacity as a 
consideration in drug use, the WHO advocates for the RUD with the lowest cost wherever 
possible, irrespective of the particular health system (Almarsdóttir & Traulsen, 2005). 
The WHO estimates that the appropriate RUD can result in about 50%–70% cost-
efficiency in medicines expenditure (WHO, 2008b).  
2.2.7 Availability of local formulary in hospitals 
Availability of local formulary is consider as a challenge, lack of systematic procurement, 
supply and distribution system and poor demand management are all the key reasons for 
low availability (Aitken, 2005). 
In the past, local formulary was typically drawn up by selecting drugs from existing stock 
lists or formularies. However, it is now generally recommended that the selection of drugs 
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be based on a list of common conditions and complaints and the treatments of choice 
(Laing, Hogerzeil, & Ross-Degnan, 2001). local formulary is a natural result of the 
national STGs. The drugs included in the treatment guidelines for a certain level of health 
care will constitute the local formulary for that level. Ideally, the two should be developed 
together. The recommended criteria for the selection of essential drugs are published 
elsewhere (WHO, 2003b). To prevent conflicts of interest, manufacturers should not be 
involved in the decision-making process of defining local formulary (Laing, Hogerzeil, & 
Ross-Degnan, 2001). 
Many national EDL indicate the level of use for each drug, e.g. dispensary, health centre, 
hospital, the leveled local formulary should be revised frequently. The local formulary can 
be used as the basis for procurement and distribution of drugs, and for developing a 
national formulary. It can also be used to identify product areas for selective support to the 
national pharmaceutical industry, for targeted quality assurance, or as a basis for insurance 
reimbursement. As with clinical guidelines, local formulary must be actively implemented. 
Implementing local formulary or formulary in hospitals is sometimes perceived as an 
unnecessary restriction on specialists‘ freedom to prescribe. Some of these perceptions can 
be overcome by developing supplementary STGs and local formulary for defined specialist 
departments. Flexibility can also be increased by reserving a certain percentage of the 
hospital drug budget for nonformulary items. However, a budgetary set-aside invites 
misuse and should be monitored carefully (Laing, Hogerzeil, & Ross-Degnan, 2001). 
2.2.8 EDL or local formulary benefits 
EDL or local formulary is a limited list of drugs and their properties, intended to guide 
physicians in their prescribing. Most formularies are issued by institutions (such as 
hospitals) or by health systems within which physicians work. They are not usually a 
complete listing of all the drugs available; they present a selection of products, chosen in 
the light of their merits, their safety and their cost. It follows that a formulary can have a 
strong influence on physicians' choice of products and their uses (Reynolds, Fajemisin, & 
Wilds, 2012). 
Formularies are the basis of the management and governance systems used to influence the 
range of drugs available within healthcare organizations. They exist in many primary care 
organizations and hospitals in the developed world, and within these settings individual 
departments and General Practices often have their own abbreviated versions tailored to 
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reflect their specific needs. The extent to which these formularies are managed varies 
considerably – some are simply descriptive lists (in effect pharmacy stock lists) and others 
are actively managed and used to complement other strategies for ensuring high quality 
and cost-effective prescribing. Most individual prescribers have their own informal 
repertoire of drugs with which they feel comfortable, at least insofar as they are familiar 
with the dosing requirements and the likely common side effects. Straying outside one's 
usual area of prescribing competence is associated with a high risk of error and so having a 
‗preferred list of drugs‘ reinforces familiarity and competence in their use. One of the 
major advantages of having EDL or local formulary is that it becomes possible to make 
changes rapidly as new information becomes available. When new pharmaceuticals are 
launched and marketed, trends in prescribing (particularly in primary care) can be picked 
up and new agents or indications can be assessed and formulary choice can be reviewed, 
regarding cost effectiveness, Drug formularies have a major role in the containment of cost 
within a healthcare setting. In secondary care the agreed formulary list is in effect the list 
of drugs available as pharmacy stock and as a consequence prescribing off formulary is 
difficult and the process of obtaining non-formulary drugs is usually well managed 
(Reynolds, Fajemisin, & Wilds, 2012). 
Essential use of drugs is perhaps the most cost-effective element of public health after 
immunizations and key health promotion habits such as regular exercise. Safe, effective 
drugs of good quality that are appropriately used already save millions of lives each year 
and prevent untold suffering. Much has been achieved since the first WHO model list of 
essential drugs was drawn up. Fairer financing, affordable prices, rational selection and 
use, effective drug regulation, and efficient supply systems are all central to closing the gap 
between those who today benefit from essential drugs and those who do not (Quick, 
Hogerzeil, Velásquez et al., 2002). 
2.2.9 EDL in Palestine 
The Palestinian MOH established the first Palestinian National Drug Policy in 1996. This 
was followed by the preparation of the EDL in the year 2000. Since then, several initiatives 
were undertaken by the MOH and some local NGOs such as Union of Palestinian Medical 
Relief Committees. Health Work Committees and the Palestinian Red Crescent Society to 
implement actively of the EDL and to help promote the concepts and practices of RUD. 
Unfortunately, other NGOs and the private sector were excluded from such schemes. 
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UNRWA, on the other hand, has its own EDL and implements its policies accordingly 
(Khatib, Daoud, & Mataria, 2004). Every PNGOs has their own local formulary. 
Procurement and selling polices differ between the various PNGOs, where patients pay 
higher prices for the medications prescribed than for those available at the MOH but lower 
than for those prescribed at the private sector. The impact of these initiatives, however, on 
RUD has not been fully evaluated, largely because of the prevailing unstable political 
situation (Khatib, Daoud, Abu‐Rmeileh et al., 2008). 
2.2.10 National Drug Policies 
The promotion of RUD and the preparation and implementation of local formulary are 
amongst the most frequently addressed key-issues in the National Drug Policies (NDP), 
which are proven critical steps in the process of reforming any health system. The national 
policy becomes the expression of government commitment to a common goal and a 
framework for action (H. Hogerzeil, 2004). To ensure an adequate supply of safe and 
effective drugs of good quality, NDP should be incorporated into the national health 
policy. Elements of NDP include: identification of therapeutic needs; objective selection of 
essential drugs; drug supply and distribution system; effective legislation and regulation; 
quality assurance; manpower development; and dissemination of drug-related information. 
Drug availability does not ensure their rational prescribing or dispensing or appropriate 
patient use. It is proposed that a flexible multi-disciplinary curriculum be established for 
healthcare professionals and students and public policy formulators to provide instruction 
in NDP elements and the principles of RUD. Such courses may stimulate multi-
disciplinary drug-related scholarly activities (Laing, Hogerzeil, & Ross-Degnan, 2001).  
The Palestinian MOH established the first Palestinian National Drug Policy in 1996. This 
was followed by the preparation of the local formulary in the year 2000. The underlying 
objective in these policies has emphasized “ensuring that safe and effective drugs are 
available to the entire population at affordable prices and those drugs of good quality are 
used rationally” (Khatib, Daoud, & Mataria, 2004). 
2.2.11 National Standard Treatment Guidelines (STGs)  
STGs called also clinical policies, treatment protocols or best-practice guidelines, 
structured approaches to diagnosis and therapy have considerable potential to promote 
RUD. Guidelines vary in complexity from simple algorithms to detailed protocols that 
include diagnostic criteria, investigations needed, patient advice, and cost information. The 
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success of guidelines in changing practice seems to depend on many factors, including: the 
complexity of the targeted practice; the credibility of the group developing the guidelines; 
involvement of end-users in the development process; the format of the resulting 
guidelines; and, most importantly, how they are disseminated. In a number of settings 
where STGs have been developed by an expert committee and simply sent out to health 
workers, no impact has occurred (Laing, Hogerzeil, & Ross-Degnan, 2001).  
Improving the use of drugs through STGs requires both initial work and continuous effort. 
It is now generally accepted that STGs in developing countries should be developed for 
each level of care, based on the prevalent morbidities and the competency of available 
prescribers (physician, nurse, medical assistant, community worker). Substantial 
involvement and consultation of end-users helps to ensure the practicality of diagnostic and 
treatment recommendations, and the acceptability of guideline content and format. As far 
as possible, the selection of treatments should be evidence-based and take into account 
local economic realities. When completed, the STGs should be introduced through an 
official launch combined with an intensive training programme. Supervision and further 
training should reinforce their use. In a study from Uganda by Kafuko and others, 
provision of STGs alone was compared with facilities receiving either training alone or 
training plus supervision. Statistically significant improvements were obtained for reducing 
the number of drugs prescribed, injection use and increasing generic drug use. Compliance 
with recommended guidelines was significantly improved for malaria and diarrhoea. 
Improvements in consultation and dispensing times and in adequacy of drug labelling were 
also observed. When the two intervention groups were compared, improvements were 
somewhat greater in the combined (training and supervision) group, though this was not 
always statistically significant. 
To be realistic, STGs must be time-limited and open for regular revision. STGs will gain 
greater acceptance if the focus is put on improving the quality of care, rather than simply 
reducing cost. National STG manuals should be consistent with treatment guidelines issued 
by national disease programmes, such as malaria, diarrhoea, tuberculosis and sexually 
transmitted diseases control. The first edition of the STGs should be reviewed after 1 year, 
as there are usually errors, omissions or ambiguities; after that, the revision interval can be 
2–3 years. Once they are finalized, STGs should be used for pre-service training and 
examinations; in-service training; as a basis for supervision and audit; and for developing a 
list of essential drugs (Laing, Hogerzeil, & Ross-Degnan, 2001). 
 28 
National STGs for the most common illnesses are produced/endorsed by the MOH in 
Palestine. These were last updated in 2004. Specific STGs cover primary care (updated in 
2004). A mechanism aligning the local formulary with the STGs is not in place (Shahin, 
2011). 
2.2.12 Drug therapeutic committee (DTC) 
Drug Therapeutics Committees (DTC) are a forum to bring together all stakeholders 
(prescribers and financial mangers) involved in decisions about drug use; they may exist at 
any level within the health-care system (Holloway & Green, 2003).  
The beneficial effect of DTCs in monitoring and promoting quality use of drugs and 
containing costs in hospital and other institutional settings has been generally accepted in 
developed countries. Unfortunately, there has been little critical evaluation of the clinical 
or economic impacts of this approach in developing countries. Some inefficiencies result 
from lack of an effective forum that brings together pharmacists, clinicians and 
administrators to balance the demand for quality care with financial constraints. There may 
be tension between prescribers and financial managers about which drugs should be 
available for what problems. In developed countries hospital DTC have been shown to be 
very effective in safeguarding and promoting efficient and RUD (Holloway & Green, 
2003). 
Despite the lack of evidence from developing countries, we nevertheless recommend that 
DTCs should be established in each hospital. This action will require both policy direction 
and institutional support (Laing, Hogerzeil, & Ross-Degnan, 2001). 
Two essential tasks of a DTC are to develop and revise institutional STGs (usually adapted 
from national guidelines), and to maintain an institutional EDL or formulary. The DTC can 
also perform drug utilization reviews, using drug consumption data or simple prescription 
surveys, and establish systems for audit of patient records, peer-review and continuing 
education. Antibiotic utilization and infection control are two cross-cutting topics that can 
serve as a focus for DTC activities. While computerized databases may not exist in 
developing countries, hospital clinical and pharmacy records can be manually reviewed for 
audit and feedback. Operations research is needed in both public and private hospitals in 
developing countries to determine how DTCs can function most effectively (Laing, 
Hogerzeil, & Ross-Degnan, 2001). 
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If DTCs do not exist in a country, the Ministry of Health should require that they be 
established, at least in large hospitals. Materials to assist the committees in their initial 
phase may need to be developed. Publication in national journals of the results of 
establishing DTCs and of the success of specific approaches may help other committees to 
get started (Laing, Hogerzeil, & Ross-Degnan, 2001). 
In the Palestinian context, DTC is considered as advisory group composed of experts. It 
has two levels: a central committee concerned with national drug decisions between 
alternatives and composed mainly of physicians and pharmacists of different specialties, 
while hospital level committee composed primarily of physicians, pharmacists, and may 
include nurse and lab technicians. In hospitals, DTC serves as the communication link 
between the medical staff and the pharmacy department. Its primary goal is cost 
containment, and priority setting in case of drug shortage (Al-khodary, 2016). 
2.2.13 Prescriber knowledge and attitude about EDL or local formulary 
Regarding prescriber attitude, Dutch study conducted by Karbach and Colleagues (2011), 
40% of the physicians know the guidelines adequately; however, the study concluded that 
physicians‘ knowledge of guidelines does not in itself lead to better guideline 
implementation. Moreover, Ossoff and Thomason (2011) found that there is no one 
compliance program model to fit every organization, so there is no one educational model 
that could fit every organization. There are key factors to consider when determining how 
to approach an educational program for any organization.  
With regard to demographic characteristic of physicians, Sherman (2011) found that no 
significant demographic differences were reported between different American physician 
groups, including age, sex, and race, and concluded that Physician-specific factors have no 
impact on medication prescribing compliance with treatment and clinical outcomes.  
In the GG, knowledge level of the prescribers had been studied in MOH PHC clinics and 
hospitals and other studies had been conducted in UNRWA PHC clinics. These studies 
illustrated that most of the study participants are aware of the existence of EDL (Fattouh & 
Hamad, 2010; Baba, 2012; Al-khodary, 2016). 
Regarding prescriber knowledge, a study conducted in a Southern Ethiopian hospital, 
72.2% of physicians were aware of the existence of the EDL (Mariam, Raghavendra, & 
Bobasa, 2015). While in Kenya another study conducted and found that 80% of the study 
Participants at the Alexandrian primary health care centers informed that they have copies 
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of EDL (Mulwa, Osanjo, Ndwigah et al., 2015). In South India, a study conducted at 
tertiary care teaching hospital, 75.3% of physicians agreed that generic drugs are as safe as 
innovator drugs, 64.4% of physicians agree that generic drugs are as effective as brand-
name drugs, 63% of physicians said that they prescribe generic drugs, and 89% of 
physicians agreed that that there should be training programs to increase the awareness 
regarding generic drugs among doctors (Gupta, Nayak, & Vidyarthi, 2015). In Sri Lanka, 
the researcher studied the Knowledge in core Policies of EDL among medical practitioners 
in comparison with medical students in Sri Lanka, only 54% of the study participants have 
true Knowledge on core policies of EDL, physicians level of knowledge on time frame for 
revision of EDL was very low (17%), the level of knowledge of physicians on contents of 
EDL was 63%, the knowledge of physicians about the criteria for selection of EDL was 
83% (Hettihewa & Jayarathna, 2010). In Bangladesh, a research conducted regarding the 
rational prescribing among medical practitioners, 58.6% of the physicians reported that 
they did not have any clinical practice guidelines in their clinics (Khan & Ara, 2011). 
2.2.14 Prescribing pattern 
The word prescribe comes from a Latin word meaning to write in advance [of giving a 
drug]. But the actual writing is a late event in the prescribing process. (J. K. Aronson, 
Henderson, Webb et al., 2006). Prescribing most commonly defined as the five rights, is 
that of ‗giving the right drug, in the right dose, by the right route of administration, at the 
right time, to the right patient. But this omits some other important features. Another 
definition can be more precise is ‗A written order, which includes detailed instructions of 
what drugs should be given to whom, in what formulation and dose, by what route, when, 
how frequently, and for how long; it initiates an experiment in which the prescriber 
discusses the treatment with the patient and investigates and monitors the effects of the 
prescribed drug, with the aim of devising a dosage regimen that maximizes the beneficial 
effects and minimizes the risk of harms (J. Aronson, 2006). In writing prescriptions, A 
search of Pubmed using the term ―safe prescribing‖ yields only 36 hits, and none explicitly 
defines the term. Some imply that safe prescribing is the avoidance of medication errors or 
adverse drug reactions (Wong & Rawlins, 2000; Hick, Deady, Wright et al., 2001). 
Unsuccessful prescribing takes several forms: under prescribing, overprescribing, 
inappropriate prescribing, irrational prescribing, and prescribing errors (J. K. Aronson, 
Henderson, Webb et al., 2006). 
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Prescribing must be preceded by a number of other processes. First, the diagnosis must be 
accurately made and underpinned by an understanding of the basic pathophysiology. If a 
drug is not appropriately matched to the pathophysiology of the disease the wrong choice 
may be made. Secondly, the prescriber must assess the balance of benefit to harm of a 
particular form of treatment (i.e. whether to treat at all). Thirdly, practical matters related 
to the choice of drug must be addressed; these include picking the right drug from a range 
of alternatives, designing the dosage regimen, considering the susceptibilities of a patient 
that might lead to adverse drug reactions, and remembering possible interactions with other 
drugs, including herbal formulations, and foods. Lastly, the prescriber and patient need to 
discuss the proposed treatment and its potential effects, both beneficial and adverse, and 
the need for careful monitoring and dosage adjustment (J. K. Aronson, Henderson, Webb 
et al., 2006). 
Compliance with EDL needs a specialized medical staff who believes that EDL will 
improve the services more than other drugs (WHO, 2002a). The three main sources of 
information about the prescribing patterns of physicians are marketing research data, 
studies of general practice and monitoring of prescribing in hospitals. These sources show 
that prescribing patterns vary greatly among physicians according to their place and type of 
practice and the community in which they prescribe. Also, the clinical experience and 
trainings were the most important factors in their prescribing habits (J. K. Aronson, 
Henderson, Webb et al., 2006). 
According to WHO guidelines, the medical staff should have adequate knowledge and 
training in the health care service they provide. The medical staff attitude towards 
prescribing drugs from the local formulary will affect their compliance with it and the 
service they provide.  More than 50% of the inappropriate therapy shows that prescribers 
are not up to date with the progress in medical field and should be more responsible 
(Amin, Khan, Azam et al., 2011) 
WHO recommended groups of indicators to describe the drug use situation in any health 
facility by measuring specific aspects of the behavior of health providers in health facilities 
in a reproducible manner. The indicators can be quickly and efficiently used in many 
settings to assess potential problems in drug use, and to prioritize and focus subsequent 
efforts to correct these problems. In this study, the researcher will study two groups of core 
indicators of performance in two general areas related to the RUD in the NGHs which are 
prescribing indicators and health facility indicators. Prescribing indicators group consist of: 
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1. Average number of drugs per encounter. 
1 Percentage of drugs prescribed by generic name. 
2 Percentage of encounters with an antibiotic prescribed. 
3 Percentage of encounters with an injection prescribed. 
4 Percentage of drugs prescribed from essential drugs list or formulary. 
While the health facility indicators consist of: 
1. Availability of copy of essential drugs list or formulary 
2. Availability of key drugs 
And the complementary indicators consist of: 
1. Average drug costs per encounter.  
2. Percentage of drug costs spent on antibiotics. 
2.2.15 Prescribing in the NGHs 
Most efforts at improving drug use have focused on the public sector, particularly at the 
primary care level. The private sector frequently provides better access to pharmaceuticals 
for the general public than does the public sector, although there tends to be an urban focus 
(Walley & Wright, 2010). Yet, the private sector has unfortunately been neglected by 
public policymakers. To change practices in the private sector, it is important that policy-
makers understand the motivations of private providers. Public servants frequently 
perceive that private practitioners are purely interested in profit rather than in the quality of 
their practice. However, recent experiences have shown this perception to be an 
oversimplification. Generally, all practitioners are interested in their status as health 
professionals, and their position within the community. Professional associations, with a 
majority of their membership in the private sector, are often willing to establish 
programmes to improve the skills or knowledge of their members. Considerable 
opportunities exist for improving drug use through better licensing and inspection (Bigdeli, 
Peters, Wagner et al., 2014). Finally, controls on advertising and regulations regarding 
unethical promotion of drugs can be implemented by national governments and 
institutional administrators. To stimulate long-term improvements in drug use in the 
private sector, a range of strategies should be considered. Licensing of practitioners and 
premises is traditionally used by governments to regulate the private sector. When 
possible, enforcement of these regulations should not be simply punitive, but combined 
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with positive efforts to improve performance. Encouraging professional associations to 
provide an accreditation system and continuing education programmes has many benefits. 
Changing the way governments or insurance companies reimburse drug expenditures may 
also have positive effects on drug use (Laing, Hogerzeil, & Ross-Degnan, 2001). 
2.2.16 Prescribing writing skills 
The drug prescription and administration process in most hospitals worldwide is still based 
on handwritten medical chart entries (Bobb, Gleason, Husch et al., 2004). Proper 
prescription writing, which is an essential skill for medical practitioners, is the primary 
intervention that doctors offer to the suffering humanity (Maxwell & Walley, 2003). Any 
error in writing a proper prescription leads to prescription errors which in turn lead to 
medication errors (Nagesh, Umesh, & Gv, 2014). Several steps in this complex and 
unchecked process can engender a high number of relevant errors which may be a 
significant source of adverse drug events (Barber, Rawlins, & Franklin, 2003). Certain  
elements must be written legibly, accurately and completely on the prescription order; 
these include the physician‘s name, stamp, specialty and signature, as well as the patient‘s 
name, address, age, and the date of the prescription, drug name (preferably generic), 
formulation, strength, dose, frequency of administration, quantity and directions for use in 
the patient‘s language (Williams & Kim, 2005). The illegibility, incompleteness, or 
omission of any of these elements could result in misinterpretation of the prescription by 
the dispenser, and may lead to potentially serious prescription errors (Meyer, 2000). 
Because the art of prescription-writing is not sufficiently addressed in undergraduate 
medical education, many physicians do not have appropriate prescription-writing skills 
(Maxwell & Walley, 2003) . 
The prescription writing skills involved name, address, telephone of prescriber, date, 
generic name of the drug, strength, dosage form, total amount, label instructions, warnings, 
name, address, age of patient and signature or initials of prescriber (Williams & Kim, 
2005). 
2.2.17 Drug supply and availability 
In some countries, government health services are able to ensure access to drugs for a large 
portion of the population. But in most countries the private sector predominates. High 
prices and inadequate consumer information limit access to affordable essential drugs. At 
the same time, government health services face financial pressures and other constraints 
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(WHO, 1996). Therefore, drug shortage is a global problem, with different reasons mainly 
related to production and quality issues, or delaying and discontinuations (FDA, 2017).  
Regarding donation, in most cases the individuals and organizations involved see 
donations as tangible expressions of concern and solidarity with people in need. But 
despite good intentions, experience over the years shows that some drug donations can be 
more harmful than helpful. They may not be relevant for the emergency situation, for the 
disease pattern or for the level of care that is available; they may even be dangerous. They 
may be unknown to local health professionals and patients and may not comply with local 
drug policies or standard treatment guidelines. Many donated drugs arrive unsorted, or 
without an international nonproprietary (generic) name on the label. When this occurs, 
scarce resources are wasted and people in need continue to suffer (WHO, 1996).  
In Palestine, the political and contextual situation imposes different conditions represented 
by the Israeli occupation constrains. In the GG particularly, the long-lasting siege that had 
begun in 2000 and more tightened since 2006 after internal conflict had increased the 
suffering. Moreover, the financial crises of the PA -that is responsible for purchasing of 
drugs for governmental facilities- had aggravated the situations, in addition to the 
aggressive Israeli attacks on the GG in 2008/09, 2012, and 2014 which severely worsened 
the impact of all these conditions on social and economic sides, as well as on the health 
status of the citizens in the GG (Health cluster, 2014). During these circumstances, the 
issue of chronic essential drug shortages at MOH facilities appeared to be raised and 
escalated over the past 7 years with a highest percentage of zero stock in 2012 reaching 
58% in drugs (WHO, 2012c). 
In case of NGOs, several NGOs base their drug distribution activities on their own 
restricted drug list. For their drug supply, they tend to rely on donations from international 
NGOs and other organizations. If the Drug donations are done without well organization 
and corporations with NGOs, governments or individuals, they can cause more problems 
than benefits are, and entail high transport, storage and destruction costs for the receiving 
country (van Dijk, Dinant, & Jacobs, 2011). The GG had received drugs as donations 
which represented the largest proportion of supply (55.8%). In addition, when in need, 
NGOs buy from local manufacturers and wholesalers. The NGOs and charitable societies 
generally charge nominal fees for drugs. Reliable data on their drug expenditures are not 
available and are difficult to obtain, but they are estimated at around US$ 8 million a year 
(Obeidallah, Mahariq, Barzeq et al., 2000). 
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2.2.18 Medical education training program  
Education and training programs are important component in human resource development 
department in any organization and it is considered as a capacity building for the staff. 
Capacity building defined as provision of intellectual capability, physical facilities and 
supportive work environment to enhanced service delivery. By developing training and 
education program, the facilities management can standardize the concepts and 
disseminate the knowledge and update the medical staff information.  
Prescribing is a complex and challenging task that must be part of a logical deductive 
process based on accurate and objective information and not an automated action, without 
critical thinking or a response to commercial pressure. There are worldwide evidences of 
poor prescribing due to errors, polypharmacy, and inappropriate or irrational prescribing 
(Patrício, Alves, Arenales et al., 2012). When drugs are prescribed or used erroneously, 
they pose serious health risks to the patient and significant associated economic 
implications (WHO, 1995, 2010c). 
Factors responsible for poor prescribing have been identified, such as deficiency of 
training, failure to perceive the importance of the task, lack of identifying the errors, and 
increasingly therapeutic options (Weingart, Wilson, Gibberd et al., 2000; Barber, Rawlins, 
& Franklin, 2003). Reports from medical students show they do not feel prepared to 
prescribe (Pearson, Rolfe, & Smith, 2002; Coombes, Mitchell, & Stowasser, 2008). First-
year doctors are neither confident nor competent in writing a prescription corroborating the 
lack of undergraduate and postgraduate education in prescribing (Lempp, Seabrook, 
Cochrane et al., 2005; Heaton, Webb, & Maxwell, 2008). 
To overcome these difficulties, the WHO produced the Guide to Good Prescribing which 
takes the medical student through a structured problem-solved six-step process in choosing 
and prescribing a suitable drug for an individual patient. The WHO's Guide is based on the 
concept of  RUD which requires patients to receive appropriate medications for their 
clinical needs, in proper individual doses for the correct period of time at a low cost for 
them and the community (WHO, 1995, 2002a, 2010c, 2014). 
In prescribing a treatment, the doctor can choose between drug therapy, a combination of 
drug and non-drug therapy or only a non-drug approach. In the case of a drug based 
therapy using RUD is essential since it is a process that involves decisions made based on 
the efficacy, safety, convenience and cost. Furthermore, the correct prescription with the 
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guarantee of access to the prescribed medication and adequate dispensing followed by the 
proper use by the patient is also part of the RUM principal. (WHO, 1995). 
Considering the deficiency showed by young doctors in prescribing efficiently, in 2003 the 
RUD teaching was included in the official curriculum of the Botucatu School of Medicine, 
Brazil, as a mandatory discipline taught over a total of 24 hours, during one semester of the 
academic year. This discipline, based on the WHO's Good Prescribing Guide, trains 
students to learn a logical deductive process for selecting drugs according to the RUD 
principles (i.e., efficacy, safety, convenience and cost) and to write a correct prescription 
(Kar, Pradhan, & Mohanta, 2010). 
The medical practitioners need to keep themselves updated through attending seminars, 
conferences, and other continuing professional development programmes. These 
programmes should not be supported by pharmaceutical industries, as often there is 
conflict of interest. They should look for independent publications or drug information 
centers for drug-related information, but not from the medical representatives. The hospital 
formulary is a good source of information. The essential drugs should be the first choice 
during medical practice. Finally, they should take care of their clients, the patients, by 
spending some time with them explaining the appropriate use of prescribed drugs. The 
patients should be accepted as the partner in drug therapy prescribing (Kar, Pradhan, & 
Mohanta, 2010). 
For the implementation of regular updating about EDL and training programs in the GG, 
during the last 13 consecutive years, MOH did not implement training programs for 
physicians on the concept and content of the EDL and did not implement training about 
EDL related topics in the training programs for newly recruited physicians thus lead to lack 
of knowledge about EDL and regular updating for the MOH physicians (Al-khodary, 
2016).  
In the GG, several studies illustrated that healthcare staff in UNRWA and MOH need to 
implement a continuous education and training programs for healthcare staff concerning 
EDL and treatment protocols (Baba, 2012; Al-khodary, 2016) while no information about 
local formulary knowledge for NGOs healthcare staff provided, this kind of information 
covered during this study. 
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2.2.19 MOH Monitoring and evaluation system  
Palestinian NGHs suffer from Lack of financial resources for this reason the auditing 
system become very important. A study was undertaken in MOH about the internal audit 
which showed moderately experience in auditing field and few of the auditors have a 
professional certificate Arab Certified Professional Accountant (ACPA) so MOH at the 
GG must highly focus on internal auditing function to control activities , and enhance work 
in the MOH (Azzam, 2015). In addition, the MOH role in monitoring and evaluation is 
critical and crucial in saving resources and producing figures and indicators to have 
overview about the current situation. Pharmaceutical policy implementation is not 
regularly monitored/assessed (Shahin, 2011). Regarding MoH annual report 2018 of Unit 
of Licensing & Accreditation (UAL) the unite responsibilities summarized in; issuing a 
license to practice a profession; issuing and check health facilities license including 
PNGHs and follow up the technical and administrative matters; confiscating medical 
samples, contagious drugs, illegal and expired medical materials and solutions and 
following up the companies and warehouses supplied them, warning citizens to deal with 
them through the unit's website, follow up complaints, attending and sharing in MOH 
committees, workshops and trainings, inspection if all the working medical staff within the 
facility employee list and finally, the extent to which the quality standards are applied 
(UAL-MOH, 2018). 
2.2.20 Health facility auditing and monitoring system 
Monitoring system in the hospitals can include the following tasks: compliance with 
education & training, screening of employee applicants by making sure that the new 
employee has the appropriate background to the hire position and perform verification of 
licensure/certification, all employees have access to help if they need any, availabilities of 
local drug list copies with prescribers (HCCA, 2005). a study conducted to detect the Audit 
and Feedback effects on professional practice of physicians, found that Audit and feedback 
generally leads to small but potentially important improvements in professional practice. 
The study concluded that the effectiveness of the Audit and feedback system seems to 
depend on baseline performance and how the feedback is provided (Thomson, Oxman, 
Davis et al., 2010). 
 
 38 
3 Chapter Three 
Methodology 
3.1 Study Design 
The design of this study is triangulated, analytic, descriptive cross-sectional retrospective 
one in term of prescribing indicators and prospective in term of health facility indicator. It 
used to describe the present status of drug description and use in the NGHs in the GG. 
Those health facilities represented different geographical location, type of care provision 
and patient load. The cross-sectional design is practical, simple, cheap, easy and enable the 
researcher to get his objectives in short time (Martins, Zin, & Zin, 2005). In this study, 
methodological triangulation would provide combination between quantitative (data collect 
from patient file and self-developed questionnaire) and qualitative paradigms (in depth 
interviews with key health providers) to get findings that can remove assumptions and 
replace them with actual data on the specific variables studied during the time period 
accounted for in the cross-sectional study (study.com, 2017). 
3.2 Study Population 
The study population consists of two groups: 
1. All the patients received the SHC services in the NGHs in the GG.  
2. All prescribers in the NGHs in the GG.  
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3.3 Study Setting 
The NGHs in the GG who are provided SHC services which are eleven hospitals (Table 
3.1). 
Table (‎3.1): The study setting: The NGHs in the GG. 
No. Governorate NGHs 
1 North governorate Al-Awda Hospital 
2 
 
Gaza governorate 
Public Aid Hospital 
Al Ahli Arab Hospital 
Patient Friend's Benevolent Society (PFBS) 
Hospital 
Al-Karama specialized Hospital 
Al-Quds Hospital 
Hayfa charity hospital 
3 Middle Area governorate Yafa Hospital 
4 Khan-Younis governorate 
Al Amal Hospital 
Dar Al-Salam Hospital 
5 Rafah governorate Kuwait obstetrical and pediatric Hospital 
 
3.4 Study Period 
The study started after having the university's approval of the proposal and after obtaining 
the ethical approval from Helsinki Committee Annex (1) and selected NGHs approval 
Annex (2). Pilot study conducted and then data collection began. The study expected to 
consume 11 months; it started in August, 2017 and expected to be completed by June 
2018. Annex (3) describes the activities of the research and expected duration for each 
activity 
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3.5 Sampling 
3.5.1 Sample calculation 
According to WHO manual, the number of health facilities is not less than 20, If fewer 
facilities are included, a larger number of cases should be selected in each, so that the 
minimum of 600 encounters is reached. To compare individual  facilities at least  100 
encounters would be recommended to collect per facility to conduct the study (WHO, 
1993).  
In this study, the researcher conducted the study in eleven NGHs in the GG. The study 
focused on three domains in the hospital which were: in-patient discharge sheet, in-patient 
medication sheet, and out-patient clinic medication sheet. The total encounters were 3960, 
each hospital provided 360 encounters, the 360 encounters provided from the three 
mentioned domains in the hospitals, 120 encounters from each domain. By collecting 360 
prescription sheets from each selected hospital the researcher could conduct comparison 
between the selected NGHs in terms of prescribing pattern and health facility indicators. 
For the prescribers‘ questionnaire, the number of the prescribers of each hospital was taken 
from the manager of each hospital, the sample of the study was a proportional sample and 
representative for all prescribers working in the NGHs. The sample determined by using 
the following parameters to calculate the sample size (Table 3.2): 
a. Maximum acceptable percentage points of error 5%. 
b. Confidence level at 95%. 
c. Total population (384). 
d. Sample size of prescribers is 192, the researcher will take 200 prescribers. 
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Table (‎3.2): The total number of physicians working at the study settings and sample 
size calculation 
No. NGHs 
No. of 
prescribers 
Total sample 
(%) 
Sample size 
1 Al Awda  50 12 25 
2 Al Ahli Arab  18 4.4 9 
3 Al Amal  45 11 22 
4 Al-Karama  28 7 13 
5 Al-Quds  72 18 35 
6 Dar Al-Salam  30 7.4 15 
7 Hayfa 22 5.4 11 
8 Kuwait  20 5 10 
9 PFBS 55 13.5 27 
10 Public Aid  47 11.6 23 
11 Yafa  20 5 10 
Total 406 100% 200 
3.5.2 Sampling process 
The researcher selected 11 NGHs in the GG which were provided SHC services. The 
sample as follow; one hospital in the north governorate, six hospitals in the Gaza 
governorate, one hospital in the Middle Area governorate, two hospitals in Khan-Younis 
governorate and one hospital in Rafah governorate (Table 3.3). 
Table (‎3.3): The distribution of sample size in the selected NGHs 
No. Governorate NGHs 
Discharge 
sheet 
Medication 
sheet 
Out-patient 
sheet 
Total 
1 North governorate Al-Awda  120 120 120 360 
2 Gaza governorate 
Public Aid  120 120 120 360 
Al Ahli Arab  120 120 120 360 
PFBS 120 120 120 360 
Al-Karama  120 120 120 360 
Al-Quds  120 120 120 360 
Hayfa  120 120 120 360 
3 
Middle Area 
governorate 
Yafa 120 120 120 360 
4 
Khan-Younis 
governorate 
Al-Amal 120 120 120 360 
Dar Al-Salam  120 120 120 360 
5 Rafah governorate Kuwait  120 120 120   360 
Total 1320 1320 1320 3960 
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3.6 Eligibility criteria 
3.6.1 Inclusion criteria 
The study conducted in the five Gaza governorates by selecting eleven NGHs in the GG. 
The selected NGHs matched the following criteria: 
1) Having MOH license.  
2) Contains internal and/ or external pharmacy. 
3) Providing SHC services. 
4) Providing more than one service. 
3.6.2 Exclusion criteria 
1) Hospital working in physical therapy (rehabilitation). 
2) Hospital working in psychological therapy. 
3) Hospital working in ophthalmology. 
4) Inpatient prescriptions report from units in the selected NGHs provided tertiary 
health Care services as diagnostic radiology, ophthalmology, obstetrics and 
gynecology service, neonatal intensive care unit, open heart surgeries, 
catheterization unit. 
3.7 Study instruments 
This study utilized WHO data collection forms and self-development encounter forms 
beside self-developed questionnaire and self-developed observational checklist. 
1. Prescribing indicator forms. 
2. Facility summary form. 
3. Self-developed observational checklist for prescription writing skills. 
4. Self-developed hospital key drugs list. 
5. Self-developed questionnaire for prescribers. 
The researcher used five instruments, the first was the WHO data collection forms which 
reflected the five quantitative core indicators regarding prescribing practice, two indicators 
regarding health facility and the complementary indicators (Average drug cost per 
encounter, the percentage share of each antibiotic, percentage of drug costs spent on 
antibiotics and the percentage of using of antimicrobials). Annex (4,5,6) show WHO data 
collection forms. Annex (7) show Antimicrobial classification for prescribing 
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indicators. Annex (8) show facility summary form. The second was self-developed 
observational checklist for prescribing writing skills. Annex (9) show self-developed 
checklist for prescribing writing skills.  
The third was self-developed key drugs list in NGHs in the GG. Annex (10) show the self- 
developed hospital key drugs lists in NGH in the GG. The fourth was self-developed 
questionnaire for prescribers. Annex (11) show self-developed questionnaire for 
prescribers and Annex (12) show list of experts and professional who consulted for 
the study questionnaire. 
3.8 Data Collection 
The researcher and team of two data collectors filled the WHO forms with required data 
for 12 months ago (June 2016 to June 2017), the data collectors  collected 10 prescription 
sheets each month in different time of the month, this technique of selection and the 
interval of the study minimized bias due to seasonal variations or interruptions in the drug 
supply cycle, also permitted equal chances for sample selection and represent various days 
of the month where the prescription pattern can be affected. Data collection for the 11 
selected NGHs needed around four months to finish 3960 prescribing sheets. Annex (13) 
describes the actual sample distribution and data collection plan. 
3.9 Data entry and analysis 
Data was collected according to WHO data collection formats in order to assess 
prescribing indicators and facility indicators. The data collection was supervised on a daily 
basis by the investigators involved in this study. Completeness of the data was checked 
every day during the data collection period. The data generated for each hospital were 
entered into a computer using Statistical Package for the Social Sciences (SPSS) version 
20.0 software (IBM Corporation, Armonk, NY, USA) to be edited, cleaned, and analyzed. 
The data were analyzed descriptively and summarized using tables and a bar or Pie chart. 
Data are presented as simple frequency, mean and standard deviation (SD). The findings 
were compared and contrasted with other national and international studies. 
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3.10 Scientific rigor 
3.10.1 Validity 
The data collection forms regarding prescribing indicators didn‘t need evaluation by 
experts to assess its relevance because the researcher used WHO data collection forms 
which are well tested. 
For the self-developed questionnaire regarding prescribers‘ knowledge, attitude and 
practice was evaluated by experts to assess its relevance, and their comments were taken in 
consideration. Also, a pilot study was conducted before the actual data collection to 
examine data collectors‘ ability to fill the indicators forms and observational checklist in 
smooth and good manner, in the other hand, during the pilot study, the researcher 
examined the prescribers‘ responses to the questionnaire and how they understand it. This 
would enhance the validity of the questionnaire after modifying it to be better understood. 
3.10.2 Reliability 
The following steps done to assure instruments reliability 
 Training of data collectors to understanding WHO forms and the meaning of each 
indicator and how to calculate. 
 Then, the data entry in the same day of data collection allow possible interventions 
to check the data quality or to re-fill the questionnaire when required. 
 Re-entry of 5% of the data after finishing data entry assured correct entry procedure 
and decrease entry errors. 
3.11 Pilot study 
A pilot study was conducted before the actual data collection started to let the researcher 
train for data collection, with an aim of improvement of the study validity and reliability, 
piloting also conducted to identify potential problem areas and deficiencies in the 
questionnaire, such as the accessibility to participants or records, and to minimize the non-
response rate. The pilot study was conducted on 10% of the main study sample. The pilot 
study sample consisted of 20 physicians worked in Al-Awda hospital. 
3.12 Ethical Considerations 
During all stages, the researcher was committed to all ethical consideration required to 
conduct the study. Ethical approval (Helsinki committee approval) was obtained from the 
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Palestinian health Research Council in Gaza (Annex 1). In addition, an official admin 
approval was obtained from the nine NGHs (Al-Awda Hospital, Public Aid Hospital, 
Patient Friend's Benevolent Society Hospital, Al-Karama specialized Hospital, Yafa 
Hospital, Hayfa charity hospital, Al Amal Hospital, Dar Al-Salam Hospital, Kuwait 
obstetrical and pediatric Hospital) in the GG (Annex 2). In the same time Al Ahli Arab 
Hospital and Al-Quds Hospital refused to participate in the research. 
3.13 Limitations of the study 
 The study included a sample from the NGHs and there are other hospitals working 
in psychological field or specialized NGHs in one service as ophthalmic hospital 
were not be included. 
 The study focused in only two drug core indicator groups out of three due to the 
limited time of the study. 
 All the questions in the questionnaire are closed-ended which may hinder some 
important points on knowledge and practice of the participating physicians.  
 Two hospitals (Al Ahli Arab Hospital and Al-Quds Hospital) refused to participate 
in the research. 
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4 Chapter Four 
Results and Discussion 
The study planned to cover all NGHs in the GG which were 11 NGHs in 2017. The GG 
has 11 NGHs distributed through the five GG to provide healthcare services. Two of the 
NGHs (Al-Quds Hospital and Al-Ahli Arab Hospital) apologized and refused to participate 
in the research. 
The following chapter explores the statistical analysis of the data and the interpretation of 
findings. Firstly, presenting statistical analysis data of knowledge, attitude and practice 
questionnaire were disseminated through physicians in the two mentioned departments 
(inpatient and outpatient) in the nine participated NGHs. Secondly, the researcher 
presented the descriptive analysis of the checklist data from the 9 NGHs in the GG which 
cover two departments; inpatient and out-patient department, inpatient department findings 
extracted from discharge sheet and medication sheet (admitted cases). From the checklist 
the researcher can measure the WHO indicators (Prescribing indicators group and the 
complementary indicators) and assess the drug prescribing practice at the NGHs in the GG. 
Finally, the researcher presented the data of the health facility indicators group by using 
WHO approved facility summary form. 
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4.1 Descriptive analysis of the questionnaires 
Out of the total number of collected 200 questionnaires, 198 questionnaires were collected 
from nine selected NGHs in the GG with response rate 99% (Table 4.1). 23 questionnaires 
were collected from Al-Amal hospital, which represents 12% of the total sample, 30 out of 
32 questionnaires were collected from Al-Awda hospital, which represents 15.2% of the 
total sample, 18 questionnaires were collected from Al-Karama hospital, which represents 
9.1% of the total sample, 19 questionnaires were collected from Dar Al-Salam hospital, 
which represents 9.6% of the total sample, 15 questionnaires were collected from Hayfa 
hospital, which represents 7% of the total sample, 13 questionnaires were collected from 
Kuwait hospital, which represents 6.6% of the total sample, 36 questionnaires were 
collected from PFBS hospital, which represents 18.2% of the total sample, 31 
questionnaires were collected from Public Aid hospital, which represents 15.7% of the 
total sample and 13 questionnaires were collected from Yafa hospital, which represents 
6.6% of the total sample. As shown in Table (4.1) 
Table (‎4.1): The total number of physicians working at the study settings and the sample 
size calculation 
No NGHs No. of prescribers 
Total sample 
(%) 
Sample size 
1 Al Amal 35 12 23 
2 Al Awda  50 15.2 32 
3 Al-Karama  28 9.1 18 
4 Dar Al-Salam  30 9.6 19 
5 Hayfa  22 7 15 
7 Kuwait  20 6.6 13 
8 PFBS 55 18.2 36 
9 Public Aid  47 15.7 31 
10 Yafa  20 6.6 13 
Total 384 100% 200 
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4.1.1 Participants characteristics  
4.1.1.1 Socio-demographic characteristics of the study participants 
Table (‎4.2): Socio-demographic characteristics of study participants in the NGHs in the 
GG (n=198). 
Variable Frequency Percent 
1. Age of participants 
30 years & less 
17 
  
8.6% 
31-45 years 
93  
 
47% 
46-60 years 
55 
 
27.8% 
61 years & more 
33 
 
16.7% 
Total 
198 
 
100% 
Mean = 46.3    SD=11.28 
2. Gender of participants 
Male 
177 
 
89.4% 
Female 
21 
 
10.6% 
Total 198 100% 
3. Marital status of participants 
Single 
3.5 
 
7% 
Widow 
2 
 
1.1% 
Divorced 
1 
  
0.5% 
Married 
188  
 
94.9% 
Total 198  100% 
4. Residency governorates of participants 
North 
26  
 
13.1% 
Gaza 
105  
 
53% 
Middle area 
16 
  
8.1% 
Khan-Yonis 
34  
 
17.2% 
Rafah 
17  
 
8.6% 
Total 198 100% 
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Regarding the age of participants, as shown in Table (4.2). The overall mean age of the 
participants was 46.3 years with (SD= 11.28, Range: 47 years), the most common age 
group was 31-45 years old. About more than half 55.6% of the study participants were 
younger than 46 years old, while 16.7% of the study participants were older than 60 years 
old. Regarding gender of study participants, as shown in Table (4.2), the majority 89.4% 
were male while 10.6% were female (Figure 4.1). Regarding the marital status of the study 
participants, Table (4.2) showed that the majority of the study participants 94.4% were 
married, 7% single and 1.6% divorced and widow. Regarding the residency of the study 
participants, Table (4.2) showed that 53% of the study participants were residents of the 
GG; 17.2% were residents of Khan Younis governorate, 13.1% were residents of North, 
8.6% were residents of Rafah and 8.1% were residents of middle area 
 
 
 
Figure (‎4.1): Distribution of the study participants by gender 
 
 
 
Male 
89% 
Female 
11% 
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4.1.1.2 Work characteristics of the study participants in the NGHs in the GG 
Table (‎4.3): Work characteristics of the study participants in the NGHs in the GG (n=198) 
Variables Frequency Percent 
1. Academic qualifications 
Bachelor degree BSc. 51 25.8% 
Diploma 25  12.6% 
Master degree 65 32.8% 
Board 46 23.2% 
Doctor of Philosophy degree Ph.D 11 5.6% 
Total 198 100% 
2. Specialty 
General medicine 39 19.7% 
Internal 15  7.6% 
Urology 2 1% 
General surgery 33 16.7% 
Pediatric 19  9.6% 
ENT 16  8.1% 
Orthopedic department 17 8.6% 
Cardiology 8  4% 
Obstetrics & gynecology 28 14.1% 
Emergency 2  1% 
Dental 19  9.6% 
Total 198 100% 
3. Job description 
Director of department 6  3% 
Head of section 25 12.1% 
Head of division 10  5.1% 
Hospital director 3 1.5% 
Medical director 1 1% 
Without 153  77.3% 
Total 198 100% 
4. Total years of experience 
Lower than 10 years 48 24.2% 
11-20 years 88  44.4% 
21-30 years 35 17.7% 
31 years and more 27 13.5% 
Total 198 100% 
Mean=18.97         SD=10.4         Minimum=1 year        Maximum=47 years 
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As shown in Table (4.3), regarding to the academic qualifications of the study participants, 
74.2% of the study participants had postgraduate studies, 32.8% of the study participants 
had master degree, 23.2% of the study participants had board, 12.6% of the study 
participants had diploma, 5.6% of the study participants had Doctor of Philosophy degree 
(Ph.D) and 25.8% had a Bachelor degree.  
Regarding to specialty, 19.7% of the study participants were general medicine and 9.6% 
were dental while most of the study participants 80.3% were specialist. 16.7% had 
specialty in surgical field, 14.1% of them had specialty Obstetrics and gynecology field, 
9.6% of them had specialty in Ear, nose and throat (ENT) field, 9.6% of them had specialty 
pediatric field, 8.6% of them had specialty in Orthopedic department field, 7.6% of them 
had specialty in internal medicine field, 4% of them had specialty in Cardiology field, 1% 
of them had specialty in Emergency field and 1% of them had Urology field.  
Regarding job description of the study participants, 77.3% without any managerial 
position, in contrast, 22.7% with managerial position; 3% of them had a director of 
department managerial position, 12.1% of them had a head of section managerial position, 
5.1% of them had a head of division managerial position, 1.5% of them had a hospital 
director managerial position and 1% of them had a medical director managerial position. 
Regarding the total years of work experience of the study participants in the NGHs, the 
average years of work experience of the study participants in the NGHs was 18.97 years 
(with a minimum of 1 years and maximum 47 years, SD=10.4) and this finding are 
consistent with study participants age and specialty. the most common group of total years 
of experience 44.4% was 11-20 years followed with age group lower than 11 years with 
24.2% and total years of group 21- 30 years with 17.7% finally total years of experience 31 
years and more with 13.5%. 
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4.1.2 Knowledge, Attitude and Practice of physician in the NGHs in the GG  
4.1.2.1 Knowledge, Attitude and Practice of physicians in the NGHs in the GG 
toward local formulary 
Table (‎4.4): Knowledge, Attitude and Practice of physicians in the NGHs in the GG 
toward local formulary. 
Variables Frequency Percent 
1. Knowledge about the presence of hospital local formulary (n=198) 
Yes 90 45.5% 
No 41 20.7% 
Don’t Know 67 33.8% 
Total 198 100% 
2. Participants receive training on local formulary contents (n=90) 
Yes 11 12.2% 
No 79 87.8% 
Total 90 100% 
3. Local formulary is updated routinely (n=90) 
Yes 62 68.8% 
No 6 6.7% 
Don’t Know 22 24.4% 
Total 90 100% 
4. Receiving copy of local formulary in the hospital (n=90) 
Yearly 38 42.3% 
Every two- years 3 3.3% 
Don’t have any copy 36 40% 
Others 13 14.4% 
Total 90 100% 
5. Participation in designing and developing up hospital local formulary (n=90) 
Yes 28 31.1% 
No 62 68.9% 
Total 90 100% 
6. Attendance to refreshing lectures on the local formulary (n=90) 
Yes 13 14.4% 
Rarely 16 17.8% 
No 61 67.8% 
Total 90 100% 
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Regarding the study participants knowledge about existence of local formulary in the 
NGHs, as shown in Table (4.4), 45.5% of the study participants were aware of the 
existence of hospital local formulary. This finding in the NGHs was approximately close to 
the awareness level  of the physicians in the governmental hospitals  in the GG which was 
just 47.1% (Al-khodary, 2016). 
Regarding the results found in knowledge about the existence of local formulary in the 
NGHs, the study participants who completed the questions related to local formulary 
concept were 90 out of 198 participants of the study participants. The 90 study participants 
completed the questions related to the local formulary concept. 
Regarding knowledge and practice of physicians towered local formulary in the NGHs in 
the GG, the 90 out of 198 study participants participated in this group of questions shown 
in Table (4.4). With respect to the training process on local formulary content and concept, 
Table (4.4) shown that only 12.2% of the study participants received training on local 
formulary content and concept while, the majority of the study participants (87.8%) did not 
receive any training on local formulary content and concept. The finding of the study is 
consistent with the findings of regarding to the training process on local formulary content 
and concept in Al-Khodary study (87.6%) (Al-khodary, 2016). In fact, regarding to 
individual interviews was conducted with the NGHs management; no training on local 
formulary content and concept had been conducted in the selected NGHs through the 
previous period of time.  
Regarding local formulary updating process, Table (4.4) showed that 68.8% of study 
participants know that hospital local formulary updated routinely while 24.4% don‘t have 
any idea about updating process in hospital local formulary. Our finding is inconsistent 
with Al-Khodary study 2016 that showed that the study participants knowledge level about 
local formulary update process is better than participants knowledge level in the 
governmental hospitals in the GG (32.5%) (Al-khodary, 2016). 
With respect to receiving copy of local formulary in the hospitals, as shown in Table (4.4), 
the majority of study participants (60%) received local formulary copy in different time 
manner. 42.2% of the study participants receiving copy of local formulary yearly while 
14.4% of study participants received copy of local formulary in irregular time. This finding 
is inconsistent with Al-Khodary study 2016 that showed 10.7% of the study participants 
received hospital local formulary copy yearly to the governmental hospitals in the GG (Al-
khodary, 2016). 
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Table (4.4) revealed that more than two thirds of study participants (68.9%) neither 
involved in designing nor in developing up hospital local formulary. The finding of the 
study is consistent with the finding of regarding to the designing and developing up 
hospital local formulary in Al-Khodary study (89.1%) (Al-khodary, 2016).  
With respect to the attendance to refreshing lectures on local formulary, Table (4.4) shown 
that the majority of the study participants (85.6%) either never attended nor rarely attended 
the refreshment lecture on local formulary in the NGH. The low percentage of attendance 
to refreshing lectures on local formulary emphasizes the low percentage of receiving 
training on local formulary contents. The finding of the study is consistent with the finding 
in the governmental hospitals in the GG regarding to attendance to refreshing lectures on 
local formulary in Al-Khodary study (95.1%) (Al-khodary, 2016).  
4.1.2.1.1 Participant’s attitude toward local formulary 
Table (‎4.5): Participant‘s attitude toward local formulary (n=198) 
Variable 
Strongly 
Disagree 
Disagree Uncertain Agree 
Strongly 
Agree 
Mean 
Mean % of 
positive 
responses 
1. local formulary is necessary for provision of quality health services 
No 4 9 13 124 48 
3 75% 
% 2% 4.5% 6.6% 62.6% 24.2% 
2. local formulary is necessary to reduce wasting of health care resources 
No 3 8 30 115 42 
2.9 72.5% 
% 1.5% 4% 15.2% 58.1% 21.2% 
3. local formulary is necessary to prevent patient harm 
No 5 18 32 107 36 
2.8 70% 
% 2.5% 9.1% 16.2% 54% 18.2% 
4. local formulary selection criteria are scientifically based 
No 4 4 46 108 36 
2.8 70% 
% 2% 2% 23.2% 54.5% 18.2% 
5. local formulary must include the majority of needed drugs 
No 29 77 37 50 5 
1.6 40% 
% 14.6% 38.9% 18.7% 25.3% 2.5% 
Mean %= 65.5%                      SD=3.35 
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As shown in Table (4.5), there was a positive attitude about the local formulary, the 
overall mean of the study participant's positive attitude about local formulary was 65.5% 
(SD= 3.35).  
As shown in the Table (4.5), the majority of the study participants (86.8%) were agreed or 
strongly agreed on the value and necessity of local formulary for provision of quality 
health services within hospitals. The mean percentage was 75%. Additionally, as shown in 
the Table (4.5), the majority of the study participants (79.3%) were agreed or strongly 
agreed that the use of local formulary reduces wasting of health care resources. The mean 
percentage was 72.5%. Furthermore, as shown in the Table (4.5), 72.2% of the study 
participants were agreed or strongly agreed that the use of local formulary prevents patient 
harm, while 11.6% of the study participants disagreed on that. The mean percentage was 
70%.  
As shown in the Table (4.5), more than two thirds of the study participants (72.2%) were 
agreed or strongly agreed that the listed drugs in the local formulary are selected on 
scientific bases, while 23.2% of the study participants were uncertain. The mean 
percentage was 70%. Moreover, as shown in Table (4.5), more than one half of the study 
participants (53.5%) revealed that they were disagreed that local formulary must contain 
the majority of needed drugs for treatment of admitted patients in the hospital while 18.7% 
of the study participants were uncertain. The mean percentage was 40%. This finding 
reflects the poor knowledge toward local formulary contents and concept which 
emphasizes the need of conducting training on local formulary contents and concept as 
showed in Table (4.5). 
The main reasons that could explain limited physicians‘ knowledge about hospital local 
formulary in the NGHs are the same in other location as governmental hospitals in the GG 
which are: (1). Hospital management did not implement training programs for physicians 
on the concept and content of the local formulary (2). local formulary and other related 
topics are not included in the educational curriculum of the faculties of medicine in the 
Palestinian universities; (3). The absence of local formulary related topics in the training 
programs for newly recruited physicians; and (4). The limited availability hard copies of 
the local formulary within hospitals (Al-khodary, 2016). 
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4.1.2.2 Factors related to participant’s practices toward prescribing drugs  
Table (‎4.6): Factors related to participant‘s practices toward prescribing drugs (n=198) 
Variables frequency Percent  
1. Physicians’ communication with pharmacists regarding drugs need 
Always 
69 
 
34.8% 
Rarely 
102 
 
51.5% 
Don’t 27 13.6% 
Total 
198 
 
100% 
2. Participants sources of drugs information 
Hospital Pharmacist 
134 
 
67.7% 
Medical Re- presentative 
2 
 
1% 
Internet 
51 
 
25.8% 
A text book 
10 
 
5.1% 
Colleague 
1 
 
0.5% 
Total 
198 
 
100% 
3.  Prescription drugs influence with patient believes 
Always 
20 
 
10.1% 
Rarely 
99 
 
50% 
No 
79 
 
39.9% 
Total 
198 
 
100% 
Regarding the communication of physicians with hospital pharmacy. Table (4.6) shown 
that, two thirds (65.1%) of the study participants do not communicate with the pharmacists 
properly or regularly. The finding of the study is consistent with the finding of regarding to 
physician‘s communication with hospital pharmacy in Al-Khodary study (78.6%) (Al-
khodary, 2016).  
Regarding sources of drug information of the study participants, Table (4.6) revealed that 
the study participants do not have a particular source of drug information. The most two 
common drug information sources were the hospital pharmacists and Internet. Hospital 
pharmacists indicated by 67.7% of the study participants and Internet indicated by more 
than one-fourth 25.8% of the study participants. This finding is consistent with Al-Khodary 
study in the governmental hospitals where the hospital pharmacists and Internet were the 
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most common  drug information source in the GG (Al-khodary, 2016) while the two 
common drug information sources in UNRWA clinics in the GG were physicians 
experience and training courses (Saleh, 2008).  
Regarding influence physicians with patient desire, believes and expectations in their 
writing drug prescribing, Table (4.6) shown that 60.1% of study participants affected 
either rarely or always with patient desire, believes and expectations in writing drug 
prescriptions.  
4.1.2.2.1 Participant’s practices toward prescribing drugs 
Table (‎4.7): Participant‘s practices toward prescribing drugs (n=198) 
Variable 
Strongly 
Disagree 
Disagree Uncertain Agree 
Strongly 
Agree 
Mean 
Mean % of 
positive 
responses 
1. Explain treatment to the patient and mention the necessary warnings and instructions 
No 14 58 80 41 5 
1.83 45.75% 
% 7.1 29.3 40.4 20.7 2.5 
2. Compliance in prescribing drugs from local formulary  
No 4 11 11 108 64 
3 75% 
% 2 5.6 5.6 54.5 32.3 
3. Using hospital-approved protocols regardless of the latest protocols 
No 14 92 49 40 3 
1.62 40.5% 
% 7.1 46.5 24.7 20.2 1.5 
4. Drug prescription is based on the drugs available at the hospital pharmacy 
No 1 19 37 11 5 26 
2.73 68.25% 
% 0.5 9.6 18.7 58.1 13.1 
5. Permanent communication with the pharmacist to find out the available drugs 
No 8 52 41 86 11 
2.2 55% 
% 4 26.3 20.7 43.4 5.6 
Mean%=56.9 %                        SD=1.93 
 
Regarding physicians‘ practices toward prescribing drugs, as shown in Table (4.7), there 
was positive practice toward prescribing drugs, the overall mean of the study participant's 
about local formulary was 56.9% (SD= 1.93).  
As shown in the Table (4.7), on practical basis, unexpectedly, less than one third of the 
study participants (23.2%) agreed about writing warning and instruction during drug 
prescription while 40.4% of the study participants uncertain. The mean percentage was 
45.75%. Furthermore, as shown in the Table (4.7), the majority of the study participants 
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(86.8%) revealed that they committed to prescribing drugs included in the hospital local 
formulary during their work in the hospitals. The mean percentage was 75%.  
Regarding using hospital-approved protocols regardless of the latest protocols, as shown in 
Table (4.7), less than one third of the study participants (21.7%) agreed to compliance 
with treatment protocols approved by the hospital during their work in the hospital while 
24.7% uncertain about using the approved treatment protocols in the hospital. The mean 
percentage was 40.5%. 
Additionally, Table (4.7) revealed that how many the available drugs in the hospital 
pharmacy effect on the drug prescription of the study participants, unexpectedly, the 
majority of the study participants 71.2% agreed that the available drugs in the hospital 
pharmacy effect in the way of their writing the drug prescriptions. The mean percentage 
was 68.25%. On the other hands, Table (4.7) showed that there is low communication 
level between physicians and hospital pharmacist, less than one half of the study 
participants 49% keep good communication channel with hospital pharmacist. The mean 
percentage was 55%. The remarkable low percentage of physician‘s permanent 
communication with the hospital pharmacists to find out the available drugs (49%) is 
consistence with the findings in Table (4.6) that showed low percentage of hospital 
pharmacists as a source of drug information (67.7%) and with finding of participants 
communication with hospital pharmacists properly or regularly that showed two thirds of 
the study participants (65.1%) do not communicate with pharmacists properly or regularly, 
all these findings reflect the weak communication between physicians and hospital 
pharmacists. 
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4.1.2.3 Factors related to physician’s knowledge, attitude and practices (KAP) 
toward the treatment protocols in the NGHs 
Table (‎4.8): Factors related to physician‘s knowledge, attitude and practices (KAP) toward 
the treatment protocols in the NGHs  
Variables Frequency Percent 
1. There are treatment protocols in the hospital (n=198) 
Yes 
48 
 
24.3% 
No 
77 
 
38.8% 
I don‘t Know 
73 
 
36.9% 
Total 198 100% 
2. Treatment protocols location (n=48) 
Hospital Library 2 4.2% 
Hospital ward 27 56.3% 
Pharmacy 13 27% 
Don‘t know 4 8.3% 
Other places 2 4.2% 
Total 48 100% 
3. Source of the treatment protocols (n=48) 
Hospital director 11 22.9% 
Therapeutics committee in the hospital 16 33.3% 
Text book 15 31.3% 
I don‘t know 6 12.5% 
Total 48 100% 
4. Treatment protocols matching hospital local formulary (n=48) 
Always 23 47.9% 
Rarely 20 41.7% 
Don‘t 5 10.4% 
Total 48 100% 
5. Receiving written treatment protocols (n=48) 
Yes 19 39.5% 
Rarely or don‘t 29 60.4% 
Total 48 100% 
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Regarding factors related to physician‘s knowledge, attitude and practices (KAP) toward 
the treatment protocols in the NGHs, Table (4.8) shown that only 24.3% of the study 
participants confirmed the presence of treatment protocols in the hospital. Generally, 
physician‘s knowledge level about presence of protocols in the NGHs is lower than 
physician‘s knowledge level in the governmental hospitals in the GG (38.1%)  (Al-
khodary, 2016). 
In fact, regarding individual interviews with hospitals managements there is no presence of 
treatment protocols in the NGHs. 
As a result of the question related to the presence of the treatment protocol in the NGHs, 
only 48 out of 198 of the study participants confirmed the presence of treatment protocols 
and they were nominated to participate in the following questions which are regarding to 
the knowledge about the treatment protocols concept in the NGHs. 
Regarding treatment protocol location in the hospital, Table (4.8) shown that more than 
one half of the study participants (56.3%) confirmed that protocols location is hospital 
ward. On the other hand, 8.3% of the study participants don‘t know the location of the 
treatment protocols, this finding is inconsistent with Al-Khodary study (2016) that showed 
low knowledge level to protocols location in the governmental hospitals in the GG (55.8%) 
(Al-khodary, 2016). 
With respect to the source of protocol in the hospital, Table (4.8) shown that around one-
third of the study participants 33.3% confirmed that the most common source of the 
treatment protocols is therapeutics committee in the hospital and 31.3% of the study 
participants confirmed that text book is the second source of the treatment protocols. In 
fact, regarding to the hospital management, the NGHs don‘t have neither therapeutics 
committee as a source for the treatment protocols nor the treatment protocols. Even Al-
Awda hospital has therapeutics committee but it not working as a source for the treatment 
protocols. 
Regarding if the Treatment protocols matching hospital local formulary, Table (4.8) 
shown that 47.9% of the study participants confirmed that treatment protocols always 
matching hospital local formulary.  
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Regarding receiving physicians written treatment protocol, Table (4.8) shown that 39.5% 
of the study participants confirmed that they receive written treatment protocols although 
no treatment protocols present in any NGHs as mentioned before.  
4.1.2.3.1 Participants attitude toward the treatment protocol in the NGHs 
Table (‎4.9): Participants attitude toward the treatment protocol in the NGHs (n=198) 
Variable 
Strongly 
Disagree 
Disagree Uncertain Agree 
Strongly 
Agree 
Mean 
Mean % of 
positive 
responses 
1. Drugs included in the treatment protocols are effective 
No 7 14 74 94 9 
2.42 60.5% 
% 3.5 7.1 37.4 47.5 4.5 
2. The treatment protocols are obligatory for participants in the work 
No 5 53 42 80 18 
2.26 65.5% 
% 2.5 26.8 21.2 40.4 9.1 
3. Compliance with treatment protocols reduce total health cost 
No 5 22 38 111 22 
2.62 65.5% 
% 2.5 11.1 19.1 56.1 11.1 
4. Local formulary drugs included in the treatment protocols are less effective than others 
No 5 11 45 113 24 
2.7 67.5% 
% 2.5 5.6 22.7 57.1 12.1 
Mean%= 64.75%                          SD= 2.8 
 
As shown in Table (4.9), there was positive attitude toward treatment protocol in the 
hospital, the overall mean percentage of the study participant's attitude about the current 
treatment protocol in the hospital was 64.75% (SD= 2.8). 
As shown in Table (4.9), more than one-half of the study participants (52%) were agreed 
that drugs included in the treatment protocols are effective. The mean percentage was 
60.5%. Additionally, Table (4.9) revealed that 49.5% of the study participants were agreed 
that the treatment protocols are obligatory for participants in the work. The mean 
percentage was 65.5%. Moreover, as shown in Table (4.9), 67.2% of the study participants 
were agreed that compliance with treatment protocols reduce total health cost. The mean 
percentage was 65.5%. Unexpectedly and finally, Table (4.9) shown that 69.2% of the 
study participants were agreed that local formulary drugs are included in the treatment 
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protocols are less effective than others. The mean percentage was 67.5%. This finding 
reflects the poor knowledge toward local formulary drugs criteria and the urgent need for 
the program training for local formulary concept and contents. 
4.1.2.4 Participants opinion about hospital management efforts 
4.1.2.4.1 Participants opinion about hospital management efforts toward local 
formulary 
Table (‎4.10): Participants opinion about hospital management efforts toward local 
formulary (n=90) 
Variables Frequency Percent 
1. Having copy of hospital local formulary 
Paper 29 32.2% 
Electronic 9 10% 
Paper & Electronic 9 10% 
Do not have any copy 43 47.8% 
Total 90 100% 
2. Entity responsible for setting up hospital local formulary 
Hospital DTC 33 36.7% 
Central DTC 4 4.4% 
Hospital pharmacy committee 18 20% 
Medical director 1 1.1% 
MOH 1 1.1% 
External committee 0 0.0% 
External & internal committee 1 1.1% 
Procurement department 1 1.1% 
I don’t know 31 34.4% 
Total 90 100% 
3. Hospital management encourages physicians to be compliant with local formulary 
Always 24  26.7% 
Rarely or Do not 66 73.3% 
Total 90 100% 
4. Hospital management arrange training program and lectures on local formulary 
Yes 26 28.9% 
No or don’t know 64 71.1% 
Total 90 100% 
5. Hospital management gives feedback about physicians’ compliance with local 
formulary 
Yes 13 14.4% 
Rarely or No 77 85.6% 
Total 90 100% 
6. Hospital management takes any action against physicians don’t compliance with local 
formulary 
Yes 15 16.7% 
No 36 40% 
Don’t know 39 43.3% 
Total 90 100% 
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Regarding hospital management efforts in the NGHs in the GG, the 90 out of 198 study 
participants participated in this group of questions shown in Table (4.10). With respect to 
the participants opinion about hospital management efforts, Table (4.10) shown that 47.8% 
of the study participants didn‘t receive copy of hospital local formulary while 32.2% of the 
study participants received paper copy of the hospital local formulary. Generally finding in 
the NGHs toward physician receiving copy of hospital local formulary is better than 
finding of Al-Khodary study in the governmental hospital in the GG either in receiving any 
copy or at least having a paper copy (Al-khodary, 2016).  Additionally, regarding entity 
that was responsible for setting up hospital local formulary. As shown in Table (4.10), 
more than one third of the study participants 36.7% chose hospital DTC which was a 
correct answer for Al-Awda hospital only. Only 20% of the study participants chose 
correctly hospital pharmacy committee while 34.4% showed lack of knowledge about the 
responsible entity for setting up hospital local formulary. 
In fact, regarding NGHs managements; hospital pharmacists‘ committees in all selected 
NGHs are the responsible entity for setting up hospital local formulary except Al-Awda 
hospital which has a hospital DTC which consist of specialist physicians and hospital 
pharmacists. 
With respect to the hospital management efforts in encouraging physicians to be compliant 
with local formulary, Table (4.10) shown that 73.3% of the study participants felt that they 
were not encouraged properly by hospital management to be compliant with local 
formulary drugs. The finding of the study is consistent with the finding of regarding to 
hospital management efforts in encouraging physicians to be compliant with local 
formulary in governmental hospitals in the GG (83.5%) (Al-khodary, 2016). 
Regarding arrangement of lecture or training program on local formulary. Table (4.10) 
revealed that 28.9% of the study participants thought that the hospital management 
arranges lectures or training programs on local formulary in the selected hospitals. While 
71.1% didn‘t think or know if the hospital arranged any lectures or training program on 
local formulary in the hospital. These findings referred to a gab in communication and 
updating between the hospital managements and physicians where hospital physicians 
don‘t think or know if the hospital managements arranging any lectures or training 
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program on local formulary concept or contents. In fact, regarding to the NGHs 
management, all NGHs did not conduct any lecture or training program on local formulary 
in the selected hospitals. According to Dr. Ahmed Muhanna (Al-Awda hospital director) 
Al-Awda hospital management replace training on local formulary concept and content 
with distributing generalizations among physicians about hospital local formulary in 
regular time. 
Table (4.10) illustrated physicians‘ opinion regarding hospital management efforts in 
giving feedback about their compliance with local formulary. The study findings showed 
that physicians had negative perception about the role of the monitoring and evaluation 
system inside the hospitals to improve compliance with local formulary. As shown in the 
Table (4.10), the majority of the study participants (85.6%) received appropriate feedback 
from the hospital management about their compliance with local formulary. The same 
negative perception about the role of the monitoring and evaluation system inside the 
NGHs to improve compliance with local formulary found in governmental hospitals in the 
GG (45%) (Al-khodary, 2016) while the role of the monitoring and evaluation system in 
UNRWA health centers in the GG was better (Baba, 2012). 
Furthermore, Table (4.10) indicated the weak role of the hospital management in taking 
action against physicians who are don‘t compliance with local formulary, 40% of the study 
participants indicated that no action was taken against physicians who didn‘t compliance 
with local formulary while 43.3% did not have any idea if the hospital took any action 
against physicians who didn‘t compliance with local formulary. The finding of the study is 
not consistent with the finding of regarding to action was taken against physicians who 
didn‘t compliance with local formulary in UNRWA health centers in the GG (Baba, 2012). 
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4.1.2.4.2 Participants opinion toward monitoring efforts in the NGHs 
Table (‎4.11): Participants perception toward monitoring efforts of the hospital 
management in the NGHs (n=198) 
Variable 
Strongly 
Disagree 
Disagree Uncertain Agree 
Strongly 
Agree 
Mean 
Mean % of 
positive 
responses 
1. There is a monitoring system to measure physician’s compliance with local formulary 
No 13 89 60 34 2 
1.61 40.25% 
% 6.6 44.9 30.3 17.2 1 
2. There is a monitoring system to measure physician’s compliance with protocols 
No 16 74 65 38 5 
1.7 42.5% 
% 8.1 37.4 32.8 19.2 2.5 
3. The current hospital monitoring system is efficient and effective 
No 17 60 70 47 4 
1.8 45% 
% 8.6 30.3 35.4 23.7 2 
4. Compliance with protocol affect your performance appraisal 
No 11 49 79 51 8 
1.97 49.25% 
% 5.6 24.7 39.9 25.8 4 
5. Describing unnecessary treatments before they expire 
No 3 37 26 108 24 
2.57 64.25% 
% 1.5 18.7 13.1 54.5 12.1 
6. There are performance indicators for protocol compliance in the hospitals 
No 12 66 62 53 5 
1.86 46.5% 
% 6.1 33.3 31.3 26.8 2.5 
7. Periodically provision with a list of available drugs at the hospital pharmacy 
No 21 68 49 54 6 
1.92 48% 
% 10.6 34.3 24.7 27.3 3 
Mean% = 48%                         SD= 4.1 
As shown in Table (4.11), there was a negative perception toward hospital management 
efforts related to the monitoring system, the overall mean percentage of the study 
participant's perception about the current hospital management efforts was 48% (SD= 4.1). 
As shown in the Table (4.11), the majority of the study participants (81.8%) were either 
uncertain or declined the existence of monitoring system in the hospital to measure 
physician‘s compliance with local formulary drugs. The mean percentage was 40.25%. As 
shown in Table (4.11), 78.3% of the study participants were either uncertain or declined 
the presence of monitoring system to assess physician‘s compliance with the treatment 
protocols. The mean percentage was 42.5%. As shown in Table (4.11), the majority of the 
study participants (74.3%) were either uncertain or disagreed on the effectiveness of 
current hospital Monitoring and Evaluation system. The mean percentage was 45%. 
Moreover, Table (4.11) shown that the majority of the study participants (70.2%) were 
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either uncertain or disagreed that their compliance with the treatment protocol affects the 
performance appraisal. The mean percentage was 49.25%.  
Table (4.11) shown that the two thirds of the study participants (66.6%) were agreed that 
they describe unnecessary treatments due to near expire date of the available drugs in the 
hospital pharmacy, this happen after distribution the near expiry date drugs list that 
available in the hospital. The mean percentage was 64.25%. This finding is consistence 
with finding in Table (4:11) that showed 71.2% of the study participants agreed that the 
available drugs in the hospital pharmacy effect in the way of their writing the drug 
prescriptions. These findings reflected the profit side of the NGHs as well as the rational 
hospital management efforts in minimizing wasting resources. 
 Furthermore, as shown in the Table (4.11), 70.7% of the study participants were either 
uncertain or disagreed on the existence of performance indicators on their compliance with 
the current treatment protocols. The mean percentage was 46.5%. 
Finally, Table (4.11) shown that 44.9% of the study participants were disagreed on that 
hospital management providing list of the current available drugs at the hospital pharmacy. 
The mean percentage was 48%. 
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2.1.2.5 Comparison the compliance in prescribing drugs from local formulary by various variable   
 
Table (‎4.12): Comparison the compliance in prescribing drugs from local formulary by social and work characteristics  
   
Social and work 
characteristics 
Compliance in prescribing drugs from local formulary 
X2 Sig. 
Strongly 
disagree 
disagree neutral agree strongly agree 
n % n % N % n % n % 
1. Gender of the participants 
Male 4 100.0% 9 81.8% 9 81.8% 100 92.6% 55 85.9% 
3.778 0.437 Female 0 0.0% 2 18.2% 2 18.2% 8 7.4% 9 14.1% 
Total 4 100% 11 100% 11 100% 108 100% 64 100% 
2. Age of the participants 
30 years & less 0 0.0% 2 18.2% 1 9.1% 12 11.1% 2 3.1% 
10.083 0.609 
31-45 years 3 75% 5 45.5% 5 45.5% 51 47.2% 29 45.3% 
46-60 years 0 0.0% 3 27.3% 2 18.2% 31 28.7% 19 29.7% 
61 years & more 1 25% 1 9.1% 3 27.3% 14 13% 14 21.9% 
Total 4 100% 11 100% 11 100% 108 100% 64 100% 
3. Total years of experience  
Lower than 10 years 0 0.0% 1 9.1% 1 9.1% 12 11.1% 5 7.8% 
10.866 0.540 
11-20 years 1 25% 3 27.3% 2 18.2% 13 12% 10 15.6% 
21-30 years 2 50% 5 45.5% 5 45.5% 55 50.9% 21 32.8% 
31 years and more 1 25% 2 18.2% 3 27.3% 28 25.9% 28 43.8% 
Total 4 100% 11 100% 11 100% 108 100% 64 100% 
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Chi square test was used to examine the relationship between prescriber‘s compliance in prescribing drugs from local formulary and 
prescriber social and work characteristics. As illustrated in Table (4.12), there was no statistically significant relationship between prescriber 
gender and prescriber‘s compliance in prescribing drugs from local formulary (Sig.= 0.437). Also, there is no statistically significant 
relationship between prescriber age and prescriber‘s compliance in prescribing drugs from local formulary (Sig.=0.609), finally there is no 
statistically significant relationship between prescriber total years of experience and prescriber‘s compliance in prescribing drugs from local 
formulary (Sig.=0.540), so prescribers compliance in prescribing drugs from local formulary was not dependent in prescribers social and work 
characteristics. 
The same results found in Fattouh study were no statistically significant relationship between prescribers social and work characteristics and 
prescriber‘s compliance in prescribing drugs from EDL in the governmental PHC (Fattouh, 2005). 
Table (‎4.13): Comparison the compliance in prescribing drugs from local formulary by presence of treatment protocol in the NGHs 
Variable 
Compliance in prescribing drugs from local formulary 
x2 Sig. 
Strongly disagree disagree Neutral agree strongly agree 
n % n % n % n % n % 
  
There is treatment protocol in the hospitals 
No 2 50.0% 5 45.5% 3 30.0% 42 38.9% 26 41.3% 
2.970 .936 
Yes 1 25.0% 1 9.1% 4 40.0% 25 23.1% 16 25.4% 
I don't know 1 25.0% 5 45.5% 3 30.0% 41 38.0% 21 33.3% 
Total 4 100.0% 11 100.0% 10 100.0% 108 100.0% 63 100.0% 
 
As shown in Table (4.13), Chi square test was used to examine the relationship between prescriber‘s compliance in prescribing drugs from 
local formulary and presence of treatment protocol in the NGHs. As illustrated in Table (4.13), there is no statistically significant relationship 
between compliance in prescribing drugs from local formulary and presence of treatment protocols in the NGHs (Sig= 0.936), so prescribers‘ 
compliance in prescribing drugs from local formulary was not dependent in presence of treatment protocols in the NGHs. 
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2.1.2.6 Comparison the knowledge about the presence of hospital local formulary by 
various variable   
Table (‎4.14): Comparison the knowledge about the presence of hospital local formulary by social 
and work characteristics  
Social and work characteristics 
Knowledge about the presence of hospital local formulary 
N Mean SD t F P-value 
1. Gender of the participants 
Male 177 0.85 0.87 
-1.422 
 
0.157 Female 21 1.14 0.96 
Total 198 
  
2. Age of the participants 
30 years & less 17 1.00 0.94 
  1.010 0.389 
31-45 years 93 0.80 0.85 
46-60 years 55 1.04 0.92 
61 years & more 33 0.82 0.882 
Total 198 0.88 0.885 
3. Total years of experience 
Lower than 10 years 48 0.813 0.842 
 
2.016 0.113 
11-20 years 88 0.784 0.903 
21-30 years 35 1.200 0.833 
31 years and more 27 0.926 0.917 
Total 198 0.884 0.885 
T-test was conducted to examine the presence of statistically significant differences among 
the study settings concerning the mean of the prescriber‘s knowledge about the presence of 
hospital local formulary of the participants in the prescriber gender groups of study. As 
illustrated in Table (4.14), the gender type does not have statistically significant difference 
in the mean of prescriber‘s knowledge about the presence of hospital local formulary (t= -
1.422, P value=0.157).   
On the other hand, As shown in Table (4.14), the overall mean of age of the participants 
was 0.88 (SD=0.885). The highest mean of age of the participants was reported at 46-60 
years of participant age group (1.04) while the lowest mean of age of the participants was 
reported at 31-45 years of participant age group (0.80). 
One-way Anova test was conducted to examine the presence of statistically significant 
differences among the study settings concerning the mean of the prescriber‘s knowledge 
about the presence of hospital local formulary of the participants in the all age groups of 
study participants. As illustrated in Table (4.14), The age of the study participants was no 
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statistically significant change in the prescriber‘s knowledge about the presence of hospital 
local formulary (F=1.010, P value=0.389).  
Additionally, As shown in Table (4.14), the overall mean of total years of experience of 
the study participants was 0.88 (SD=0.885). The highest mean of total years of experience 
of the participants was reported at 21-30 years of participant age group (1.200) (SD= 
0.833) while the lowest mean of total years of experience of the participants was reported 
at 11-20 years of participant age group (0.784) (SD= 0.903). 
One-way Anova test was conducted to examine the presence of statistically significant 
differences among the study settings concerning the mean of the prescriber‘s knowledge 
about the presence of hospital local formulary of the participants in the all total years of 
experience groups of study participants. As illustrated in Table (4.14), The total years of 
experience of the study participants has no statistically significant change in the 
prescriber‘s knowledge about the presence of hospital local formulary (F=2.016, P 
value=0.113).
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4.2 Descriptive analysis of the checklist 
In this part, the researcher identified the degree of physicians‘ prescription writing 
compliance to WHO recommendation in prescription writing during their clinical practice. 
The new sample of the encounters of the nine NGHs in the GG is illustrated in Table 
(4.15). 
Table (‎4.15): The distribution of collected encounters sample in the selected NGHs 
   *N.A.: No out-patient sheets available.                                                   
   **To compare individual facilities, the size of samples drawn within each facility must be at least 100 encounters (WHO, 1993). 
  *** N.A.: No medication sheets available. 
 
As shown in Table (4.15), the total checklists assessing in the 9 NGHs are 3016 checklists 
with 360 checklists at least for each hospital except Hayfa hospital with no medication 
sheets and Al Amal hospital with no out-patient sheets. In Dar Al-Salam hospital the 
researcher only found 42 medication sheets related to the period of research June 2016 to 
June 2017. All the in-patient cases in Dar Al-Salam hospital didn‘t admit due to the high 
admission cost of hospital regarding to patients, the forty-two cases admission cost covered 
by international donor ―Doctors without borders‖ because the cases were injured as a result 
of confrontations with the Israeli army. The results generated from medication sheets in 
Dar Al-Salam hospital represent only Dar Al-Salam hospital but can‘t involve in the 
hospital comparison due to WHO recommendation in WHO manual 1993 which state that 
to study the basic indicators the sample size drown with each facility is 30 prescribing 
encounters and to compare individual facilities the sample size drown at least 100 
encounters (WHO, 1993). 
No. NGHs 
No. of  
out-patient sheet 
No. of discharge 
sheet 
No. of medication 
sheet 
Total 
1 Al-Awda 123 121 121 365 
2 Al Amal N.A.* 135 122 257 
3 Al-Karama  120 120 120 360 
4 Dar Al-Salam  120 122 42** 242 
5 Hayfa  124 124 N.A.*** 248 
6 Kuwait  121 121 121 362 
7 PFBS 120 121 122 363 
8 Public Aid 134 146 127 407 
9 Yafa  126 120 123 369 
Total 998 1130 898 3016 
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In Al-Amal hospital the out-patient department related to the MOH not for Palestinian Red 
Crescent system so the patients don‘t have any file. 
4.2.1 Prescribing indicators group 
Table (‎4.16): Result of drug use indicators in the study 
# Drug use indicator Result 
1.  Average number of drugs per prescription 2.5 
2.  Percentage of drug prescribed by generic name 3.3% 
3.  Percentage of drug prescribed from local formularies 88.7% 
4.  Percentage of encounter with injection 30.2% 
5.  Percentage of encounter with antibiotic 67.9% 
6.  Encounter cost  10.9 $ 
7.  Percentage of medicine costs spent on antibiotics 47.14% 
8.  Percentage of availability of local formulary 100% 
9.  Percentage of availability of key drugs 76.9% 
 
As illustrated in Table (4.16), the average number of drugs per encounter was 2.5. whilst 
the minimum value was 0 the maximum value was 7 (SD=1.072) with a median of 2 drugs 
per encounter. Meanwhile, the percentage of drugs prescribed by generic name was 3.3%, 
the minimum found value was 0 while the maximum revealed value was 4 (SD=0.374) and 
the median was 0. The percentage of drugs prescribed from local formularies was 88.7%, 
the minimum found value was 0 while the maximum revealed value was 7 (SD=1.144) and 
the median was 2.  On the other hand, the percentage of encounter with injection was 
88.7%, the minimum found value was 0 while the maximum revealed value was 1 
(SD=0.464) and the median was 0, the percentage of encounter with antibiotic was 67.9%, 
the minimum found value was 0 while the maximum revealed value was 1 (SD=0.469) and 
the median was 1. 
Additionally, the average encounter cost was 10.9$ and the percentage of medicine costs 
spent on antibiotics was 47.14%.  
Finally, the availability of copy of local formulary was found in all NGHs surveyed. The 
availability of key drugs was 76.9% and the minimum value was 70.8% meanwhile the 
maximum value was 100%. 
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4.2.1.1 Descriptive findings of the prescribing indicators group related to the type of 
sheet 
Table (‎4.17): Descriptive findings of the prescribing indicators group related to the type of 
sheet 
Variable Type of sheet 
No. of 
encounter 
No. of 
drugs 
No. of 
drugs/ 
prescription 
(Mean) 
SD F Sig. 
Total No. 
of 
prescribed 
drugs 
Out-patient 
sheet 
998 2540 2.55 0.964     
Discharge 
sheet 
1130 2889 2.56 0.81 11.477 0.000* 
Medication 
sheet 
898 2126 2.36 1.407 
    
Total 3016 7555 2.5 1.072     
No. of 
prescribed 
drugs from 
the local 
formulary 
Out-patient 
sheet 
998 2250 2.25 1.03     
Discharge 
sheet 
1130 2313 2.05 0.992 14.656 0.000* 
Medication 
sheet 
898 2059 2.29 1.394 
    
Total 3016 6622 2.2 1.144     
No. of 
prescribed 
drugs using 
generic 
names 
Out-patient 
sheet 
998 56 0.06 0.268     
Discharge 
sheet 
1130 14 0.01 0.111 133.157 0.000* 
Medication 
sheet 
898 236 0.26 0.58 
    
Total 3016 306 0.1 0.374     
No. of 
prescribed 
encounter 
with 
injectable 
drugs  
Out-patient 
sheet 
998 145 0.15 0.354     
Discharge 
sheet 
1130 57 0.05 0.219 1699.05 0.000* 
Medication 
sheet 
898 746 0.83 0.377   
  
Total 3016 948 0.34 0.464     
Total No. 
of 
prescribed 
encounter 
with 
antibiotic 
Out-patient 
sheet 
998 492 0.5 0.5     
Discharge 
sheet 
1130 1064 0.94 0.231 374.581 0.000* 
Medication 
sheet 
898 473 0.53 0.5 
    
Total 3016 2029 0.67 0.469     
*Statistically significant 
As shown in Table (4.17), the average total number of drugs prescribed in all type of files 
among the study settings was 2.5 drugs per sheet with drug range from 1-7 drugs per 
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prescription. The highest number of drugs prescribed was reported at discharge sheet with 
an average of 2.56 drugs per out-patient sheet, while the lowest number of drugs prescribed 
was reported at medication sheet with an average of 2.36 drugs per medication sheet. One-
way Anova test was conducted to examine the presence of statistically significant 
differences among the study settings concerning the mean of the total number of drugs 
prescribed in all type of sheets. There was a statistically significant difference in the mean 
number of drugs prescribed in the NGHs sheets among the study settings with (F=11.477, 
P value=0.000). Post Hoc - Bonfirroni test has revealed that the significant difference was 
reported between out-patient sheet and medication sheet (Sig. =0.000). It seems that 
physicians in the NGHs tend to prescribe more drugs in out-patient sheets than in the 
medication sheet, this can be attributed to the positive relationship between number of 
drugs may be  prescribed during patient admission and the admission cost in the hospital 
Another significant difference was reported between discharge sheet and medication sheet 
(Sig. =0.000). It seems that physicians in discharge sheet tend to prescribe more drugs than 
in medication sheet in the NGHs sheets. On the other hand, no significant difference was 
reported between discharge sheet and out-patient sheet (Sig. =1.000).  
Regarding the No. of local formulary drugs prescribed in the NGHs, as shown in Table 
(4.17), the overall average number of drugs prescribed from the local formulary among the 
study settings was 2.2 drugs per sheet. The highest number of drugs prescribed from the 
local formulary was reported in medication sheet with an average of 2.29 drugs per sheet, 
while the lowest number of drugs prescribed from the local formulary was reported in the 
discharge sheet with an average of 2.05 drugs per sheet. One-way Anova test was 
conducted to examine the presence of statistically significant differences among the study 
settings concerning the mean number of local formularies listed drugs prescribed in the 
study sheets. As shown in Table (4.17), there was a strong statistically significant 
difference in the mean number of the drugs prescribed from the local formulary in the 
sheets among the study settings with (F=14.656, P value=0.000). Post Hoc- Bonfirroni test- 
has revealed that the significant difference was reported between discharge report and the 
out-patient sheet and medication sheet (Sig. =0.000), clearly indicating that physicians in 
medication sheets tend to prescribe more drugs that are listed in local formulary than 
physicians prescribed in the out-patient sheets and discharge sheets. Additionally, there 
was no significant difference was reported between the out-patient sheet and medication 
sheet (Sig. =1.000). 
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Concerning the No. of drugs prescribed using generic names in the NGHs, as shown in 
Table (4.17), the average number of drugs prescribed by using generic names in the NGHs 
sheets among the study settings was 0.10 drugs per sheet. The highest number of drugs 
prescribed using generic names was reported in the medication sheets with an average of 
0.26 drugs per sheet, while the lowest number of drugs prescribed using generic names was 
reported at discharge sheet with an average of 0.01 drugs per sheet. One way Anova test 
was conducted to examine the presence of statistically significant differences among the 
study settings concerning the mean number of drugs prescribed by using generic names in 
the NGHs sheets among the study settings, there was a strong statistically significant 
difference in the mean number of the drugs prescribed by using generic names in the 
NGHs sheets with (F=133.157, P value=0.000). Post Hoc - Bonfirroni test has revealed 
that the significant difference was between the medication sheets, the discharge sheets and 
the out-patient sheets (Sig. =0.000), Also, the significant difference was between discharge 
sheet and out-patient sheet (Sig. =0.014). From researcher expectation to use generic name 
abundantly in prescriptions in medication sheets, it reflected prescribing habits beside 
physicians use the local formulary drugs so no pharmaceutical industry marketing effect.  
With respect to the No. of prescribed encounter with injectable drugs, as shown in Table 
(4.17), the average number of prescribed encounters with injectable drugs in the NGHs 
sheets among the study settings was 0.31 drugs per sheet. The highest number of 
encounters with prescribed injectable drugs was reported in the medication sheets with an 
average of 0.83 drugs per sheet, while the lowest number of encounters with prescribed 
injectable drugs was reported in the discharge sheets with an average of 0.05 drug per 
sheet. One-way Anova test was conducted to examine the presence of statistically 
significant differences among the study settings concerning the mean number of drugs 
prescribed by using injectable drugs in the NGHs sheets among the study settings with 
(F=1699.048, P value=0.000). Post Hoc - Bonfirroni test has revealed that the significant 
difference was between out-patient sheets, and discharge sheets (Sig. =0.000), clearly 
indicating that physicians prescribing injectable drugs in out-patient sheets is more than 
discharge sheets. Another significant difference was reported between out-patient sheets 
and medication sheets (Sig. =0.000), clearly indicating that physicians prescribing 
injectable drugs in out-patient sheets less than medication sheets. Over prescribing 
injectable drugs in medication sheets is reflect prescribing habits among physicians as well 
as  the majority of previous studies which have been conducted regarding injections, 
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mainly have considered issues associated to patients such as their beliefs in order to faster 
and better effect of injection in comparison to oral formulations, lack of awareness 
regarding the side effects of injections, and socio-cultural factors
 
that cause patients asks 
their doctors to prescribe injectable drugs (Choi, Park, Lee et al., 2012).The other studies 
considerably highlight some factors related to doctors, including economic and financial 
reasons, competition and pressure from third parties (pharmacies, injection units, and 
patients) that have been taking into account as the main factors drive them to prescribe 
injectable drugs regardless of actual indications.(Hwang, Kim, Lee et al., 2007; 
Chowdhury, Roy, Faroque et al., 2011). This finding clearly appeared the absence of 
Monitoring and Evaluation efforts of the hospital managements and the absence of any role 
for the pharmacists in increasing awareness level of physicians and nurses toward the side 
effects of over prescribing injection drugs. 
With respect to the No. of prescribed encounters with antibiotics, as shown in Table 
(4.17), the average number of prescribed encounters with antibiotics in the NGHs sheets 
among the study settings was 0.67 drugs per sheet. The highest number of prescribed 
encounters with antibiotic by physicians was reported in the discharged sheets with an 
average of 0.94 antibiotic per sheet, while the lowest number of prescribed encounters with 
antibiotic by physicians was reported in the out-patient sheets with an average of 0.50 
antibiotic per sheet. One-way Anova test was conducted to examine the presence of 
statistically significant differences among the study settings concerning the mean number 
of drugs prescribed antibiotics in the NGHs sheets among the study settings with 
(F=374.581, P value=0.000). Post Hoc - Bonfirroni test has revealed that the significant 
difference was between out-patient sheets and discharge sheets (Sig. =0.000), clearly 
indicating that physicians at discharge sheets tend to prescribe more antibiotic drugs than 
in out-patient sheets. Another significant difference was reported between discharge sheets 
and medication sheets (Sig. =0.000), clearly indicating that physicians in discharge sheets 
tend to prescribe antibiotic drugs more than medication sheets (Sig. =0.000). Additionally, 
there was no significant difference was reported between medication sheets and out-patient 
sheets (Sig.=0.463) This finding reflects prescribing habits of prescribing antibiotic where 
approximately one antibiotic was prescribed in every discharge sheet. Additionally, the 
absence of Monitoring and Evaluation efforts of the hospital managements appear clearly 
beside the absence of any role for the pharmacists in increasing awareness level of 
physicians and nurses toward side effects of antibiotics over prescribing in the GG. 
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4.2.1.2 Descriptive findings of the prescribing indicators group related to the type of 
sheet and the NGHs 
4.2.1.2.1 Average number of drugs prescribed per encounter  
Table (‎4.18): Differences in average number of drugs prescribed per encounter according 
to the NGHs. (No. of prescriptions =3016, No. of drugs =7555) 
Average number of drugs prescribed per encounter 
# NGHs 
Total average of drugs 
F Sig. 
Average SD 
1 Al-Amal 2.52 1.163 
30.255 0.000* 
2 Al-Awda 2.53 1.015 
3 Al-Karama 3.08 1.139 
4 Dar Al-Salam 2.60 1.052 
5 Hayfa 2.54 0.814 
6 Kuwait 2.09 0.875 
7 PFBS 2.75 1.042 
8 Public Aid 2.23 1.074 
9 Yafa 2.28 1.048 
Total 2.5 1.072 
WHO standard 1.6 - 1.8 
   *Statistically significant 
Table (4.18), the 3016 prescriptions were for a total 7555 drugs with average number of 
drugs per encounter is 2.5 (SD=1.072). polypharmacy was observed in all NGHs, Al-
Karama hospital showed the highest average number of drugs per encounter 3.08 
(SD=1.139) while Kuwait hospital showed the lowest average number of drugs per 
encounter 2.09 (SD=0,875). Regarding the GG, our findings is higher than that reported in 
the governmental PHC 2 (Ayoub, Musalam, & Mahadi, 2017) but lower than that reported 
in UNRWA 2.77 (Baba, 2012). Globally, this is higher than that reported 2008 in the 
Dubai private hospital (2.2) (Sharif, Al-Shaqra, Hajjar et al., 2008) and less than the 
situation in study was conducted in 4 private hospitals in U.A.E (2.9) (Sharif, Al-Shaqra, 
Hajjar et al., 2008; Rasool, Fahmy, Abu-Gharbieh et al., 2010),Yemen private hospitals 
(2.9) (Bashrahil, 2010) and Western India private hospitals (3.38) (Shelat & Kumbar, 
2015). One-way Anova test was conducted to examine the presence of statistically 
significant differences among the study settings concerning the mean of the total number 
of drugs prescribed in all NGHs in the GG. As shown in Table (4.18), there was a 
 78 
 
statistically significant difference in the total average of drugs prescribed in the NGHS 
reported among the study settings with (F=30.255, P value=0.000). Post Hoc - Bonfirroni 
test has revealed that Al-Karama hospital was statistically significant with all the NGHs 
(Sig. =0.000) while Kuwait hospital was statistically significant with all the NGHs (Sig. 
=0.000) except Public Aid hospital (Sig. =1.000) and Yafa hospital (Sig. =0.409). It seems 
that physicians in Al-Karama hospital tend to prescribe more drugs per encounter than all 
other eight NGHs physicians while it seems that physicians in Kuwait hospital tend to 
prescribe less drugs per encounter than all other eight NGHs. 
Table (‎4.19): Differences in average number of drugs prescribed per encounter according 
to the type of sheet (No. of prescriptions =3016, No. of drugs =7555) 
# NGHs 
Average number of drugs prescribed per encounter 
Out-patient sheet Medication sheet Discharge sheet 
Average SD Average SD Average SD 
1 Al-Amal 0 0 2.4 1.443 2.6 0.83 
2 Al-Awda 2.5 0.843 2.5 1.218 2.6 0.951 
3 Al-Karama  2.7 0.653 3.6 1.602 3 0.727 
4 Dar Al-Salam  2.4 1.157 3.6 1.037 2.5 0.707 
5 Hayfa 2.8 0.91 0 0 2.3 0.606 
6 Kuwait  2.3 0.867 1.7 0.831 2.3 0.777 
7 PFBS 2.6 1.056 2.6 1.132 3 0.865 
8 Public Aid  2.2 0.914 2.1 1.413 2.4 0.813 
9 Yafa  3.1 0.883 1.4 0.745 2.3 0.571 
Total 2.57 0.964 2.36 1.407 2.56 0.81 
WHO standard 1.6 - 1.8 
As shown in Table (4.19), the highest average number of drugs per encounter is in out-
patient sheets 2.57 (SD=0.964) while the lowest average number of drugs per encounter is 
in medication sheets 2.36 (SD=1.407). Our findings is lower than that reported in 
medication sheets in governmental hospitals in the GG 5.21 (SD=3.138) and in discharge 
sheets in governmental hospitals in the GG 3 (SD=1.701) (Al-khodary, 2016), In out-
patient sheet, Yafa hospital reported the highest average number of drugs prescribed per 
encounter 3.1 (SD=0.883) while Public Aid hospital reported the lowest average number of 
drugs prescribed per encounter 2.2 (SD=0.914). On the other hand, in medication sheets 
Al-Karama hospital reported the highest average number of drugs prescribed per encounter 
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3.6 (SD=1.602) while Yafa hospital reported the lowest average number of drugs 
prescribed per encounters 1.4 (SD=0.745). 
Table (‎4.20): percentage of prescriptions according to number of drugs per prescriptions 
# NGHs 
One drug 
(%) 
Two drugs 
(%)  
Three 
drugs (%) 
Four drugs 
(%) 
More than 
4 drugs (%) 
1 Al-Amal  12 51.8 18.7 10.9 6.6 
2 Al-Awda  11.4 45.8 25.8 12.6 4.4 
3 Al-Karama  4.2 28.3 38.1 17.8 11.6 
4 Dar Al-Salam  10.5 42.8 27.4 13.7 5.6 
5 Hayfa  2 56.5 29.8 10.1 1.6 
6 Kuwait 26.3 46.1 21.3 5.5 0.8 
7 PFBS 8.9 33.3 40.5 11 6.3 
8 Public Aid  25.3 43.7 18.7 7.6 4.7 
9 Yafa  26.9 31.9 29.9 8.9 2.4 
Total (%) 14.2 42.2 27.8 10.9 4.9 
Regarding to polypharmacy, the majority of prescriptions (85.8%) contained two drugs and 
more (WHO standard 1.6-1.8) as shown in Table (4.20), Conversely, (14.2%) of 
prescriptions with less than 2 drugs. Ayoub study indicated that 66.2% of the study 
prescriptions contained two drugs and more in the governmental PHC in the GG (Ayoub, 
Musalam, & Mahadi, 2017). This indicating that GG physicians in the NGHs had tendency 
towards polypharmacy more than physicians in the governmental PHCs. Hayfa hospital 
topped up the majority of prescriptions with two drugs and more (98%). The over-
prescribing lead to increase possibility of drug-drug interaction and low patient compliance 
rate. One possible  explanation for overprescribing is patient demand, i.e. Patients prefer 
doctors who prescribe more drugs because they think this will ensure improvement and 
cure of their condition quickly (H. V. Hogerzeil, 1995).  
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4.2.1.2.2 Percent of drugs prescribed by generic name  
Table (‎4.21): Differences in percent of drugs prescribed by generic name according to the 
NGHs (n=7555) 
# NGHs 
 Percent of drugs prescribed by generic name 
Total 
Mean SD F Sig. 
No % 
1 Al-Amal 29 4.5 0.11 0.352 
12.394 0.000*  
2 Al-Awda  47 5.1 0.13 0.381 
3 Al-Karama 79 7.1 0.22 0.628 
4 Dar Al-Salam  52 7 0.18 0.512 
5 Hayfa 1 0.2 0 0.064 
6 Kuwait 20 2.6 0.06 0.241 
7 PFBS 44 4.4 0.12 0.381 
8 Public Aid  9 1 0.02 0.147 
9 Yafa 25 3 0.07 0.252 
Total 306 3.3 0.1 0.374 
WHO standard 100% 
              *Statistically significant. 
As showed in Table (4.21), the mean number of drugs prescribed by using generic name 
per prescription is 0.10 (SD=0.374). The study revealed that the minority of drugs were 
prescribed using their generic names (3.3%). This result is lower than Dubai 4.4% (Sharif, 
Al-Shaqra, Hajjar et al., 2008), Western India 6.7% (Shelat & Kumbar, 2015) and Yemen 
39.2% (Bashrahil, 2010) and higher than reported in 2017 in India hospital where no single 
prescribed drugs was reported with generic name (Bashrahil, 2010; Aravamuthan, 
Arputhavanan, & Subramaniam, 2017). In this study all selected NGHs showed very low 
tendency to use drugs generic name, Hayfa hospital prescriptions showed the lowest 
percentage in using drugs generic name 0.2% while Al-Karama hospital recorded just 7.1% 
as a best percentage of using drugs generic name. One-way Anova test was conducted to 
examine the presence of statistically significant differences among the study settings 
concerning the mean of number of drugs prescribed by using generic name in all NGHs in 
the GG. As shown in Table (4.21), there was a statistically significant difference in the 
mean of number of drugs prescribed by using generic name in the NGHs reports among the 
study settings with (F=12.394, P value=0.000). Post Hoc - Bonfirroni test has revealed that 
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the significant difference was reported between Al-Karama hospital (Sig. =0.033), Public 
Aid hospital (Sig. =0.000), PFBS hospital (Sig. =0.012), Hayfa hospital, Kuwait hospital, 
Yafa hospital (Sig. =0.000) and Al-Amal hospital (Sig. =0.014). It seems that physicians in 
Al-Karama hospital tend to prescribe more drugs by using generic name than in Public Aid 
hospital, PFBS hospital, Hayfa hospital, Kuwait hospital, Yafa hospital and Al-Amal 
hospital physicians. On the other hand, no statistically significant between Al-Karama 
hospital and Dar Al-Salam hospital (Sig. =1.000). while Hayfa hospital was statistically 
significance with all NGHs except Public Aid hospital, Kuwait hospital and Yafa hospital 
(Sig. =1.000). It seems that physicians in Hayfa hospital tend to prescribe less drugs by 
using generic name than all NGHs physicians. 
Table (‎4.22): Differences in percent of drugs prescribed by generic name according to the 
type of sheet 
# NGHs 
 Percent of drugs prescribed by generic name 
Outpatient sheet Medication sheet Discharge sheet 
No % No % No % 
1 Al-Amal 0 0 26 4 3 0.5 
2 Al-Awda  24 2.6 20 2.2 3 0.3 
3 Al-Karama 0 0 79 7.1 0 0 
4 Dar Al-Salam  11 1.5 39 5.3 2 0.3 
5 Hayfa 0 0 0 0 1 0.2 
6 Kuwait 8 1.1 12 1.6 0 0 
7 PFBS 11 1.1 32 3.2 1 0.1 
8 Public Aid  2 0.2 6 0.7 1 0.1 
9 Yafa 0 0 22 2.6 3 0.4 
Total 56 0.7 236 2.4 14 0.2 
WHO standard 100% 
As showed in Table (4.22), the highest percentage of using generic name is in medication 
sheets 2.4% while the lowest percentage of using generic name is in discharge sheets 0.2%. 
These results may indicate a strong influence of the pharmaceutical industry on 
prescribers. The high ratio showed in prescribing drugs with trade name reflect the clear 
influence of drug companies through their representatives. Economic factors may play a 
role, as some pharmaceutical companies pay rewards to doctors who prescribe their 
products and this discourages generic prescribing (Mohlala, Peltzer, Phaswana-Mafuya et 
al., 2010). A study conducted in Zimbabwe found that other factors, such as the desire to 
sustain income, play a role in the prescribing and dispensing habits of private doctors 
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(Trap, Hansen, & Hogerzeil, 2002).  It is bad practice, drugs with similar names have been 
cross-prescribed. Here the hapless patient assumes only risk (sometimes life-threatening) 
and expense for no potential benefit (Flegel, 2012). 
4.2.1.2.3 Percent of encounter with injection  
Table (‎4.23): Differences in percent of encounter with injection according to the NGH 
      *Statistically significant. 
As shown in Table (4.23), the mean of number of encounters with injectable drugs per 
prescription is 0.31 (SD=0.464). As shown in Table (4.23), regarding to using injectable 
drugs, over prescribing injectable drugs was reported, one third of encounter 30.2 % with 
injection drugs (range 1-7 drugs per prescription), (WHO standard: 13.4% -24.1%). This 
finding is higher than reported in PHC in the GG  1.3% (Ayoub, Musalam, & Mahadi, 
2017), Yemen hospitals 22.2% (Bashrahil, 2010), Western India hospital 20.8% (Shelat & 
Kumbar, 2015) and U.A.E. private hospitals 2.9% (Rasool, Fahmy, Abu-Gharbieh et al., 
2010). All NGHs in the study are not matching WHO standard in prescribed injectable 
drugs percentage except Hayfa hospital 14.1% and Dar Al-Salam hospital 11.6%. The 
highest percentage of encounter with injectable drugs were recorded in Al-Amal hospital 
50.2%. while the lowest percentage of encounter with injectable drugs were recorded in 
Dar Al-Salam hospital 11.6%. One-way Anova test was conducted to examine the presence 
of statistically significant differences among the study settings concerning the mean of 
# NGHs 
Percent of encounter with injection  
Total 
Mean  SD F Sig. 
No % 
1 Al-Amal  124 50.2 0.48 0.501 
11.957 0.000*  
2 Al-Awda  115 31.7 0.32 0.465 
3 Al-Karama 121 33.6 0.34 0.473 
4 Dar Al-Salam  69 11.6 0.24 0.429 
5 Hayfa  35 14.1 0.14 0.349 
6 Kuwait 116 32 0.32 0.467 
7 PFBS 147 40.3 0.4 0.492 
8 Public Aid  115 29.6 0.28 0.451 
9 Yafa  106 28.3 0.29 0.453 
Total 948 30.2 0.31 0.464 
WHO standard 13.4% -24.1% 
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prescribing encounters with injectable drugs in study participated NGHs in the GG. As 
shown in Table (4.23), there was a statistically significant difference in the mean number 
of encounters with injectable drugs prescribed in the NGHs reports among the study 
settings with (F=11.957, P value=0.000). Post Hoc - Bonfirroni test has revealed that the 
significant difference was reported between Al-Amal hospital and all NGHs (Sig.=0.000) 
except PFBS hospital (Sig.=1.000). This clearly indicated that physicians in Al-Amal 
hospital tend to prescribe encounters with injectable drugs more than all NGHs in the GG. 
Another significant difference was reported between Dar Al-Salam hospital, Al-Amal 
hospital and PFBS hospital (Sig.=0.000), clearly indicating that physicians in Dar Al-
Salam hospital tend to prescribe encounters with injectable drugs less than all NGHs. 
Additionally, there was no significant difference was reported between Dar Al-Salam 
hospital and Public Aid hospital, Yafa hospital, Al-Awda hospital, Kuwait hospital, 
(Sig.=1.000) Al-Karama hospital (Sig.=0.347) and Hayfa hospital (Sig.=0.400) 
Table (‎4.24): Differences in percent of encounter with injection according to the type of 
sheets  
# NGHs 
Percent of encounter with injection  
Outpatient sheet Medication sheet Discharge sheet 
No % No % No % 
1 Al-Amal  0 0 107 87.7 17 12.6 
2 Al-Awda  2 1.6 111 91.7 2 1.7 
3 Al-Karama 2 1.7 119 99.2 0 0 
4 Dar Al-Salam  27 22.3 41 97.6 1 0.8 
5 Hayfa  24 19.4 0 0 11 8.9 
6 Kuwait 11 9.2 103 85.1 2 1.7 
7 PFBS 22 18.3 115 94.3 10 8.3 
8 Public Aid  24 17.9 85 66.9 6 4.1 
9 Yafa  33 26.2 65 52 8 6.8 
Total 145 14.5 746 84.3 57 5.6 
WHO standard 13.4% -24.1% 
As shown in Table (4.24), The lowest percentage of encounters with injectable drugs were 
recorded in discharge sheets 5.6% while the highest percentage of encounters with 
injectable drugs were recorded in medication sheets 84.3%. In medication sheets Al-
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Karama hospital topped up the percentage of prescribing injectable drugs 99.2% followed 
with PFBS hospital 94.3% and Al-Awda hospital 91.7%. On the other hand, in discharge 
sheets, Al-Amal hospital topped up the percentage of prescribing injectable drugs 12.6% 
followed with Hayfa hospital 8.9% and PFBS hospital 8.3%. Injection use has advantages 
as well as disadvantages, injections disadvantages are inconvenient, more expensive, less 
safe, painful and require skilled personnel to administer, unsafe injection has become a 
very common issue and is practiced in many countries due to poor practical practice 
for  injection safety standards; it is the major cause of transmission of diseases such as 
hepatitis B, hepatitis C and HIV, WHO estimates that 50% of injections performed in 
developing countries are unsafe (Van Tuong, Phuong, Anh et al., 2017). Injections are 
always more expensive than oral formulations (WHO, 2002a), so the use of injections 
should be limited for emergency cases only. 
4.2.1.2.4 Percent of drugs prescribed from local formulary 
Table (‎4.25): Differences in percent of drugs prescribed from local formulary according to 
the NGH. 
# NGHs 
Percent of drugs prescribed from local formulary 
Total 
Mean  SD F Sig. 
No % 
1 Al-Amal  328 54.2 1.28 1.460 
61.588 0.000* 
2 Al-Awda  789 85.6 2.16 1.002 
3 Al-Karama 1077 96.9 2.99 1.157 
4 Dar Al-Salam  708 95 2.48 1.030 
5 Hayfa  557 89.1 2.25 0.854 
6 Kuwait  643 85.4 1.78 0.904 
7 PFBS 873 88 2.40 0.999 
8 Public Aid  879 97 2.16 1.070 
9 Yafa  768 92.3 2.08 1.034 
Total 6622 88.7 2.20 1.144 
WHO standard 100% 
                *Statistically significant. 
With regards to prescribing drugs from the local formulary, local formulary in the NGHs, 
the researcher didn‘t find any official local formulary so the constant purchasing drug list 
for the last 2 years considered as the local formulary for the health facility. As showed in 
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Table (4.25), the mean of number of drugs prescribed from local formulary per 
prescription is 2.20 (SD=1.144). The majority of prescribed drugs were from local 
formulary (88.7%). This finding is better than reported in Yemen hospital 78.9% 
(Bashrahil, 2010) and in Western India 70% (Shelat & Kumbar, 2015) but less than south 
Africa hospitals 92.6% (Mohlala, Peltzer, Phaswana-Mafuya et al., 2010). The highest 
percentage of prescribing local formulary drugs reported in Public Aid Hospital 97%. The 
lowest percentage of prescribing local formulary drugs reported in Al-Amal hospital 
54.2%. The NGHs managements justified the reason of percentages of prescribing local 
formulary drugs lower than 100% that number of drugs not listed in local formulary due 
low consumption rate but the NGH provide these drugs under physicians‘ requests. 
One-way Anova test was conducted to examine the presence of statistically significant 
differences among the study settings concerning the mean of prescribing local formulary 
drugs in all NGHs in the GG. As shown in Table (4.25), there was a statistically 
significant difference in the mean number of prescribing local formulary drugs in the 
NGHs reports among the study settings with (F=61.588, P value=0.000). Post Hoc - 
Bonfirroni test has revealed that the significant difference was reported between Public Aid 
hospital and Al-Karama hospital, Al-Amal hospital, Kuwait hospital (Sig.=0.000), Dar Al-
Salam hospital (Sig.=0.003) and PFBS hospital (Sig.=0.05). The physicians tend to 
prescribe local formulary drugs in Public Aid hospital more than physicians in Al-Karama 
hospital, Al-Amal hospital, Kuwait hospital, Dar Al-Salam hospital and PFBS hospital. 
There was no statistically significance was reported between Public Aid hospital, Hayfa 
hospital, Yafa hospital and Al-Awda hospital (Sig.=1.000). Additionally, Al-Amal hospital 
was statistically significance with all NGHs. The physicians tend to prescribe local 
formulary drugs in Al-Amal hospital less than physicians in all study participated NGHs. 
The NGHs‘ managements justified the poor compliance in prescribing local formulary 
drugs due to; pharmaceutical companies offer for physicians to prescribe drugs by certain 
trade names, local formulary drug list is not mandatory for physicians, weak 
communication channels between physicians, hospital managements and hospital 
pharmacists, NGHs design local formulary to cover certain common ailments and it is 
therefore not possible to have all prescribed drugs which could be out of the local 
formulary drug list, thus could be due to the weak economic status of the NGHs during the 
last 10 years as a result from the Israeli siege. 
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Table (‎4.26): Differences in percent of drugs prescribed from local formulary according to 
the type of sheet. 
# NGHs 
 Percent of drugs prescribed from local formulary 
Outpatient sheet Medication sheet Discharge sheet 
No % No % No % 
1 Al-Amal  0 0 287 96.6 41 11.7 
2 Al-Awda  239 77.3 290 97.3 260 82 
3 Al-Karama 319 98.2 428 100 330 92.4 
4 Dar Al-Salam  267 92.7 146 96.7 295 97.4 
5 Hayfa  286 82.4 0 0 271 95.8 
6 Kuwait  209 76.8 178 88.1 256 91.1 
7 PFBS 285 91.3 297 93.4 291 79.3 
8 Public Aid  279 95.9 262 100 338 95.2 
9 Yafa  366 92.4 171 100 231 84 
Total 2250 88.4 2059 96.9 2313 81 
WHO standard 100% 
 
As shown in Table (4.26), The highest percentage of prescribing local formulary drugs 
reported in medication sheets (96.9%) and the lowest percentage of prescribing local 
formulary drugs reported in discharge sheets (81%). thus, clearly indicate that physicians 
in the NGHs showed more compliance in prescribing local formulary drugs in mediation 
sheets more than in discharge sheet. In the governmental hospital in the GG, a study 
showed that same orientation in prescribing EDL drugs in medication sheets and discharge 
sheets (Al-khodary, 2016). 
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4.2.1.2.5 The most common prescribed therapeutic class in the NGHs in the GG 
Table (‎4.27): Percentage of drug prescribed groups to the total number of drugs prescribed 
# NGHs 
Analgesic  Antibiotic  Others* 
No (%) No (%) No (%) 
1 Al-Amal  274 42.3 229 35.2 145 22.6 
2 Al-Awda  247 26.7 430 46.5 247 26.7 
3 Al-Karama  381 34.3 445 40.1 284 25.6 
4 Dar Al-Salam  272 36.7 263 35.4 207 27.9 
5 Hayfa  290 46 190 30 150 24 
6 Kuwait 290 38.4 240 31.8 225 29.6 
7 PFBS 382 38.3 288 28.9 327 32.8 
8 Public Aid 357 39.3 315 34.7 236 26 
9 Yafa  449 53.4 163 19.4 229 27.2 
Total  2942 38.9 2563 33.9 2050 27.2 
    *Others consist of Corticosteroids, Anti-acid, Minerals, Vitamins and food supplements, cardiovascular drugs, Hormones…etc. 
 
Figure (‎4.2): Percentage of drugs group prescribed to the total number of drugs prescribed 
in the NGHs in the GG 
As shown in Table (4.27), The most commonly prescribed therapeutic class was analgesics 
group, these were encountered in 38.9% of drugs were prescribed in the study and NSAIDs 
was the most commonly prescribed of this group (71.5%). Regarding the GG, our finding 
is higher than that reported in the governmental PHC 20.8% (Ayoub, Musalam & Mahadi, 
2017). 
Analgesic 
38.9% 
Antibiotic  
33.9% 
Others 
27.2% 
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Antibiotics were the second most commonly prescribed medication 33.9 % (range 1-4 
antibiotic per prescription). Antibiotic prescription is remarkably less than reported in the 
governmental PHC in the GG (40.9%) (Ayoub, Musalam & Mahadi, 2017). Globally, our 
finding is more than reported in Dubai 21.4% (Sharif, Al-Shaqra, Hajjar et al., 2008) but 
less than reported in other both western and eastern countries as Sudan 63% (Forshaw, 
Fresle, Salami et al., 1991), Iran 61.9% (Moghadamnia, Mirbolooki, & Aghili, 2002), 
England 60.7% (Majeed & Moser, 1999) and Norway 48% (Lindbaek, Berild, Straand et 
al., 1999). 
Other medications as corticosteroids, anti-acid, minerals, vitamins and food supplements, 
cardiovascular drugs, hormones…etc prescribed in small proportions which collectively 
encountered 27.2% (Figure 4.2).  
Regarding to percentage of analgesic prescription in the NGHs in the GG, the highest 
percentage of prescribing analgesic was reported in Yafa hospital (53.4%) while the lowest 
percentage of prescribing analgesic was reported in Al-Awda hospital (26.7%) 
Additionally, for antibiotic use, the highest percentage of prescribing antibiotics was 
reported in Al-Awda hospital 46.5% while the lowest percentage of prescribing antibiotics 
was reported in Yafa hospital (19.4%). 
In Yafa hospital, the percent of antibiotic and analgesic 19.4% and 53.4% respectively 
considered as an underestimated result, this consideration is due to most of available 
outpatient sheets were for orthopedic department. 
4.2.1.2.6 The most common prescribed analgesic groups 
Table (‎4.28): Percentage of analgesic groups to the total number of prescribed analgesics 
in the NGHs in the GG 
# Analgesic 
Percentage from analgesic group 
(%) 
1 Single 
analgesic 
Non-Steroidal Anti-inflammatory 
Drugs (NSAIDs) 
71.5 
2 Opioid analgesic 12.5 
3 Combination analgesic* 16 
Total 100 
*Combination analgesics include Opioid+ NSAIDs combination, NSAIDs+ codeine or/with caffeine combination. 
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Figure (‎4.3): Percentage of analgesic groups to the total number of prescribed analgesics 
in the NGHs in the GG. 
As showed in Table (4.28) Analgesic group is the major group of drugs prescribed in the 
NGHs (39.9%), (range 1-3 drugs per prescription). As showed in Table (4.28), the 
majority of prescribed analgesics was related to single analgesic drug (84%) and non-
steroidal anti-inflammatory drugs (NSAIDs) was the most commonly analgesic prescribed 
71.5%. The Finding of prescribed NSAIDs in the study was more than reported in Dubai 
private hospital 23.4% (Sharif, Al-Shaqra, Hajjar et al., 2008). Additionally, 12.5% of 
prescribed analgesic was opioid analgesic and 16% of prescribed analgesic was 
combination analgesics include Opioid + NSAIDs combination, NSAIDs + codeine or/with 
caffeine combination. 
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4.2.1.2.7 Percent of encounter with antibiotic 
Table (‎4.29): Differences in percent of encounter with antibiotic according to the NGH 
# NGHs 
Percent of encounter with antibiotic 
Total 
Mean  SD F Sig. 
No % 
1 Al-Amal 196 75.9 0.76 0.426 
35.171 0.000* 
2 Al-Awda 304 83.4 0.83 0.374 
3 Al-Karama  289 80.3 0.8 0.398 
4 Dar Al-Salam  237 81.9 0.83 0.375 
5 Hayfa  169 68.2 0.68 0.467 
6 Kuwait 201 55.5 0.56 0.498 
7 PFBS 233 64.2 0.64 0.48 
8 Public Aid  248 59.8 0.61 0.488 
9 Yafa  152 42.3 0.41 0.493 
Total 2029 67.9 
0.68 0.44 
WHO standard 20%-26% 
          *Statistically significant. 
As shown in Table (4.29) more than two thirds of encounters with an antibiotic 67.9% 
(WHO standard 20% - 26%). As shown in Table (4.29), the mean of number of encounters 
with antibiotics is 0.68 (SD=0.44). The highest percentage of encounter with antibiotic 
reported in Al-Awda hospital 83.4% (range 2-3 antibiotics per prescription) while the 
lowest percentage of encounter with antibiotic reported in Yafa hospital 42.3%.  
Overprescribing of antibiotic in the NGHs in the GG is a common problem which found 
also in UNRWA clinics 32.9% (Baba, 2012) and in the governmental PHC in the GG 
67.5% (Ayoub, Musalam & Mahadi, 2017). These results are similar in other studies done 
in some neighboring Arab countries in the Middle East and gulf countries, Syria, Jordan, 
U.A.E, Yemen and Sudan, where over use of antibiotics was the most common drug use 
problem in these countries. Percentage of prescriptions containing antibiotics in Syria, 
Jordan were 45% ,55% (Lewis), in U.A.E 31.1% (Rasool, Fahmy, Abu-Gharbieh et al., 
2010), in Yemen 64.5% (Bashrahil, 2010) and in Sudan 63% (H. V. Hogerzeil, Ross-
Degnan, Laing et al., 1993). Additionally, Ethiopia 58.1% (Desalegn, 2012), Uganda 56% 
(H. V. Hogerzeil, Ross-Degnan, Laing et al., 1993), 47% in Lao (Keohavong, Syhakhang, 
Sengaloundeth et al., 2006) and 58% in the Islamic Republic of Iran (Cheraghali, Nikfar, 
Behmanesh et al., 2004) have the same overuse antibiotics problem. 
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One-way Anova test was conducted to examine the presence of statistically significant 
differences among the study settings concerning the mean of encounter with antibiotic in 
all NGHs in the GG. As shown in Table (4.29), there was a statistically significant 
difference in the mean of encounter with antibiotic in the NGHs reports among the study 
settings with (F=35.171, P value=0.000). Post Hoc - Bonfirroni test has revealed that the 
significant difference was reported between Al-Awda hospital, Public Aid hospital, PFBS 
hospital, Kuwait hospital, Yafa hospital (Sig=0.000) and Hayfa hospital (Sig=0.002). The 
physicians tend to prescribe antibiotic drugs in Al-Awda hospital more than physicians in 
Public Aid hospital, PFBS hospital, Kuwait hospital, Yafa hospital and Hayfa hospital. 
There was no statistically significance was reported between Al-Awda hospital and Al-
Amal hospital, Al-Karama hospital and Dar Al-Salam hospital (Sig.=1.000). Additionally, 
Yafa hospital was statistically significance with all the NGHs (Sig=0.000). The physicians 
tend to prescribe antibiotic drugs in Yafa hospital less than physicians in all the NGHs. 
Table (‎4.30): Differences in percent of encounter with antibiotic according to the NGH 
# NGHs 
Percent of encounter with antibiotic 
Outpatient sheet Medication sheet Discharge sheet 
No % No % No % 
1 Al-Amal 0 0 83 68 113 83.7 
2 Al-Awda 74 60.2 111 91.7 119 98.3 
3 Al-Karama  93 77.5 79 65.8 117 97.5 
4 Dar Al-Salam  79 65.3 38 90.5  120 98.4 
5 Hayfa  46 37.1 0 0 123 99.2 
6 Kuwait 55 45.8 36 29.8 110 90.9 
7 PFBS 65 54.2 52 42.6 116 95.9 
8 Public Aid  59 44 57 44.9 132 90.4 
9 Yafa  21 16.7 17 13.6 114 96.6 
Total 492 50.1 473 50.9 1064 94.5 
WHO standard 20%-26% 
 
As shown in Table (4.30), the highest percentage of encounter with antibiotic recorded in 
discharge sheets 94.5%, Hayfa Hospital 99.2% represent the highest percentage of 
encounter with antibiotic recorded in discharge sheets while the lowest percentage of 
encounter with antibiotic recorded in Al-Amal hospital 83.7%. On the other hand, the 
lowest percentage of encounter with antibiotic recorded in out-patient sheets 50.1%, in out-
patient sheets Al-Karama Hospital represent the highest percentage of encounter with 
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antibiotic 77.5% while the lowest percentage of encounter with antibiotic recorded in Yafa 
hospital 16.7%. 
4.2.1.2.8 The most common types of prescribed antibiotics in the NGHs in the GG 
Table (‎4.31): The classification of antibiotics prescribed in the NGHs in the GG 
# NGHs 
Cephalosporins 
(%) 
Fluoroquinolones 
(%) 
Metronidazole 
(%) 
Penicillin’s 
(%) 
Macrolides 
(%) 
Others* 
(%) 
1 Al-Amal  61.1 20.5 10.5 4.4 0 3.5 
2 Al-Awda  42.9 15.6 14.9 10.7 2.8 13.1 
3 Al-Karama  37.7 11.3 29.8 9.4 14 1.1 
4 Dar Al-Salam  44.8 22.6 3.8 21.5 5.7 1.5 
5 Hayfa  55.3 29.5 5.3 5.8 1.1 3.2 
6 Kuwait 51.6 16 12.3 10.2 1.6 8.2 
7 PFBS 42.7 17 13.9 11.5 8.3 6.6 
8 Public Aid  47.9 7.9 17.1 14.9 8.6 3.5 
9 Yafa  63.8 12.9 1.8 20.2 0 1.2 
Total 49.8 17 12.2 12.1 4.7 4.7 
*Others: Tetracyclines,Aminoglycosides, Sulphonamides/trimethoprim,Lincosamide, Fusidic acid and Nitrofurantoin 
 
Figure (‎4.4): The most common prescribed antibiotic groups at the NGH in the GG. 
Overuse of antibiotics can lead to serious clinical problems mainly as antibiotic resistance 
which in turn lead to longer hospital stays, higher medical costs and increased mortality 
(WHO, 2018). As shown in Table (4.27), our findings revealed that the second most 
commonly prescribed therapeutic class in the NGHs in the GG is antibiotics (33.9%). 
Additionally, all NGHs reported percentages of encounter with antibiotics more than WHO 
Cephalosporins 
49% 
Fluoroquinolones 
17% 
Metronidazole 
12% 
Pencillin's 
12% 
Marcolids 
5% 
Others 
5% 
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optimal value (20%-26%), the major prescribed groups of antibiotics are; Cephalosporins 
49.8%, Fluoroquinolones 17%, Metronidazole 12.2%, Penicillin‘s 12.1%, Macrolides 4.7% 
and other groups 4.7% (include Aminoglycosides, Tetracyclines, Nitrofurantoin Fusicdic 
acid, Lincosamide and Sulphonamides- trimethoprim). Regarding to Cephalosporins group, 
the third generation of cephalosporin (Cefotaxime, Ceftazidime, Ceftriaxone) reported the 
highest percentage of prescribed antibiotic 26% followed with the second generation of 
cephalosporin (Cefuroxime, Cefaclor, Cefixime) with 19.8%, and ceftriaxone 15.6% was 
the most common antibiotic in this class. Globally, the most common prescribed antibiotic 
is amoxicillin-clavulanate 13.5% in Dubai hospital (Sharif, Al-Shaqra, Hajjar et al., 2008) 
and amoxicillin in Ethiopia hospitals 16.4% (Desalegn, 2012) and Barasil hospitals 23.6% 
(Ferreira, Heineck, Flores et al., 2013). Our results revealed the antibiotic resistance 
problem in the GG due to antibiotics overprescribing which lead to use third generation 
cephalosporins in most of medical treatments while amoxicillin still the first drug of choice 
in number of countries. 
4.2.1.3 Complementary indicators in the selected NGHs in the GG 
 Table (‎4.32): Complementary indicators in the selected NGHs in the GG. 
# NGHs Encounter cost ($) 
Medicine costs spent on 
antibiotics (%) 
1 Al-Amal  9 54.2 
2 Al-Awda  8.5 58.3 
3 Al-Karama  11.7 55 
4 Dar Al-Salam  9.8 53.5 
5 Hayfa  17.9 39.3 
6 Kuwait  7.9 46.5 
7 PFBS 11.1 44.1 
8 Public Aid  11.4 47.3 
9 Yafa  10.8 26.1 
Total 10.9 47.14 
 
Regarding to the average drug costs per encounter, Data on drug costs will always be 
important in managing policy related to drug supply, pricing and use (WHO, 2003a). As 
shown in Table (4.32), the average drug costs per encounter in the NGHs was 10.9$, The 
average cost directly linked with the average number of drugs prescribed per encounter. 
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The lowest average drug costs per encounter reported in Kuwait hospital 7.9 $ which 
reported the lowest average number of drugs prescribed per encounter (2.09) as showed in 
Table (4.18) while the highest average drug costs per encounter reported in Hayfa hospital 
17.9$ although Hayfa hospital didn‘t report the highest average number of drugs 
prescribed per encounter (2.54) as showed in Table (4.18) thus may be because no 
medication sheets were available in Hayfa Hospital as well as all reported drugs cost were 
for drugs in discharge sheets and out-patient sheets. On the other hand, Al-Karama hospital 
reported the second highest average drug costs per encounter 11.7$ thus due to Al-Karama 
hospital reported the highest average number of drugs prescribed per encounter (3.08) as 
showed in Table (4.18). 
The average cost in the NGHs in the GG was higher than reported in India 1$ (Hazra, 
Tripathi, & Alam, 2000). Researcher found difficulties to find updated studies highlighted 
the average drug costs per encounter indicator. 
On the other hand, less than one half of the drug costs in the selected NGHs spent on 
antibiotics (47.14%) which indicated the overuse of antibiotic and explain the bad health 
consequences indicated in reporting high percentage of using third generation of 
cephalosporins 26% due to antibiotics resistance. The high percentage of drug costs spent 
on antibiotics reflected in percentage of antibiotic prescribed 33.9% as shown in Table 
(4.27) and percent of encounter with antibiotic 67.9% as shown in Table (4.29), the 
highest percentage of drug costs spent on antibiotics reported in Al-Awda hospital (58.3%) 
which in turn reported the highest percentage of prescribed antibiotic (46.5%). On the 
other hand, the lowest percentage of drug costs spent on antibiotics reported in Yafa 
hospital (26.1%) which in turn reported the lowest percentage of prescribed antibiotics 
(19.4%). 
The general trend in the world is managing use of antibiotic because of antibiotic 
resistance and its health problems consequences. In 1996, a study was conducted in U.S.A. 
and showed that the total acquisition costs of antibiotics (adjusted for inflation) decreased 
from 24.8% (987$ to 547$) of the pharmacy drug expenditure budget in 1988 to 12.9% 
(612$ to 500$) in 1994, this achievement has been achieved by using computerized an 
antibiotic management program and prescribing guidelines were developed for inpatient 
prophylactic, empiric, and therapeutic uses of antibiotics (Pestotnik, Classen, Evans et al., 
1996). 
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4.3 Prescription writing skills  
4.3.1 Prescriber information 
Table (‎4.33): Prescriber information for the selected NGHs 
# NGHs 
Prescriber 
name  
(%) 
Prescriber 
stamp  
(%) 
Prescriber 
signature 
(%) 
Prescriber specialty 
degree (100%) 
Prescription 
date 
(%) GP SP Unknown 
1 Al-Amal 80.9 24.5 78.6 22.6 58.8 18.7 84.4 
2 Al-Awda 53 30 60 14 24 62 91 
3 Al-Karama 53.1 22.8 78.3 12.2 46.9 40.9 78.1 
4 Dar Al-Salam 35.1 39.6 52.3 17.9 31.6 50.5 94 
5 Hayfa 100 49.6 58.5 0.8 50.4 48.8 98.8 
6 Kuwait 24.3 66.3 77.1 19.9 61.3 18.8 93.9 
7 PFBS 61.7 54.8 66.4 5.8 50.7 43.5 82.9 
8 Public Aid 0.8 0.2 68.3 15.8 72.7 11.5 78.1 
9 Yafa 4 63 57 6.8 59.4 33.8 85 
Total 45.9 39 66.3 12.9 50.6 36.5 87 
With regards to the prescriber information in Table (4.33), showed that physician name, 
stamp, signature, specialty and prescription date were omitted in 54.1%, 61%, 33.7%, 
36.5% and 13% of prescriptions, respectively. Conversely, in 2008 a study was conducted 
in Dubai hospital and reported that physician name, signature, specialty and stamp were 
omitted in 12.2%, 10.3%, 20.3%, and 54.9% of prescriptions (Sharif, Al-Shaqra, Hajjar et 
al., 2008), in Nigeria private hospitals a study showed physician name and signature were 
omitted in 80% and 30% respectively (Akoria & Isah, 2008).  
Regarding date of visit, the NGHs registration recorded 87% while in Nigeria recorded 
90% (Akoria & Isah, 2008) and in U.A.E. recorded 85% (Rasool, Fahmy, Abu-Gharbieh et 
al., 2010). Generally, date of visit records showed low missing through all NGHs in the 
GG. The good results are due to physician interest in the time of review which is 
associated with financial issues as well as to monitor the patient's improvement during the 
treatment period. 
The highest percentage of prescriber name reported in Hayfa hospital encounters which 
showed perfect compliance in recording prescriber name while the lowest percentage of 
prescriber name reported in Public Aid hospital 0.8%. 
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Similar in prescriber stamp, Kuwait hospital recorded the highest percentage of prescriber 
stamp with 66.3% while Public Aid hospital recorded the lowest percentage of prescriber 
stamp with 0.2%. 
Regarding to prescriber signature, the highest percentage of prescriber signature reported 
in Al-Amal hospital 78.6% while the lowest percentage of prescriber name reported in Dar 
Al-Salam hospital 52.3%. 
With respect to specialty of prescribers‘ omission was also seen. the highest percentage of 
prescriber specialty omission reported in Al-Awda hospital 62% while the lowest 
percentage of prescriber specialty omission reported in Public Aid hospital 11.5%. 
Finally, the highest percentage in recording prescription date reported in Hayfa hospital 
98.8% while the lowest percentage in recording prescription date reported in Al-Karama 
hospital and Public Aid hospital 78.1%. 
The NGHs management justified prescriber‘s poor compliance in doing stamp, signature 
and specialty due to their dependence on the ability of medical staff to distinction the 
prescribers from their hand writing style and common type of drugs were written in the 
prescriptions. 
These errors hinder the researcher to determine the accurate reason of overprescribing of 
antibiotics. Previous studies showed significant alterations in prescribing antibiotics by 
raising of academic detailing, this alteration was in the following areas; inappropriate 
prescription, development of resistance, choice of drug and cost  (MacDonald, Collins, 
McGilchrist et al., 1995; Ilett, Johnson, Greenhill et al., 2000), By linking findings in 
Table (4.27) and Table (4.33), comparing to the other NGHs, Al-Awda hospital reported 
the highest percentage of antibiotics prescription 46.5% and lowest specialist percentage 
24% with the highest unknown prescriber‘s specialty percentage 62%, on the other hand, 
the opposite occur in Public Aid hospital where the highest specialist percentage reported 
72.7% with relatively low ratio in prescribing antibiotics 34.7%.  
Regarding to prescriber address and telephone, no address or telephone for the prescriber 
were written in the prescriptions because physicians use the NGHs pre-printed forms on 
prescription order blanks the name and address of the NGHs. 
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4.3.2 Patient information 
Table (‎4.34): Patient information for the NGHs in the GG 
# NGHs 
Patient 
name 
(%) 
Patient 
address 
(%) 
Patient 
telephone 
(%) 
Patient 
age 
(%) 
1 Al-Amal  100 0.4 64.2 98.1 
2 Al-Awda  99.7 82.2 85.5 86.3 
3 Al-Karama  99.4 59.2 27.5 74.2 
4 Dar Al-Salam  98.9 74 53.3 95.8 
5 Hayfa  99.2 50.8 54.4 89.1 
6 Kuwait 98.3 71.8 64.4 75.4 
7 PFBS 99.4 98.9 33.6 99.2 
8 Public Aid  97.3 57 42.3 86.7 
9 Yafa  100 67 58 67 
Total 99.1 62.4 53.7 85.8 
As shown in Table (4.34), patient information in the NGHs in the GG showed that patient 
name reported in 99.1% of  the study prescriptions while U.A.E. recorded patient name in 
97% of  the study prescriptions (Rasool, Fahmy, Abu-Gharbieh et al., 2010) and Nigeria 
recorded 70% of  the study prescriptions (Akoria & Isah, 2008).  
On the other hand, as shown in Table (4.34), patient address reported 62.4% while in 
Nigeria reported 50% (Akoria & Isah, 2008).  
Additionally, as shown in Table (4.34), patient telephone recorded 53.7% while in U.A.E. 
30% (Rasool, Fahmy, Abu-Gharbieh et al., 2010). 
Finally regarding patient age, as shown in Table (4.34),  in the NGHs in the GG patient 
age recorded in 85.8%  while in Nigeria recorded 80% (Akoria & Isah, 2008) and in 
U.A.E. recorded 36% (Rasool, Fahmy, Abu-Gharbieh et al., 2010).  
As shown in Table (4.34), the highest percentage in recording patient name reported in 
Yafa hospital and Al-Amal hospital where recording was perfect while the lowest 
percentage in recording patient name reported in Public Aid hospital 97.3%. 
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Regarding patient address, the highest percentage in recording patient address reported in 
PFBS hospital 98.9% while the lowest percentage in recording patient address reported in 
Al-Amal hospital 0.4%. 
Additionally, the highest percentage in recording patient telephone reported in Al-Awda 
hospital 85.5% while the lowest percentage in recording patient address reported in Al-
Karama hospital 27.5%. 
Finally, the highest percentage in recording patient age reported in PFBS hospital 99.2% 
while the lowest percentage in recording patient age reported in Yafa hospital 67%. 
Regarding NGH managements, such errors in recording patient information occur because 
of professional negligence, doing multiple tasks, tiring or busy schedule and unavailable 
computerized system or preferring use pre-printing forms.  
Omission errors include those related to patient information (patient's name, age) and 
errors related to the prescriber's information (prescriber's name, address, phone number, 
qualification, registration and date) (Atif, Azeem, Sarwar et al., 2018). Omission errors 
mainly occurred in inpatient sheets (medication sheets and discharge sheets), NGHs did 
not use computerized system in inpatient department. On the other hands, out-patient sheet 
may be entered into an electronic medical record system as in Hayfa hospital, Dar Al-
Salam hospital, patient friend‘s hospital and Kuwait hospital or it may be handwritten on 
preprinted prescription forms as in the remaining NGHs. Using computerized system 
decrease the rate of omission errors could present. Patient name and contact information 
are important to ensure that correct patient receives correct drug and for maintaining 
patient records. Also, this information will help pharmacist to contact patient in case of any 
dispensing error (Ash, Berg, & Coiera, 2004). 
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4.3.3 Prescription information  
Table (‎4.35): Prescription information for the NGHs in the GG 
# NGHs 
Eligible 
hand 
writing 
(%) 
Label  
(%) 
Non- 
official 
Abb. 
(%) 
Dosing 
frequency 
(%) 
Strength 
(%) 
Treat. 
length 
(%) 
Total 
amount 
(%) 
Dosage 
form 
(%) 
1 Al-Amal 98.1 60.3 3.1 76.8 86.2 14.6 10.6 66.3 
2 Al-Awda 91.5 31.8 10.7 69.7 78.4 33.9 13.9 49.6 
3 Al-Karama 98.6 25.8 16.4 52.6 75.1 23.5 53.6 43.4 
4 Dar Al-Salam  93.3 24.9 4.2 76.5 78.8 42.9 32.5 43.1 
5 Hayfa 95.2 27.4 13.7 87 91.6 62.1 4.9 44.1 
6 Kuwait 94.2 34.3 3.6 64 75.1 29.1 24.1 54.3 
7 PFBS 71.6 34.2 5.2 58.2 67.4 28.9 25.1 49.9 
8 Public Aid  86.2 27.3 14 73.1 72.6 36 26.9 54.4 
9 Yafa  75 17 3 42.9 64.7 12.2 38.2 35.3 
Total 89.3 31.4 8.2 66.8 76.7 31.5 25.5 48.9 
As shown in Table (4.35), The results of this study demonstrate percentage of encounters 
written with eligible hand writing, percentage of the study prescriptions drugs with 
instructions and warnings, percentage of the study prescriptions drugs with nonofficial 
abbreviation and percentage of the study prescriptions drugs with commission errors 
(Commission errors included errors related to the dose, dosage form, strength, frequency, 
amount and duration of the treatment) (Atif, Azeem, Sarwar et al., 2018). 
With regards to hand writing eligibility, as shown in Table (4.35), all the study 
prescriptions were handwritten, and the majority of study prescriptions (89.3%) were 
written clearly enough to be read by all three examiners (data collectors) which important 
to prevent life-threatening mistake during drug dispensing by the pharmacist. On the other 
hand, in the West Bank eligible and readable encounters was  95.8% (Tayem, Ibrahim, 
Qubaja et al., 2013). The highest percentage of the study prescriptions written with eligible 
and readable hand writing recorded in Al-Karama hospital 98.6% while the lowest 
percentage of the study prescriptions written with eligible and readable hand writing 
recorded in Patient Friends' Hospital 71.6%. Additionally, regarding the percentage of the 
study prescriptions with instructions and warnings either among the drugs prescribed or for 
certain drugs for patient use were around one-third 31.4% of the study prescribed drugs. In 
Nigeria the percentage of the study prescriptions with instructions and warnings was 10% 
 100 
 
found in Nigeria (Akoria & Isah, 2008). The highest percentage of the study prescriptions 
written with instructions and warnings recorded in Al-Amal hospital 60.3% while the 
lowest percentage of the study prescriptions written with instructions and warnings 
recorded in Yafa hospital 17%. The reason of high percentage of missing instructions and 
warnings in the study prescriptions is that the researcher use outpatient sheets to follow the 
prescribers writing skills and these sheets are for physicians' usage only.  
As shown in Table (4.35), our result revealed a percentage of prescriptions with 
nonofficial abbreviations is 8.2% of the study prescriptions.  Nonofficial abbreviations 
were found in the governmental facilities in the GG with higher percentage 87.4% (Ayoub, 
Musalam, & Mahadi, 2017). In the NGHs the majority of nonofficial abbreviations 
reported in 18% of the out-patient sheets and 27% of the discharge sheets. The highest 
percentage of the study prescriptions written with nonofficial abbreviations recorded in Al-
Karama hospital 16.4% while the lowest percentage of the study prescriptions written with 
nonofficial abbreviations recorded in Yafa hospital 3%.  
Using nonofficial abbreviations can lead to harmful effects and subsequently be 
catastrophic for the patients and their families specially when abbreviations use in drugs 
name by creating problems in dispensing drugs by putting the responsibility of selecting a 
proper drug on the shoulders of the pharmacist (Chen, Neil, Avery et al., 2005). 
Regarding commission errors, Table (4.35) shown that the dosing frequency was written in 
66.8% of the study prescriptions drugs. Our result was lower than other countries which 
was 84% in U.A.E. (Rasool, Fahmy, Abu-Gharbieh et al., 2010) and in Nigeria 94% 
(Akoria & Isah, 2008) but higher than result reported in Bahrain 19.9% (Al Khaja, 
Sequeira, Al-Ansari et al., 2008). The highest percentage of the study prescriptions written 
with dosing frequency recorded in Hayfa hospital 87% while the lowest percentage of 
study prescriptions written with dosing frequency recorded in Yafa hospital 42.9%.  
As shown in Table (4.35), the prescribed drug dose strength was specified in 76.7% of 
prescribed drugs. Our results were remarkably close to Brasil 76% (Ferreira, Heineck, 
Flores et al., 2013) while lower than in  U.A.E 79% (Rasool, Fahmy, Abu-Gharbieh et al., 
2010) and Nigeria 95.8% (Akoria & Isah, 2008).  
In the other hand, with regards to prescribed drugs length, total amount of the prescribed 
drugs and prescribed drugs forms. As shown in Table (4.35), the length of the treatment 
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was reported in 31.5 % of the study prescribed drugs. In other countries, studies reported 
better findings;  Brasil reported  91.7% of the study prescribed drugs with length of the 
treatment (Ferreira, Heineck, Flores et al., 2013) and Nigeria reported 85.8% of the study 
prescribed drugs with length of the treatment (Akoria & Isah, 2008). The highest 
percentage of   prescribed drugs length recorded in Hayfa Hospital 62.1% while the lowest 
percentage of prescribed drugs length recorded in Yafa Hospital 12.2%. 
Regarding to the total amount of the drug, one-fourth of the study prescribed drugs 25.5% 
in the NGHs in the GG contain the quantity that the pharmacist should dispense. In Nepal 
drugs quantity reported in 60% of the study prescribed drugs (Ansari & Neupane, 2009). 
By comparing within the level of the GG NGHs, the highest percentage of prescribed 
drugs total amount recorded in Al-Karama hospital 53.6% while the lowest percentage of 
prescribed drugs total amount recorded in Hayfa hospital 4.9%.  
Finally, the prescribed drugs pharmaceutical dosage forms was 48.9%, the result was 
remarkably better reported in brasil 91.4% (Ferreira, Heineck, Flores et al., 2013) while it 
was remarkably worse reported in Nigeria 14.2 % (Akoria & Isah, 2008). The highest 
percentage of prescribed drugs pharmaceutical dosage forms recorded in Al-Amal hospital 
66.3% while the lowest percentage of prescribed drugs pharmaceutical dosage forms 
recorded in Yafa hospital 35.3%.  
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4.4 Health Facility indicators 
Table (‎4.36): Health Facility indicators for the NGHs in the GG 
Health Facility 
indicators 
Al-
Amal 
Al-
Awda 
Al-
Karama 
Dar 
Al-
Salam 
Hayfa Kuwait PFBS 
Public 
Aid 
Yafa Total 
Availability of 
copy of local 
formulary or 
formulary 
Yes/No* 
1 1 1 1 1 1 1 1 1 1 
Availability of 
key drugs in the 
stock (%) 
76.9 76.9 89.2 100 86.2 76.9 70.8 90.8 76.9 76.9 
Yes/No*: Yes=1/No=0 
4.4.1 Availability of copy of EDL or formulary 
Regarding health facility indicators, none of the NGHs in the GG have a national local 
formulary. In our study the researcher considered the last two years stable drugs list until 
the time of the study for the selected NGHs is the local formulary. The result of the study 
revealed that all the nine NGHs had a copy of a local formulary as shown in Table (4.36). 
This makes the overall availability100% which is much better than availability percentage 
of copy of local formulary in other studies. In Ethiopia one half (50%) of the study private 
hospitals have local formulary (Angamo, Wabe, & Raju, 2011). The overall availability for 
10 health centers in Saudi Arabia was found to be 90 % (El Mahalli, 2012). However, the 
availability of the present study can be said to be better than a study in India where 0% 
availability was reported (Gopalakrishnan, Ajitha, Ganeshkumar et al., 2012). By 
conducting focus group with the hospital director, manager of procurement department, 
administration department and responsible pharmacist of each hospital to clarify the reason 
of selecting drugs in the local drug list.  The researcher found that drugs list designed 
according to medical point of view regarding to hospital needs and nature of services by 
participation of hospital physicians, also, according to the financial point of view to ensure 
achieving cost effectiveness and efficiency. 
4.4.2 Percent of the availability of key drugs in the stock 
The researcher didn‘t use the key drugs model in the WHO manual because it just cover 
the outpatient department key drugs, so the researcher developed a key drugs list based on 
national drug list which match WHO key drugs list in the WHO manual 1993 (WHO, 
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1993) and WHO handbook 2010 (WHO, 2010a). The researcher distributed the national 
drug list to the 9 selected NGHs to choose the basic drugs according to their nature of 
services and needs as well as cover all hospital departments (ICU, outpatient, inpatient 
department and Emergency department). The nine participated hospitals nominated 65 
drugs and consider them as a key drugs list (Annex 10). The researcher made sure that the 
18 key drugs mentioned in WHO manual 1993 and WHO handbook 2010 as key drugs 
were included in the list. Finally, the researcher redistributed the key drug list among the 
nine NGHs. The participated NGHs checked the availability of the key drugs during the 
time of data collection. The results were as follow; the overall key drugs provision among 
the NGHs was 76.9%, as shown in Table (4.36), while in Yemen hospitals 45% 
(Bashrahil, 2010) and in Ethiopia hospitals 65.7% (Gidebo, Summoro, Kanche et al., 
2016). As shown in Table (4.36) and Figure (4.5), the highest percentage of key drugs 
availability was recorded in Dar Al-Salam hospital (100%) while the lowest percentage of 
key drugs availability was recorded in PFBS hospital (70.8%). Ethiopia private hospitals 
were recorded the following result 62.5%, 81.3%, 68.8% and 50% (Gidebo, Summoro, 
Kanche et al., 2016). Low key drugs availability in the local formulary hospital list was 
regarding to; no chronic disease clinics in NGHs because the MOH and UNRWA clinics 
dispense chronic diseases drugs (hypertensive and diabetic drugs) for free in the GG so the 
NGHs don‘t consider chronic disease drugs as a priority; opioid analgesics as morphine 
and pethidine were supplied from the MOH drugs store which in turn suffer from drugs 
shortage during the time of the study. As a special case, Al-Amal hospital drug supply 
system mainly depend on the MOH drug storage so the MOH drug shortage problem 
affected Al-Amal hospital drug storage directly (76.9%).  
As shown in Table (4.37), regarding limited availability of local formulary drugs, Al-Amal 
hospital reported the lowest percentage of prescribing local formulary drugs 54.2%. 
Additionally, Public Aid Hospital providing the majority of drugs in the local formulary 
(90.8%) and reported the best compliance of physicians with hospital local formulary 
(97%), also, Dar Al-Salam hospital provided 100% of the local formulary drugs and the 
compliance with local formulary prescribing was 95% thus can indicate the good 
communication channels between physicians, hospital management and hospital 
pharmacists.  
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Figure (‎4.5): Percent of the availability of key drugs in the stock of the NGHs in the GG 
Table (4.37): showed checked list of the Key drugs in the stock of the NGH in the GG 
during time of data collection 
Table (‎4.37): Checked list of the Key drugs in the stock of the NGH in the GG during time 
of data collection 
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1 Adrenaline  1 0 1 1 0 0 0 1 0 
2 Amikacin Sulphate 0 0 1 1 1 1 0 0 0 
3 Aminophylline 1 0 1 1 0 0 0 0 1 
4 Amlodipine 1 0 0 1 1 0 0 1 0 
5 Amoxicillin  1 0 0 1 1 0 0 1 0 
6 Amoxicillin + Clavulanic acid 1 0 0 1 1 0 0 1 0 
7 Atenolol 0 0 0 1 0 1 1 0 0 
8 Atracurium Besylate 0 0 1 1 1 1 0 1 1 
9 Atropine Sulphate  0 0 1 1 1 0 1 1 1 
10 Beclomethasone 1 0 1 1 1 1 1 1 1 
11 Bupivacaine Hcl 0 0 1 1 1 1 1 1 1 
12 Captopril 0 0 1 1 1 1 1 1 1 
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13 Ceftriaxone 0 0 0 1 1 1 0 1 0 
14 Cefuroxime  0 0 1 1 0 1 0 1 0 
15 Ciprofloxacin 0 0 1 1 0 0 0 0 1 
16 Dexamethasone 1 1 1 1 1 1 1 1 1 
17 Diazepam 1 1 1 1 1 1 1 1 1 
18 Diclofenac Sodium 1 1 0 1 1 1 0 1 0 
19 Enalapril 1 1 1 1 1 1 1 1 1 
20 Ephedrine Hcl 1 1 1 1 1 1 1 1 1 
21 Fentanyl 1 1 1 1 1 1 1 1 1 
22 Ferrous sulphate + Folic acid 1 1 1 1 1 1 1 1 1 
23 Fluconazole 1 1 1 1 1 1 1 1 0 
24 Furosemide 1 1 1 1 1 1 0 1 1 
25 Gentamicin 1 1 1 1 1 0 0 1 1 
26 Glibenclamide 1 1 1 1 1 0 1 1 1 
27 Glycine Irrigation 1 1 1 1 1 1 1 1 1 
28 Griseofulvin  1 1 1 1 1 1 1 1 1 
29 Halothane  1 1 1 1 1 1 1 1 1 
30 Heparin 1 1 1 1 1 1 1 1 1 
31 Hydrocortisone 1 1 1 1 1 1 1 1 1 
32 Insulin 1 1 1 1 1 1 1 1 1 
33 Isoflurane 1 1 1 1 1 1 1 1 1 
34 Isosorbide Dinitrate  1 1 1 1 1 1 1 1 1 
35 Isosorbide Mononitrate 1 1 1 1 1 1 1 1 1 
36 Ketamine Hcl 1 1 1 1 1 1 1 1 1 
37 Lidocaine Hcl 1 1 1 1 1 1 1 1 0 
38 Magnesium Sulphate 0 1 1 1 1 1 0 1 1 
39 Mebendazole 1 1 1 1 1 1 1 1 1 
40 Metformin 1 1 0 1 1 1 1 1 1 
41 Prednisolone 1 1 1 1 1 1 1 1 1 
42 Methylene Blue  1 1 1 1 1 1 1 1 1 
43 Metoclopramide 1 1 1 1 1 0 0 1 0 
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44 Metronidazole   1 1 1 1 1 1 1 1 1 
45 Midazolam  0 1 1 1 1 0 0 0 0 
46 Morphine 0 1 1 1 1 0 0 1 0 
47 Norepinephrine 1 1 1 1 1 1 1 1 1 
48 Omeprazole  0 1 1 1 1 1 1 1 1 
49 Oral Rehydration Salt (O.R.S.)  1 1 1 1 1 1 1 1 1 
50 Oxytocin 0 1 1 1 0 1 1 1 1 
51 Paracetamol  1 1 1 1 1 1 1 1 0 
52 Pethidine 0 1 1 1 0 0 1 1 1 
53 Povidone Iodine 1 1 1 1 1 1 1 1 1 
54 Promethazine 1 1 1 1 1 1 1 1 1 
55 Propofol 1 1 1 1 1 1 1 1 1 
56 Ranitidine Hcl 1 1 1 1 1 1 1 1 1 
57 Salbutamol        1 1 1 1 1 1 1 1 1 
58 Silver sulfadiazine 1 1 1 1 0 0 0 0 1 
59 Simvastatin 1 1 1 1 1 0 0 1 1 
60 Sulfamethoprim + Co-trimoxazole 1 1 1 1 1 1 1 1 1 
61 Thiopental 1 1 1 1 1 1 1 1 1 
62 Tramadol 1 1 1 1 0 1 1 1 1 
63 Tranexamic acid   1 1 1 1 1 1 1 1 1 
64 Vitamin A 500 U + Vitamin D 200 U  1 1 1 1 1 1 1 1 1 
65 Warfarin Sodium 1 1 1 1 1 1 1 1 1 
Total 50 50 58 65 56 50 46 59 50 
Percent (%) 76.9 76.9 89.2 100 86.2 76.9 70.8 90.8 76.9 
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Chapter Five 
Conclusion and Recommendations  
4.5 Conclusion 
Hence, we would like to conclude that in our study we assessed the RUD at the NGHs in 
the GG based on the recommended WHO core prescribing indicators, assessed prescribing 
writing skills and finally assessed prescriber‘s knowledge, attitude and practice toward 
hospital local formulary. Regarding physicians‘ attitude and practice toward local 
formulary, the study findings revealed that less than one half of the study participants were 
aware of the existence of hospital local formulary. The study findings revealed that out of 
total study participants who aware of the existence of hospital local formulary; two thirds 
of the study participants, received local formulary copy in different time manner; more 
than two thirds of study participants neither involved in designing nor in developing up 
hospital local formulary and two thirds of the study participants do not communicate with 
pharmacists properly or regularly. On the other hand, the study participants do not have a 
particular source of drug information. The most two common drug information sources 
were the hospital pharmacists and Internet. Two thirds of the study participants indicated 
hospital pharmacists as source of drug information while more than one fourth of study 
participants indicated Internet as source of drug information. The majority of the study 
participants neither never attended nor rarely attended the refreshment lecture on local 
formulary in the NGH. Two thirds of the study participants affected either rarely or always 
with patient desire, believes and expectations in writing drug prescriptions. The finding 
showed that more than one half of the study participants indicated positive attitude about 
the hospital local formulary and its benefits. Two thirds of the study participants agreed the 
necessity of local formulary in provision of quality health services while less than two 
thirds of the study participants agreed the necessity of local formulary in reducing wasting 
of health care resources and in preventing patient harm. Less than two thirds of the study 
participants agreed that local formulary selection criteria are scientifically based. Only 
more than one third of the study participants agreed the necessity of local formulary in 
including the majority of needed drugs. More than one half of the study participants shown 
positive practice toward prescribing drugs. More than one third of the study participants 
agreed that they explain treatment to the patient and mention the necessary warnings and 
instructions. Also, two thirds of the study participants agreed with compliance with local 
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formulary drugs during their prescribing practices. More than one third of the study 
participants agreed with using hospital-approved protocols regardless of the latest 
protocols. Additionally, more than one half of the study participants agreed with 
prescription drugs based on the drugs available at the hospital pharmacy. Less than one 
half of the study participants agreed that they keep permanent communication with the 
pharmacist to find out the available drugs. Less than one half of the study participants 
didn‘t receive any copy of hospital local formulary (soft copy or hard copy). In fact, 
hospital pharmacists committee in all NGHs are the responsible entity for setting up 
hospital local formulary except Al-Awda hospital which have a hospital DTC consist of 
hospital specialists and pharmacists. More than one third of the study participants chose 
hospital DTC which was a correct answer for Al-Awda hospital only. Less than one fourth 
of the study participants chose correctly hospital pharmacy committee which indicate a 
huge gab in the participants knowledge about the responsible entity for setting up hospital 
local formulary. The majority of the study participants felt that they were not encouraged 
properly by hospital management to be compliant with local formulary drugs. Although all 
NGHs managements did not conduct any lecture or training program on local formulary in 
the hospitals except Al-Awda hospital use generalizations instead of lecture or training 
program on local formulary content among physicians in regular time. One third of the 
study participants thought that the hospital management arrange lectures or training 
programs on local formulary and the majority of the study participants didn‘t receive any 
training on local formulary content and concept. All these findings toward NGHs 
management efforts in hospital local formulary in the hospital clearly investigate the poor 
communication channel between the hospital managements and the prescribers. More than 
two thirds of the study participants know that hospital local formulary update routinely as 
well as receiving local formulary copy in different time manner. Less than one half of the 
study participants received copy of local formulary yearly. The majority of the study 
participants have not received appropriate feedback from the hospital management about 
their compliance with local formulary. Less than one half of the study participants 
indicated that no action was taken against physicians who didn‘t compliance with local 
formulary. These results indicated weak monitoring and evaluation system in the NGHs.  
On the other hand, there was a negative perception toward hospital management efforts. 
The majority of the study participants were either uncertain or declined the existence of 
monitoring system in the hospital to measure physician‘s compliance with local formulary 
drugs. The majority of the study participants were either uncertain or declined the 
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followings; the presence of monitoring system to assess physician‘s compliance with the 
treatment protocols, the effectiveness of current hospital monitoring and evaluation system, 
the  compliance with the treatment protocol affects the performance appraisal, the 
existence of performance indicators on their compliance with the current treatment 
protocols and the providing list of the current available drugs at the hospital pharmacy. 
Unexpectedly, more than two thirds of the study participants were agreed that they 
describe unnecessary treatments due to near expire date of the available drugs in the 
hospital pharmacy, this happen after distribution the near expiry date drugs list which were 
available in the hospital. Although the NGHs don‘t have neither therapeutics committee as 
a source for the treatment protocols nor treatment protocols. One fourth of the study 
participants confirmed the presence of treatment protocols in the hospital. One half of 
those who confirmed the presence of treatment protocols in the hospital, confirmed that 
protocols location is hospital ward. Also, one third of the study participants confirmed that 
the most common source of the treatment protocols is therapeutics committee in the 
hospital and one third of the study participants confirmed that text book is the second 
source. Additionally, less than one half of the study participants confirmed that treatment 
protocols matching hospital local formulary and two thirds of the study participants 
confirmed that they rarely or didn‘t receive any written treatment protocols. These findings 
reflect how much the prescribers don‘t know the reality status of the management system 
in the NGHs and thought that the NGHs have the same managements system in the 
governmental hospitals. Regarding attitude toward treatment protocol in the hospital. one 
half of the study participants showed positive attitude. More than one-half of the study 
participants were agreed that drugs included in the treatment protocols are effective, 
compliance with treatment protocols reducing total health cost and unexpectedly local 
formulary drugs are included in the treatment protocols are less effective than others while 
less than one half of the study participants were agreed the treatment protocols are 
obligatory for participants in the work. 
The findings of the study have shown that the NGHs recorded results more than WHO 
recommendations in the following: average number of drugs prescribed per encounter, 
encounters with injection as well as encounter with antibiotic. While The findings were 
less than WHO recommendations in the using generic name of drugs in prescription and 
prescribing drugs from hospital local formulary. Our study found that most of prescribed 
drugs related to analgesic groups and antibiotics groups. NSAID was the most common 
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analgesic group while third generation of cephalosporin is the most common antibiotic 
group was prescribed. Regarding complementary indicators the average drug costs per 
encounter in the NGHs was around eleven dollars and approximately half of the drug costs 
in the selected the NGHs spent on antibiotics. The using of antimicrobials was negligible. 
Regarding prescriber information, less one half of encounter were with prescriber name, 
more than one third with prescriber stamp, more than two thirds with prescriber signature 
and more than half of encounters with clean mention for prescriber‘s specialty. The study 
findings revealed that the majority of encounters with patient name, patient age and 
prescriptions date. Additionally, more than two thirds of encounters with patient address 
while more than one half of encounters with patient telephone. For prescribing writing 
skills, the NGHs in the GG reported omission errors in prescriber information and patient‘s 
information. Regarding prescriber information, more than half of the study prescriptions 
were omitted name, two thirds of the study prescriptions were omitted stamp, more than 
one third of the study prescriptions were omitted signature and specialty. On the other 
hand, patient information recorded omission error as follow; in more than one third of the 
study prescriptions were omitted patient address, less than one half of the study 
prescriptions were omitted patient telephone, less than one fourth of the study prescriptions 
were omitted patient age while almost study prescriptions were with good compliance in 
recording patient name and date of prescription. Additionally, regarding prescription 
information, the majority of the study prescriptions were with eligible and readable hand 
writing, around one third of the study prescriptions with instructions and warnings, the 
majority of the study prescriptions were without non-official abbreviations. Regarding 
commission errors, more than two thirds of the study prescriptions were with dosing 
frequency and strength, around one third of the study prescriptions with treatment length, 
around one fourth of the study prescriptions with total amount and finally less than one 
half of the study prescriptions with dosage form. 
Finally, regarding availability of copy of hospital local formulary, all the NGHs have 
hospital local formulary copy because the researcher considered the last two years local 
formulary for the hospital is the hospital local formulary while the availability of key drugs 
in the stock during the time of data collection range from moderate to complete. 
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4.6 Recommendation  
1. The hospital managements of the NGHs need to develop appraisal form for the 
physicians to assess periodically to identify any defects and introduce corrective 
measures such as educational programmes on rational prescribing, followed by 
reminders and feedback to assess the physicians‘ response. 
2. The hospital managements of the NGHs need to develop annual appraisal form for the 
hospital management performance and how much they match WHO health facility and 
patient care indicators. 
3. Forcing functions and constraints they allow for designing processes to ensure that 
errors are virtually impossible or at least difficult to make. Examples include software 
programs with ―forcing functions ―that require the entry of additional pertinent patient 
information before the order is completed and the medication is dispensed. 
Automation and computerization of medication use processes and tasks can lessen 
human fallibility by limiting reliance on memory. 
4. Policy makers, decision makers and healthcare professionals should implement and 
support policies and programmes to reduce inappropriate drug use as antibiotic and 
analgesics, preventing antibiotic resistant and over use analgesic health problems 
while at the same time lowering costs and improving health outcomes. 
5. Under supervision of WHO Gaza office, training specialist of the international and 
local non-governmental organization who work in health field as JUZOOR for Health 
& Social Development which can conduct trainings for rational use of drugs and local 
formulary concept and content in the NGHs. 
6. The quality and nature of prescriptions written in the GG is substandard and it requires 
use of a standardized prescription format to be used. Also, regarding legibility, 
computerization can be the answer to the problem. 
7. The hospital managements of the NGHs need to improve the role of Monitoring and 
auditing system, especially to improve physician‘s compliance with local formulary. 
8. With good integration from hospital managements of the NGHs with MOH to arrange 
continuous education and training programs for healthcare staff concerning local 
formulary and treatment protocols especially for new graduation physicians. Hospital 
managements of the NGHs needs to identify training priority areas that physicians 
need to attain during their work.  
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9. There is a need to improve the communication among the hospital managements of the 
NGHs.  
10. Develop hospital DTC and involve hospital specialists and pharmacists in the updating 
process of hospital local formulary.  
4.7 Further research  
1. Conduct research including both qualitative and quantitative methods for NGHs in 
the West Bank.  
2. Conduct research including both qualitative and quantitative methods to compare 
patient care indicators in the governmental hospital and NGHs in the GG. 
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Annex (1): Helsinki Committee research approval 
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Annex (2) Sample of the NGHs approval  
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Annex (3): Describes the activities of the research and expected duration for each activity 
 2017 2018 
Activity Duration March April May June July Aug. Sept. Octo. Nov. Dec. Jan. Feb. March April May June 
Proposal 
writing 
2 months                 
Proposal 
defense and 
approval 
 
2 months 
                
Prep. period 
2 months                 
Pilot study 
1 month                 
Data 
collection 
4 months                 
Data entry 
4 months                 
Data 
analysis 
4 months                 
Thesis 
writing 
3 months                 
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Annex (4) Shows WHO data collection forms (prescribing indicator form) 
Location:……………..                                       Facility name:…………………                 
Investigator:………………..                              Date:…………………………. 
Seq. # 
Type  
R/P 
Date 
of 
Rx 
Age  
(yrs) 
# 
Drugs 
# 
generic 
Antibiotic 
(0/1) * 
Injection 
(0/1) * 
# on           
local 
formulary 
Diagnosis 
(optional) 
1          
2          
3          
4          
5          
6          
7          
8          
9          
10          
11          
12          
13          
14          
15          
16          
17          
18          
19          
20          
TOITAL           
AVERAGE          
PERCENTAGE          
*0=No  1=Yes 
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Annex (5) Shows WHO data collection forms  
Location:……………..                              Facility name:…………………                   
Investigator:………………..        Date:…………………………. 
 
Seq. # 
T
y
p
e R
/P
 
D
a
te o
f R
x
 
#
 D
ru
g
s 
A
ctu
a
l co
st o
f 
D
ru
g
s 
A
n
tib
io
tic 
n
a
m
e 
A
ctu
a
l co
st o
f 
a
n
tib
io
tic 
A
n
tib
io
tic 
(0
/1
) *
 
A
n
tib
io
tic 
In
jectio
n
 
(0
/1
) *
 
#
 o
n
 lo
ca
l 
fo
rm
u
la
ry
 
D
ia
g
n
o
sis 
(o
p
tio
n
a
l) 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
16           
17           
18           
19           
20           
TOTAL            
AVERAGE           
PERCENTAGE           
*0=No        1=Yes 
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Annex (6) Shows WHO data collection forms (antimicrobial prescribing indicator 
form). 
Location:……………..                  Facility name:…………………                                   
Investigator:………………..         Date:…………………………. 
Seq. # 
T
y
p
e  
R
/P
 
D
ate o
f R
x
 
#
 D
ru
g
s 
A
ctu
al co
st o
f 
d
ru
g
s 
A
n
tim
icro
b
ial 
(0
/1
) *
 
A
n
tim
icro
b
ial 
n
am
e 
A
ctu
al co
st o
f 
an
tim
icro
b
ial 
d
ru
g
 
D
iag
n
o
sis 
(o
p
tio
n
al) 
1         
2         
3         
4         
5         
6         
7         
8         
9         
10         
11         
12         
13         
14         
15         
16         
17         
18         
19         
20         
TOITAL          
AVERAGE         
PERCENTAGE         
          *0=No       *1=Yes
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Annex (7) Shows Antimicrobial classification for prescribing indicators 
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Annex (8) Shows WHO data collection forms (Facility summary form). 
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Annex (9) Observational checklist for prescribing writing skills 
No Prescriber Prescription Patient 
N
a
m
e 
a
d
d
ress 
T
elep
h
o
n
e 
sig
n
a
tu
re 
D
a
ta
 
G
en
eric n
a
m
e 
S
tren
g
th
 
D
o
sa
g
e fo
rm
 
T
o
ta
l a
m
o
u
n
t 
L
a
b
el 
(in
stru
c
tio
n
s, 
w
a
rn
in
g
s) 
N
a
m
e 
A
d
d
ress 
A
g
e 
1              
2              
3              
4              
5              
6              
7              
8              
9              
10              
11              
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Annex (10) The self- developed Key drugs lists in NGHs in the GG. 
# Drugs # Drugs # Drugs 
1 Adrenaline  23 Fluconazole 45 Midazolam  
2 Amikacin Sulphate 24 Furosemide 46 Morphine 
3 Aminophylline 25 Gentamicin 47 Norepinphrine 
4 Amlodipine 26 Glibenclamide 48 Omeprazole  
5 Amoxicillin  27 Glycin Irrigation 49 Oral Rehydration Salt (O.R.S.)  
6 Amoxicillin +Clavulanic acid 28 Grisofulvin  50 Oxytocin 
7 Atenolol 29 Halothane  51 Paracetamol  
8 Atracurium Besylate 30 Heparin 52 Pethidine 
9 Atropine Sulphate  31 Hydrocortisone 53 Povidone Iodine 
10 Beclometason 32 Insulin 54 Promethazone 
11 Bupivacaine Hcl 33 Isoflurane 55 Propofol 
12 Captopril 34 Isosorbide Dinitrate  56 Rantidine Hcl 
13 Ceftriaxone 35 Isosorbide Mononitrate 57 Salbutamol        
14 Cefuroxime  36 Ketamine Hcl 58 Silver Sulphadiazine 
15 Ciprofloxacin 37 Lidocaine Hcl 59 Simvastatin 
16 Dexamethasone 38 Magnesium Sulphate 60 Sulfamethoprim + Co-trimoxazole 
17 Diazepam 39 Mebendazole 61 Thiopental 
18 Diclofinac Sodium 40 Metformin 62 Tramadol 
19 Enalapril 41 Prednisolone 63 Tranexamic acid   
20 Ephedrine Hcl 42 Methylene Blue  
64 
Vitamin A as Palmitate 500 U+ Vitamin D 200 U  21 Fentanyl 43 Metoclopramide 
22 Ferrous sulphate + Folic acid 44 Metronidazole   65 Warfarin Sodium 
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  :noisrev cibarA ni mrof tnesnoc eht dna eriannoitseuq ehT :)11( xennA
 
 بسم الله الرحمن الرحيم
 انًوافقت عهي إجراء استبَاٌ حول دراست:
 آث انصحَت غَر انحكويَت فٌ يحافظاث غزةيذى الاستخذاو انرشَذ نلأدوٍت فٌ انًنشتقََى  دراست
 ٚ٘ٛألَٛ ثعًّ ثؾش عٍّٟ  اٌمذط،ـٟ ثشٔبِظ ِبعغز١ش اٌظؾخ اٌعبِخ ـٟ عبِعخ  ؽٗ، ؽبٌجخأٔب اٌجبؽضخ: ؽٕ١ٓ ِؾّذ 
الاعزخذاَ اٌشش١ذ ٌلأدٚ٠خ ـٟ إٌّشآد اٌظؾ١خ ؼ١ش اٌؾىِٛ١خ ـٟ ٠ٙذؾ دساعخ ِذٜ عضء ِٓ دساعزٟ ـٟ اٌغبِعخ 
 أْ إٌزبئظ لذ رؤدٞ اٌٟ رؾغ١ٓ اٌخذِبد اٌظؾ١خ. ؽ١ش .ِؾبـظبد ؼضح
ٕ٘بن خ١بساد ٌلإعبثخ عٓ وً عؤاي، اٌشعبء اخز١بس الإعبثخ الألشة إٌ١ه ٌّّٚبسعزه اٌٛالع١خ، ِع اٌعٍُ أٗ لا رٛعذ 
 إعبثبد خبؽئخ ٚإعبثبد طؾ١ؾخ.
 ش٠خ اٌّعٍِٛبد.اٌّشبسوخ ـٟ ٘زا اٌجؾش رطٛع١خ ٌٚه اٌؾك ـٟ الأغؾبة ِزٝ رشبء ِع اٌزؤو١ذ عٍٝ ع
 دل١مخ. 55الاعزج١بْ لذ ٠غزؽشق ؽٛاٌٟ 
 ألذس عبٌ١ب ِشبسوزه ـٟ اٌجؾش.
 ٚرفؼٍٛا ثمجٛي عض٠ً اٌشىش
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  يذى الاستخذاو انرشَذ نلأدوٍت فٌ انًنشآث انصحَت غَر انحكويَت فٌ يحافظاث غزة.تقََى دراست استبَاٌ 
 .....انرقى انًتسهسم ......... ..8102/………/..…انتارٍخ :
 اٌغٕظ: .5
  روش  أٔضٝ 
 اٌعّش: .......................... عٕخ .2
 
 اٌؾبٌخ الاعزّبع١خ: .3
 أعضة 
 
 ِزضٚط  ِطٍك  أسًِ 
 
 ِىبْ اٌغىٓ (اٌّؾبـظخ): .4
 شّبي ؼضح  
 
 سـؼ  خبٔ١ٛٔظ  إٌّطمخ اٌٛعطٝ  ؼضح  
 
 اٌذسعخ اٌعٍّ١خ (آخش شٙبدح ؽظٍذ عٍ١ٙب): .5
ثىبٌٛس٠ٛط  
 ؽت                
دثٍَٛ  
 ٟعبٌ
 دوزٛساٖ  ثٛسد  /صِبٌخ   ِبعغز١ش                
  
 اٌزخظض:   .6
      
أؿ ٚأرْ   أؽفبي  عشاؽخ عبِخ  ثبؽٕخ ؽت عبَ                   
 ٚؽٕغشح
  ٔغبء ِٚزبثع  لٍت  عظبَ 
 ؽًّ
 أعٕبْ  اٌطٛاسا 
  
 اٌّغّٝ الإششاـٟ:      .7
 ِذ٠ش دائشح  
             
 ثذْٚ            سئ١ظ شعجخ    سئ١ظ لغُ              
 
 اعّبٌٟ عذد عٕٛاد اٌعًّ (اٌخجشح) ـٟ عّ١ع اٌّغزشف١بد:.....................عٕخ. .8
 
ؽغت ِعشـزه ً٘ ٠ٛعذ لبئّخ ثبلأدٚ٠خ الأعبع١خ ـٟ اٌّغزشفٝ ؼ١ش اٌؾىِٟٛ اٌزٞ رعًّ ـ١ٗ؟ (إرا وبٔذ اعبثزه ثلا  .9
 ):52اٚ لا أعشؾ أزمً ٌٍغؤاي 
  لا أعشؾ  لا  ٔعُ 
 عٍٝ رذس٠ت ؽٛي لبئّخ الأدٚ٠خ الأعبع١خ ـٟ اٌّغزشفٝ اٌزٞ رعًّ ـ١ٗ؟     ً٘ ؽظٍذ  .15
   لا  ٔعُ 
 ؽغت ِعشـزه ً٘ ٠زُ رؾذ٠ش لبئّخ الأدٚ٠خ الأعبع١خ اٌخبطخ ثبٌّغزشفٝ اٌزٞ رعًّ ـ١ٗ؟ .55
  لا أعشؾ  لا  ٔعُ 
 ً٘ رؾظً عٍٝ ٔغخخ ِٓ لبئّخ الأدٚ٠خ الأعبع١خ اٌخبطخ ثبٌّغزشفٝ؟     .25
 ؼ١ش رٌه  لا أؽظً  ٓعٕز١  ن  عٕٛ٠ب   
  
 ً٘ شبسوذ ـٟ اعذاد ٚرؾذ٠ش لبئّخ الأدٚ٠خ الأعبع١خ اٌخبطخ ثبٌّغزشفٝ اٌزٞ رعًّ ثٗ؟   .35
 لا  ٔعُ 
 
 
 
 ٠ٛعذ ٌذ٠ه ٔغخخ ِٓ لبئّخ الادٚ٠خ الاعبع١خ اٌخبطخ ثبٌّغزشفٝ: .45
 لا ٠ٛعذ  اٌىزشٚٔ١خ + ٚسل١خ  اٌىزشٚٔ١خ  ٚسل١خ 
 
  .55
 بطخ ثبٌّغزشفٝ رزُ ثٛاعطخ:رؾذ٠ش لبئّخ الأدٚ٠خ الأعبع١خ اٌخ 51.
ٌغٕخ اٌظ١ذٌ١خ ٚاٌعلاعبد  
 ثبٌّغزشفٝ
 اٌظ١ذٌ١خ  ٌغٕخ ِشوض٠خ ثبٌّغزشفٝ 
 ٌغٕخ خبسع١خ  ٚصاسح اٌظؾخ  اٌّذ٠ش اٌطجٟ 
  لا أعشؾ  لغُ اٌّشزش٠بد  خ١ٌغٕخ داخٍ١خ ٚخبسع 
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 رمَٛ إداسح اٌّغزشفٝ ثؾضه عٍٝ اٌزم١١ذ ثٛطؿ الأدٚ٠خ اٌّذسعخ ثبٌمبئّخ الأعبع١خ: .65
  لا  أؽ١بٔب    ب  دائّ 
 رمَٛ إداسح اٌّغزشفٝ ثزٕف١ز ثشاِظ رذس٠ت ِٚؾبػشاد ثخظٛص لبئّخ الأدٚ٠خ الأعبع١خ ثبٌّغزشفٝ: .75
 لا أعشؾ  لا  ٔعُ 
  
 رشبسن ـٟ اٌّؾبػشاد اٌزٕش١ط١خ اٌخبطخ ثمبئّخ الأدٚ٠خ الأعبع١خ: .85
  لا  أؽ١بٔب    ٔعُ 
 خ الأدٚ٠خ الأعبع١خ ثبٌّغزشفٝ:رمَٛ إداسح اٌّغزشفٝ ثّشاععزه ـٟ ؽبي عذَ اٌزضاِه ثمبئّ .95
  لا  أؽ١بٔب    دائّب   
رمَٛ إداسح اٌّغزشفٝ ثبرخبر اعشاء أ٠ب  وبْ ٔٛعٗ ٌّٓ ٠خبٌفْٛ ثشىً رٍمبئٟ اٚ ِزعّذ لأطٕبؾ لبئّخ الأدٚ٠خ  .12
 الأعبع١خ:
  لا أعشؾ  لا  ٔعُ 
 ٝ خلاي عٍّه ثبٌّغزشفٝ:رمَٛ ثئثلاغ ط١ذٌ١خ اٌّغزشفٝ ثمبئّخ الأدٚ٠خ الأعبع١خ اٌزٟ رؾزبعٙب ٌعلاط اٌّشػ .52
  لا أثٍػ أؽذا    أؽ١بٔب     دائّب    
 ):72٠ٛعذ ـٟ اٌعًّ ثشٚرٛوٛلاد علاع١خ ِعزّذح ِٚىزٛثخ: (إرا وبٔذ اعبثزه ثلا اٚ لا أعشؾ أزمً ٌٍغؤاي  .22
 لا أعشؾ  لا  ٔعُ  
 
 ؽذد ِىبْ ٚعٛد اٌجشٚرٛوٛلاد اٌعلاع١خ اْ ٚعذد: .32
 ـٟ اٌظ١ذٌ١خ  ـٟ اٌمغُ         ـٟ ِىزجخ اٌّغزشفٝ                   
   .....ؽذد: ........... /أخشٜ  لا أعشؾ 
 ِظذس اٌجشٚرٛوٛلاد اٌعلاع١خ: .42
ٌغٕخ اٌظ١ذٌخ   ِذ٠ش اٌّغزشفٝ           
 ع١بد        لاٚاٌع
وزت ِٚشاعع  
 عٍّ١خ           
 لا أعشؾ 
 
 بٌّغزشفٝ:اٌخبطخ ث رٕغغُ اٌجشٚرٛوٛلاد اٌعلاع١خ ِع لبئّخ الأدٚ٠خ الأعبع١خ .52
  لا  أؽ١بٔب    دائّب   
 رظٍه اٌجشٚرٛوٛلاد ثزعّ١ّبد ِىزٛثخ ِٓ إداسح اٌّغزشفٝ ٌؾضه عٍٝ الاٌزضاَ ثٙب: .62
  لا  أؽ١بٔب    ٔعُ 
 ـٟ ؽبي وٕذ ثؾبعخ ٌّعٍِٛبد دٚائ١خ ِغزعغٍخ رخض اٌذٚاء رمَٛ ثبلاعزعبٔخ ثـــ: .72
 ) )tenretnIأزشٔذ  ط١ذٌٟ ِٕذٚة دعب٠خ  ط١ذٌٟ ِٓ اٌّغزشفٝ 
  ؽذد:............ /أخشٜ  صِ١ً أ ِٓ ِشعع عٍّٟ               الش 
 رٍعت سؼجخ اٌّش٠غ دٚسا ٌـٟ ٚطؿ اٌعلاط اٌلاصَ: .82
  لا  أؽ١بٔب    دائّب   
 
  تيا يذى تؤٍَذك نًا ورد فٌ انعباراث انتانَ
 
 انعبـــــــــــــــــــــــــــــــــارة
 
 
غَر 
يوافق 
 بشذة
  
غَر  
 يوافق
 
 لا أدرً
 ذيحاٍ/
 
 يوافق
 
يوافق 
 بشذة
 راد طؾ١خ خذِخ ٌزمذ٠ُ ػشٚسٞ الأعبع١خ الأدٚ٠خ لبئّخ ٚعٛد .92
 عبٌ١خ. عٛدح
     
 اٌّبٌ١خ اٌّٛاسد ٘ذس ِٓ ٠مًٍ الأعبع١خ الأدٚ٠خ لبئّخ ٚعٛد .13
 ٌلأدٚ٠خ. اٌّخظظخ
     
 ٠ظ١ت لذ اٌزٞ اٌؼشس ِٓ ٠مًٍ الأعبع١خ الأدٚ٠خ لبئّخ ٚعٛد .53
 اٌّش٠غ.
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غَر 
يوافق 
 بشذة
  
غَر  
 يوافق
 
 لا أدرً
 ذيحاٍ/
 
 يوافق
 
يوافق 
 بشذة
 ِعب٠١ش الأعبع١خ الأدٚ٠خ لبئّخ ػّٓ الأطٕبؾ اخز١بس ِعب٠١ش .23
 ٚطؾ١ؾخ. عٍّ١خ
     
 ٌٛطؿ اٌلاصِخ الاؽز١بعبد أؼٍت رٍجٟ الأعبع١خ الأدٚ٠خ لبئّخ .33
 اٌزٞ ٠ؾزبعٗ اٌّش٠غ. اٌعلاط
     
ـٟ ؽبي ٚعٛد ثشٚرٛوٛي علاعٟ ثبٌّغزشفٝ، ـئْ الأدٚ٠خ  .43
 اٌّزوٛسح ثٗ ِٕبعجخ.
     
      ٌٟ خلاي اٌعًّ. اٌجشٚرٛوٛلاد اٌعلاع١خ ٍِضِخ .53
الاٌزضاَ ثبٌجشٚرٛوٛلاد اٌعلاع١خ اٌّعزّذح ثبٌّغزشفٝ ٠مًٍ ِٓ  .63
 اٌزىٍفخ اٌّبٌ١خ ٌٍخذِخ.
     
الأدٚ٠خ اٌّٛعٛدح ـٟ اٌجشٚرٛوٛلاد اٌعلاع١خ ألً ـبعٍ١خ ِٓ  .73
 الأدٚ٠خ الأخشٜ.
     
٠ٛعذ ـٟ اٌّغزشفٝ ٔظبَ رذل١ك ِٚشالجخ ٌّعشـخ ِذٜ اٌزضاَ  .83
 طٕبؾ لبئّخ الأدٚ٠خ الأعبع١خ.اٌطج١ت ثٛطؿ أ
     
٠ٛعذ ـٟ اٌّغزشفٝ ٔظبَ ِزبثعخ ٚرذل١ك ٌّعشـخ ِذٜ اٌزضاَ  .93
 اٌطج١ت ثبٌجشٚرٛوٛلاد اٌعلاع١خ.
     
      ٔظبَ اٌّزبثعخ ٚاٌزذل١ك ـٟ اٌّغزشفٝ ـعبي ٚرٚ وفبءح. .14
اٌزضاِه ثٛطؿ الأدٚ٠خ ؽغت اٌجشٚرٛوٛلاد اٌعلاع١خ ٠ؤصش  .54
 عٍٝ اٌزم١١ُ اٌغٕٛٞ لأدائه اٌٛظ١فٟ.
     
٠ٛعذ ثبٌّغزشفٝ ِؤششاد ٌم١بط ِذٜ اٌزضاَ الأؽجبء  .24
 ثبٌجشٚرٛوٛلاد اٌعلاع١خ.
     
رمَٛ ثششػ و١ف١خ أخز اٌذٚاء ٌٍّش٠غ ٚروش اٌزؾز٠شاد  .34
 ٚاٌزٕج١ٙبد اٌلاصِخ.
     
      أدٚ٠خ ِٓ لبئّخ الأدٚ٠خ الأعبع١خ ٌٍّغزشفٝ.رٍزضَ ثٛطؿ  .44
ثؽغ إٌظش اٌجشٚرٛوٛلاد اٌعلاع١خ اٌّمشح ثبٌّغزشفٝ اعزخذَ  .54
 .أؽذس اٌجشٚرٛوٛلاد اٌعلاع١خعٓ 
     
٠عزّذ ٚطفٟ ٌٍعلاط عٍٝ الأدٚ٠خ اٌّزٛـشح ـٟ ط١ذٌ١خ  .64
 اٌّغزشفٝ.
     
 ارٛاطً ثشىً شخظٟ ٚدائُ ِع ط١ذٌٟ اٌّغزشفٝ ٌّعشـخ ِب .74
 ٟ٘ الادٚ٠خ اٌّزٛـشح ـٟ ط١ذٌ١خ اٌّغزشفٝ.
     
رمَٛ إداسح اٌّغزشفٝ ثؾضٟ عٍٝ ٚطؿ ثعغ اٌعلاعبد ؼ١ش  .84
 اٌلاصِخ ثؽشع طشـٙب لجً أزٙبء ِٛعذ٘ب.
     
رمَٛ إداسح اٌّغزشفٝ ثزضٚ٠ذٔب ثشىً دٚسٞ ثمبئّخ الادٚ٠خ  .94
 اٌّزٛـشح ثظ١ذٌ١خ اٌّغزشفٝ.
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Annex (12): Experts and professional consulted 
1. Dr. Bassam Abu Hamad, Al Quds University  
2. Dr. Yehia Abed, Al Quds University  
3. Dr. Khitam Abu Hamad, Al Quds University 
4. Dr.Adnan AlWhaidi Pediatrics specialist 
5. Dr.Hala Al Agha; AlAzhar University 
6. Dr.Mahmoud Taleb; Al-Azhar University 
7. Dr.Ihab AlMasri; Al-Azhar University 
8. Dr.Naser Abu Jaser.UNRWA 
9. Dr.Jahad Matar; Al-Quds Open University 
10. Dr.Nancy Nashwan; Al-Quds Open University 
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Annex (13) describes the actual sample distribution and data collection plan 
 
Area 
Total 
sample 
(3600) 
# of 
NGHs 
Sample distribution 
Month 1 Month 2 Month 3 Month 4 
1-
10 
11-
20 
21-
30 
1-
10 
11-
20 
21-
30 
1-
10 
11-
20 
21-
30 
1-
10 
11-
20 
21-
30 
North 360 1             
Gaza 1800 5             
Middle 
Area 
360 1             
Khan-
Younis 
720 2             
Rafah 360 1             
Total 3600 10 
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 cibarA ni tcartsbA
لمنلو ا اليوحي  ايور الحفنميو   و  مح   و ا مو ا اتسوت  ام الرلوي  لف نيو   و  اتقيويم العنونان  
 .ازة
 .إعداد الباحثة/ حنين محمد طه
  ./ د. شيرين أيوبإشراف
 مل ص 
يعتبر الاستخدام غير الرشيد للأدوية بمثابة المصدر الرئيسي لإهددار المدوارد  دي الم داص الصدحي حيدث شد عت من مدة 
النفقدات  إ مدالي% مدن 5والتدي يمندن مدن خالتدا تدو ير دواء لدل لمناسدبالصحة العالمية البلدان علد  تع يدي الاسدتخدام ا
 .للدوصالصحية 
نما ، معر ة مدى اتباع الأطباء للمعايير التي وضعتتا من مة الصحة العالمية نمؤشرات لصرف الدواءلهد ت الدراسة 
 ي المستشفيات طباء العاملين لتقييم مدى معر ة الأ وتقيم الممارسات المتعلقة بالوصف الدوائي تقييم إل هد ت الدراسة 
 .الأساسية الأدويةوممارساتتم المتعلقة بقائمة  غير الحنومية
أدوات أولتدا اسدتبانة يدتم تعبئتتدا بواسدطة  ثاثدةالدراسة عبارة عن دراسة وصفية تحليلية شملت البيانات النمية باسدتخدام 
عليتدا مدن  متفد نمداجج  إلد بالإضدا ة  الأساسدية الأدويدةة وممارسداتتم المتعلقدة بقائمد الأطبداءلتقييم مدى معر ة  الأطباء
 دددي  قبدددص من مدددة الصدددحة العالميدددة لقيددداد مؤشدددرات صدددرف الددددواء تخدددتص بتددددوين الأدويدددة التدددي قدددام بوصدددفتا الأطبددداء
 إلد الرئيسدية المقترحدة اسدتنادا   قائمدة بالأدويدةتدم وضد  خيدرًا أو  .الوصفات الطبية وممارسداتتم المتعلقدة بالوصدف الددوائي
تدم  .دوية الطوارئ  ي مستشفيات ويارة الصحة والمتضمنة للأدوية الرئيسية المقترحدة مدن من مدة الصدحة العالميدةأقائمة 
 199 ،وموصددفة خدروج مددريو مندد 191، وصدفة لمددريو مندوم 0111. اسددتبانة جاتيدة التعبئددة مدن الأطبدداء 191 مد  
 )SSPSالاعزّبع١ةخ (دام برندام  الحيمدة الإحصدائية للعلدوم تم تحليص البيانات باسدتخ ة.وصفة لمريو من عيادة خار ي
حيددث أ ريددت التو يعددات والتددرددات والنسددب المئويددة وال ددداوص نمددا حسددبت النسددب المئويددة المتوسددطة والعامددة و دددداوص 
 العاقات بين المتغيرات. لإي اد tset erauqs ihCٚ   avonA yaw enOالمتقاطعة وتم استخدام
غلبيددة أاتفدد  حيددث الأساسددية و ائدددتتا  الأدويدةهنددام موقددف إي دابي لدددى الأطبدداء حددوص قائمددة ن أسددة  تدرت نتددائ  الدراأ
للحد مدن هددر ونجلم دوية الأساسية لتقديم خدمة صحية عادلة، جات  ودة، الأ أهمية قائمةالمشارنين  ي الدراسة عل  
دويددة دويددة المدر ددة  ددي قائمددة الأاختيددار الأ نأحددد مددن حدددوث ضددرر للمددريو، وا معددوا علدد  حقيقددة الالمددوارد الماليددة، و 
بأدويددة القائمددة الأساسددية عنددد نتابددة حددوص التدديامتم  إي ددابيولنددن نددان هنددام موقددف الأساسددية يددتم علدد  أسددد علميددة، 
وقددد نتددم ليسددوا علدد  تواصددص مد  صدديادلة المستشددف  بشددنص صددحي . أ مدد  غالبيددة المشددارنين  الدراسدة أنمددا  .الوصدفات
ن ال تددود المبجولددة مددن قبددص إدارة المستشددف  غيددر نا يددة  ددي أالدراسددة بددي  ماعددًا مددن قبددص المشددارنين  ددإأ تددرت النتددائ  
تددددو ير إدارة المستشددددفيات  ددددي إهمدددداص ونددددجلم دويددددة الأساسددددية لالتدددديام بوصددددف أدويددددة قائمددددة الأعلدددد  اتشدددد ي  الأطبدددداء 
 بروتونولات عا ية.
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دواء  دي  )5.2( بلغدت معددصللمرضد   الوصدفات الطبيدةف  دي التدي توصد الأدويدةمتوسدط عددد  أننما أ ترت الدراسة 
المضادات الحيوية بنسبة  تليتا )%9.83(نما بلغت نسبة وصف نص من المسننات بمختلف أنواعتا  وصفة طبية.نص 
 . وبلغددت نسددبة الوصددفات المحتويددة علدد  مضدداد حيددوي ددي الدراسددة مددن الم مددوع النلددي للأدويددة الموصددو ة )%9.33(
الموصددو ة بالاسددم العلمددي  الأدويددة، بلغددت نسددبة )%2.03(ومددا يقددارب ثلددث الوصددفات تحتددوي علدد  حقددن  ،)%9.76(
مددن  )%7.88(الأساسددية الخاصددة بالمستشددف   الأدويددةالموصددو ة والمتوا قددة مدد  قائمددة  الأدويددة، بلغددت نسددبة )%3.3(
اقص مدن نصدف م مدوع أسدعار أن و ، )$9.01(بلغ متوسط سعر الوصفة الطبية  نما الم موع النلي للأدوية الموصو ة.
 يما يتعل  بمتارات نتابدة الوصدفات الطبيدة، أ تدر الأطبداء  من ناحية أخرى؛ الدواء تم صر ه عل  المضادات الحيوية.
المريو الخاصة بدمعلومات لنتابة المعلومات الخاصة بالطبيب  ي الوصفة الطبية أما بالنسبة ليخص   يماالتيامًا  يدا  
 الأدويددةنسددبة  قددد تراوحددت  الآخددرعلدد  ال انددب التدديام بنتابتتددا  ددي الوصددفات الطبيددة.  عدددم  قددد  تددروالوصددف الدددوائي 
 .)001%(إل   )8.07%( من دوية الرئيسيةالمتو رة من قائمة الأ
ن هندام حا دة ملحدة لتدو ير قائمدة أدويدة أساسدية وبروتوندولات عا يدة  دي ندص مستشدف  والعمدص أ إلد خلصدت الدراسدة 
الأساسدية والبروتوندولات العا يدة للندوادر الطبيدة،  الأدويدةقائمدة التعريدف بنام  تددريبي مسدتمر بخصدوص عل  تنفيج بر 
دويدة الأساسدية، تفعيدص ن دام المتابعدة والن دام المحوسدب مدن قبدص إدارة المستشدف  لقائمدة الأ وا  لنترونيدةلتو ي  نسخ ورقية 
ماسة لإ دراء الم يدد مدن الأبحداث النميدة والنيفيدة حدوص الا ة حنما ت تر ال .لدى الأطباء الأدويةلتحسين أنماط صرف 
 .عل  حد سواء المؤشرات الخاصة برعاية المريو  ي المنشآت الحنومية والخاصة  ي قطاع غية
 
 
 
